EurekaMag PDF full texts Chapter 55,634

Khan, R.S.; Fonseca-Kelly, Z.; Callinan, C.; Zuo, L.; Sachdeva, M.M.; Shindler, K.S. 2012: SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Frontiers in Cellular Neuroscience 6: 63

Khan, R.S.; Dine, K.; Das Sarma, J.; Shindler, K.S. 2014: SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathologica Communications 2: 3

Li, L.; Osdal, T.; Ho, Y.; Chun, S.; McDonald, T.; Agarwal, P.; Lin, A.; Chu, S.; Qi, J.; Li, L.; Hsieh, Y.-T.; Dos Santos, C.; Yuan, H.; Ha, T.-Q.; Popa, M.; Hovland, R.; Bruserud, Øy.; Gjertsen, B.ør.T.; Kuo, Y.-H.; Chen, W.; Lain, S.; McCormack, E.; Bhatia, R. 2014: SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell 15(4): 431-446

Yang, Y.; Duan, W.; Lin, Y.; Yi, W.; Liang, Z.; Yan, J.; Wang, N.; Deng, C.; Zhang, S.; Li, Y.; Chen, W.; Yu, S.; Yi, D.; Jin, Z. 2013: SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radical Biology and Medicine 65: 667-679

Shin, S.Y.; Kim, T.H.; Wu, H.; Choi, Y.H.; Kim, S.G. 2014: SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis. European Journal of Pharmacology 727: 115-124

Dai, H.; Kustigian, L.; Carney, D.; Case, A.; Considine, T.; Hubbard, B.P.; Perni, R.B.; Riera, T.V.; Szczepankiewicz, B.; Vlasuk, G.P.; Stein, R.L. 2010: SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. Journal of Biological Chemistry 285(43): 32695-32703

Zhou, X.-L.; Xu, J.-J.; Ni, Y.-H.; Chen, X.-C.; Zhang, H.-X.; Zhang, X.-M.; Liu, W.-J.; Luo, L.-L.; Fu, Y.-C. 2014: SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling. Journal of Ovarian Research 7: 97

Yang, H.; Zhang, W.; Pan, H.; Feldser, H.G.; Lainez, E.; Miller, C.; Leung, S.; Zhong, Z.; Zhao, H.; Sweitzer, S.; Considine, T.; Riera, T.; Suri, V.; White, B.; Ellis, J.L.; Vlasuk, G.P.; Loh, C. 2012: SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. Plos one 7(9): E46364

Kugel, S.; Mostoslavsky, R. 2013: SIRT1 activators: the evidence STACks up. Aging 5(3): 142-143

Li, L.; Zhang, H.-N.; Chen, H.-Z.; Gao, P.; Zhu, L.-H.; Li, H.-L.; Lv, X.; Zhang, Q.-J.; Zhang, R.; Wang, Z.; She, Z.-G.; Zhang, R.; Wei, Y.-S.; Du, G.-H.; Liu, D.-P.; Liang, C.-C. 2011: SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circulation Research 108(10): 1180-1189

Narala, S.R.; Allsopp, R.C.; Wells, T.B.; Zhang, G.; Prasad, P.; Coussens, M.J.; Rossi, D.J.; Weissman, I.L.; Vaziri, H. 2008: SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity. Molecular Biology of the Cell 19(3): 1210-1219

Chen, H.; Liu, X.; Zhu, W.; Chen, H.; Hu, X.; Jiang, Z.; Xu, Y.; Wang, L.; Zhou, Y.; Chen, P.; Zhang, N.; Hu, D.; Zhang, L.; Wang, Y.; Xu, Q.; Wu, R.; Yu, H.; Wang, J.'a. 2014: SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin. Frontiers in Aging Neuroscience 6: 103

Wang, Y.; Liang, Y.; Vanhoutte, P.M. 2011: SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. Febs Letters 585(7): 986-994

Shin, D.H.; Choi, Y.-J.; Park, J.-W. 2014: SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin. Cancer Research 74(1): 298-308

Yao, Q.-P.; Qi, Y.-X.; Zhang, P.; Cheng, B.-B.; Yan, Z.-Q.; Jiang, Z.-L. 2013: SIRT1 and Connexin40 Mediate the normal shear stress-induced inhibition of the proliferation of endothelial cells co-cultured with vascular smooth muscle cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 31(2-3): 389-399

Rehan, L.; Laszki-Szcząchor, K.; Sobieszczańska, M.łg.; Polak-Jonkisz, D. 2014: SIRT1 and NAD as regulators of ageing. Life Sciences 105(1-2): 1-6

Donmez, G.; Outeiro, T.F. 2013: SIRT1 and SIRT2: emerging targets in neurodegeneration. Embo Molecular Medicine 5(3): 344-352

Hirschey, M.D.; Shimazu, T.; Capra, J.A.; Pollard, K.S.; Verdin, E. 2011: SIRT1 and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2. Aging 3(6): 635-642

Geng, Y.-Q.; Li, T.-T.; Liu, X.-Y.; Li, Z.-H.; Fu, Y.-C. 2011: SIRT1 and SIRT5 activity expression and behavioral responses to calorie restriction. Journal of Cellular Biochemistry 112(12): 3755-3761

Jang, K.Y.; Noh, S.J.; Lehwald, N.; Tao, G.-Z.; Bellovin, D.I.; Park, H.S.; Moon, W.S.; Felsher, D.W.; Sylvester, K.G. 2012: SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas. Plos one 7(9): E45119

Imai, S.-i. 2009: SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty. Current Opinion in Clinical Nutrition and Metabolic Care 12(4): 350-356

Tang, B.L.; Chua, C.E.L. 2008: SIRT1 and neuronal diseases. Molecular Aspects of Medicine 29(3): 187-200

Chang, H.-C.; Guarente, L. 2014: SIRT1 and other sirtuins in metabolism. Trends in Endocrinology and Metabolism: Tem 25(3): 138-145

Yi, J.; Luo, J. 2010: SIRT1 and p53, effect on cancer, senescence and beyond. Biochimica et Biophysica Acta 1804(8): 1684-1689

Pazienza, V.; Piepoli, A.; Panza, A.; Valvano, M.R.; Benegiamo, G.; Vinciguerra, M.; Andriulli, A.; Mazzoccoli, G. 2012: SIRT1 and the clock gene machinery in colorectal cancer. Cancer Investigation 30(2): 98-105

Colak, Y.; Ozturk, O.; Senates, E.; Tuncer, I.; Yorulmaz, E.; Adali, G.; Doganay, L.; Enc, F.Y. 2011: SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(5): Hy5-Hy9

Bae, J.U.; Lee, S.J.; Seo, K.W.; Kim, Y.H.; Park, S.Y.; Bae, S.S.; Kim, C.D. 2013: SIRT1 attenuates neointima formation by inhibiting HIF-1α expression in neointimal lesion of a murine wire-injured femoral artery. International Journal of Cardiology 168(4): 4393-4396

Jung, T.W.; Lee, K.-T.; Lee, M.W.; Ka, K.-H. 2012: SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. Biochemical and Biophysical Research Communications 422(2): 229-232

Mercken, E.M.; Hu, J.; Krzysik-Walker, S.; Wei, M.; Li, Y.; McBurney, M.W.; de Cabo, R.; Longo, V.D. 2014: SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice. Aging Cell 13(1): 193-196

Clark-Knowles, K.V.; Dewar-Darch, D.; Jardine, K.E.; McBurney, M.W. 2013: SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer. Plos one 8(11): E82106

Cao, C.; Lu, S.; Kivlin, R.; Wallin, B.; Card, E.; Bagdasarian, A.; Tamakloe, T.; Wang, W.-j.; Song, X.; Chu, W.-m.; Kouttab, N.; Xu, A.; Wan, Y. 2009: SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. Journal of Cellular and Molecular Medicine 13(9b): 3632-3643

Pan, M.; Yuan, H.; Brent, M.; Ding, E.C.; Marmorstein, R. 2012: SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. Journal of Biological Chemistry 287(4): 2468-2476

Liang, X-Jie.; Finkel, T.; Shen, D-Wu.; Yin, J-Jie.; Aszalos, A.; Gottesman, M.M. 2008: SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism. Molecular Cancer Research: Mcr 6(9): 1499-1506

Palacios, J.A.; Herranz, D.; De Bonis, M.Luigia.; Velasco, S.; Serrano, M.; Blasco, M.A. 2010: SIRT1 contributes to telomere maintenance and augments global homologous recombination. Journal of Cell Biology 191(7): 1299-1313

Jung-Hynes, B.; Ahmad, N. 2009: SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 23(9): 2803-2809

García-Rodríguez, J.L.; Barbier-Torres, L.ía.; Fernández-Álvarez, S.; Gutiérrez-de Juan, V.; Monte, M.ía.J.; Halilbasic, E.; Herranz, D.; Álvarez, L.; Aspichueta, P.; Marín, J.J.G.; Trauner, M.; Mato, J.M.; Serrano, M.; Beraza, N.; Martínez-Chantar, M.ía.L. 2014: SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology 59(5): 1972-1983

Amat, R.; Planavila, A.; Chen, S.L.; Iglesias, R.; Giralt, M.; Villarroya, F. 2009: SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. Journal of Biological Chemistry 284(33): 21872-21880

Monteiro, J.P.; Cano, M.I.N. 2011: SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview. Protein and Peptide Letters 18(2): 167-173

Ramadori, G.; Fujikawa, T.; Fukuda, M.; Anderson, J.; Morgan, D.A.; Mostoslavsky, R.; Stuart, R.C.; Perello, M.; Vianna, C.R.; Nillni, E.A.; Rahmouni, K.; Coppari, R. 2010: SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metabolism 12(1): 78-87

Ramadori, G.; Fujikawa, T.; Anderson, J.; Berglund, E.D.; Frazao, R.; Michán, S.; Vianna, C.R.; Sinclair, D.A.; Elias, C.F.; Coppari, R. 2011: SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metabolism 14(3): 301-312

Wilking, M.J.; Singh, C.; Nihal, M.; Zhong, W.; Ahmad, N. 2014: SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation. Archives of Biochemistry and Biophysics 563: 94-100

Yamamori, T.; DeRicco, J.; Naqvi, A.; Hoffman, T.A.; Mattagajasingh, I.; Kasuno, K.; Jung, S.-B.; Kim, C.-S.; Irani, K. 2010: SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic Acids Research 38(3): 832-845

Wang, R.-H.; Xu, X.; Kim, H.-S.; Xiao, Z.; Deng, C.-X. 2013: SIRT1 deacetylates FOXA2 and is critical for Pdx1 transcription and β-cell formation. International Journal of Biological Sciences 9(9): 934-946

Xue, Z.; Lv, X.; Song, W.; Wang, X.; Zhao, G.-N.; Wang, W.-T.; Xiong, J.; Mao, B.-B.; Yu, W.; Yang, B.; Wu, J.; Zhou, L.-Q.; Hao, D.-L.; Dong, W.-J.; Liu, D.-P.; Liang, C.-C. 2012: SIRT1 deacetylates SATB1 to facilitate MAR HS2-MAR ε interaction and promote ε-globin expression. Nucleic Acids Research 40(11): 4804-4815

Ponugoti, B.; Kim, D.-H.; Xiao, Z.; Smith, Z.; Miao, J.; Zang, M.; Wu, S.-Y.; Chiang, C.-M.; Veenstra, T.D.; Kemper, J.K. 2010: SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. Journal of Biological Chemistry 285(44): 33959-33970

Stein, S.; Lohmann, C.; Schäfer, N.; Hofmann, J.; Rohrer, L.; Besler, C.; Rothgiesser, K.M.; Becher, B.; Hottiger, M.O.; Borén, J.; McBurney, M.W.; Landmesser, U.; Lüscher, T.F.; Matter, C.M. 2010: SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. European Heart Journal 31(18): 2301-2309

Park, G.; Jeong, J.-W.; Kim, J.-E. 2011: SIRT1 deficiency attenuates MPP+-induced apoptosis in dopaminergic cells. Febs Letters 585(1): 219-224

Ou, X.; Chae, H.-D.; Wang, R.-H.; Shelley, W.C.; Cooper, S.; Taylor, T.; Kim, Y.-J.; Deng, C.-X.; Yoder, M.C.; Broxmeyer, H.E. 2011: SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood 117(2): 440-450

Chae, H.-D.; Broxmeyer, H.E. 2011: SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. Stem Cells and Development 20(7): 1277-1285

Yoon, D.S.; Choi, Y.; Jang, Y.; Lee, M.; Choi, W.J.; Kim, S.-H.; Lee, J.W. 2014: SIRT1 directly regulates SOX2 to maintain self-renewal and multipotency in bone marrow-derived mesenchymal stem cells. Stem Cells 32(12): 3219-3231

Yoshizaki, T.; Milne, J.C.; Imamura, T.; Schenk, S.; Sonoda, N.; Babendure, J.L.; Lu, J.-C.; Smith, J.J.; Jirousek, M.R.; Olefsky, J.M. 2009: SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Molecular and Cellular Biology 29(5): 1363-1374

Chen, Y.; Xie, Y.; Wang, H.; Chen, Y. 2013: SIRT1 expression and activity are up-regulated in the brain tissue of epileptic patients and rat models. Nan Fang Yi Ke da Xue Xue Bao 33(4): 528-532

Xiong, H.; Dai, M.; Ou, Y.; Pang, J.; Yang, H.; Huang, Q.; Chen, S.; Zhang, Z.; Xu, Y.; Cai, Y.; Liang, M.; Zhang, X.; Lai, L.; Zheng, Y. 2014: SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss. Experimental Gerontology 51: 8-14

Noguchi, A.; Kikuchi, K.; Zheng, H.; Takahashi, H.; Miyagi, Y.; Aoki, I.; Takano, Y. 2014: SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer. Cancer Medicine 3(6): 1553-1561

Jang, K.Y.; Hwang, S.H.; Kwon, K.S.; Kim, K.R.; Choi, H.N.; Lee, N.-R.; Kwak, J.-Y.; Park, B.-H.; Park, H.S.; Chung, M.J.; Kang, M.J.; Lee, D.G.; Kim, H.S.; Shim, H.; Moon, W.S. 2008: SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. American Journal of Surgical Pathology 32(10): 1523-1531

Zhang, T.; Rong, N.; Chen, J.; Zou, C.; Jing, H.; Zhu, X.; Zhang, W. 2013: SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC. Plos one 8(11): E79162

Antoniali, G.; Lirussi, L.; D'Ambrosio, C.; Dal Piaz, F.; Vascotto, C.; Casarano, E.; Marasco, D.; Scaloni, A.; Fogolari, F.; Tell, G. 2014: SIRT1 gene expression upon genotoxic damage is regulated by APE1 through nCaRE-promoter elements. Molecular Biology of the Cell 25(4): 532-547

Kishi, T.; Yoshimura, R.; Kitajima, T.; Okochi, T.; Okumura, T.; Tsunoka, T.; Yamanouchi, Y.; Kinoshita, Y.; Kawashima, K.; Fukuo, Y.; Naitoh, H.; Umene-Nakano, W.; Inada, T.; Nakamura, J.; Ozaki, N.; Iwata, N. 2010: SIRT1 gene is associated with major depressive disorder in the Japanese population. Journal of Affective Disorders 126(1-2): 167-173

Kilic, U.; Gok, O.; Bacaksiz, A.; Izmirli, M.; Elibol-Can, B.; Uysal, O. 2014: SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. Plos one 9(2): E90428

Kilic, U.; Gok, O.; Elibol-Can, B.; Ozgen, I.T.; Erenberk, U.; Uysal, O.; Dundaroz, M.R. 2015: SIRT1 gene variants are related to risk of childhood obesity. European Journal of Pediatrics 174(4): 473-479

Kuningas, M.; Putters, M.ël.; Westendorp, R.G.J.; Slagboom, P.E.; van Heemst, D. 2007: SIRT1 gene, age-related diseases, and mortality: the Leiden 85-plus study. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 62(9): 960-965

Kishi, T.; Fukuo, Y.; Kitajima, T.; Okochi, T.; Yamanouchi, Y.; Kinoshita, Y.; Kawashima, K.; Inada, T.; Kunugi, H.; Kato, T.; Yoshikawa, T.; Ujike, H.; Ozaki, N.; Iwata, N. 2011: SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. Genes Brain and Behavior 10(3): 257-263

Weyrich, P.; Machicao, F.; Reinhardt, J.; Machann, J.ür.; Schick, F.; Tschritter, O.; Stefan, N.; Fritsche, A.; Häring, H.-U. 2008: SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention--the TULIP Study. Bmc Medical Genetics 9: 100

Zillikens, M.C.; van Meurs, J.B.J.; Sijbrands, E.J.G.; Rivadeneira, F.; Dehghan, A.; van Leeuwen, J.P.T.M.; Hofman, A.; van Duijn, C.M.; Witteman, J.C.M.; Uitterlinden, A.é G.; Pols, H.A.P. 2009: SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin. Free Radical Biology and Medicine 46(6): 836-841

Zillikens, M.Carola.; van Meurs, J.B.J.; Rivadeneira, F.; Amin, N.; Hofman, A.; Oostra, B.A.; Sijbrands, E.J.G.; Witteman, J.C.M.; Pols, H.A.P.; van Duijn, C.M.; Uitterlinden, Aé.G. 2009: SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 58(12): 2828-2834

Kitada, M.; Koya, D. 2013: SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes and Metabolism Journal 37(5): 315-325

Luo, X.-Y.; Qu, S.-L.; Tang, Z.-H.; Zhang, Y.; Liu, M.-H.; Peng, J.; Tang, H.; Yu, K.-L.; Zhang, C.; Ren, Z.; Jiang, Z.-S. 2014: SIRT1 in cardiovascular aging. Clinica Chimica Acta; International Journal of Clinical Chemistry 437: 106-114

Herskovits, A.Z.; Guarente, L. 2014: SIRT1 in neurodevelopment and brain senescence. Neuron 81(3): 471-483

Zhu, L.; Chiao, C.Y.; Enzer, K.G.; Stankiewicz, A.J.; Faller, D.V.; Dai, Y. 2015: SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27. Molecular Cancer Research: Mcr 13(1): 41-49

Botti, C.; Chiara, B.; Caiafa, I.; Ilaria, C.; Coppola, A.; Antonietta, C.; Cuomo, F.; Francesca, C.; Miceli, M.; Marco, M.; Altucci, L.; Lucia, A.; Cobellis, G.; Gilda, C. 2014: SIRT1 inhibition affects angiogenic properties of human MSCs. Biomed Research International 2014: 783459

Cheng, Y.; Cai, L.; Jiang, P.; Wang, J.; Gao, C.; Feng, H.; Wang, C.; Pan, H.; Yang, Y. 2013: SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. European Journal of Pharmacology 715(1-3): 219-229

Zhou, X.-M.; Zhang, X.; Zhang, X.-S.; Zhuang, Z.; Li, W.; Sun, Q.; Li, T.; Wang, C.-X.; Zhu, L.; Shi, J.-X.; Zhou, M.-L. 2014: SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage. Journal of Neuroscience Research 92(6): 714-722

Vachharajani, V.T.; Liu, T.; Brown, C.M.; Wang, X.; Buechler, N.L.; Wells, J.D.; Yoza, B.K.; McCall, C.E. 2014: SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. Journal of Leukocyte Biology 96(5): 785-796

Herbert, K.J.; Cook, A.L.; Snow, E.T. 2014: SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes. Toxicology and Applied Pharmacology 277(3): 288-297

Chen, X.-p.; Li, M.-h.; Cong, M.-l.; Kang, Y.-j.; Guo, W.-p.; Zhang, Y.-z. 2011: SIRT1 inhibits IL-1β mRNA transcription in lipopolysaccharide tolerant THP-1 cells. Zhonghua Liu Xing Bing Xue Za Zhi 32(6): 613-616

Wang, W.; Yan, C.; Zhang, J.; Lin, R.; Lin, Q.; Yang, L.; Ren, F.; Zhang, J.; Ji, M.; Li, Y. 2013: SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis: An International Journal on Programmed Cell Death 18(6): 689-701

Li, L.; Gao, P.; Zhang, H.; Chen, H.; Zheng, W.; Lv, X.; Xu, T.; Wei, Y.; Liu, D.; Liang, C. 2011: SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy. Acta Biochimica et Biophysica Sinica 43(2): 103-109

Yoshizaki, T.; Schenk, S.; Imamura, T.; Babendure, J.L.; Sonoda, N.; Bae, E.J.; Oh, D.Y.; Lu, M.; Milne, J.C.; Westphal, C.; Bandyopadhyay, G.; Olefsky, J.M. 2010: SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. American Journal of Physiology. Endocrinology and Metabolism 298(3): E419-E428

Cho, I.-R.; Koh, S.S.; Malilas, W.; Srisuttee, R.; Moon, J.; Choi, Y.-W.; Horio, Y.; Oh, S.; Chung, Y.-H. 2012: SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin. Biochemical and Biophysical Research Communications 423(2): 270-275

Chen, Y.-R.; Lai, Y.-L.; Lin, S.-d.; Li, X.-T.; Fu, Y.-C.; Xu, W.-C. 2013: SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats. Molecular Biology Reports 40(4): 3373-3380

McBurney, M.W.; Clark-Knowles, K.V.; Caron, A.Z.; Gray, D.A. 2013: SIRT1 is a Highly Networked Protein that Mediates the Adaptation to Chronic Physiological Stress. Genes and Cancer 4(3-4): 125-134

Suh, J.H.; Sieglaff, D.H.; Zhang, A.; Xia, X.; Cvoro, A.; Winnier, G.E.; Webb, P. 2013: SIRT1 is a direct coactivator of thyroid hormone receptor β1 with gene-specific actions. Plos one 8(7): E70097

Lappas, M.; Mitton, A.; Lim, R.; Barker, G.; Riley, C.; Permezel, M. 2011: SIRT1 is a novel regulator of key pathways of human labor. Biology of Reproduction 84(1): 167-178

Caito, S.; Rajendrasozhan, S.; Cook, S.; Chung, S.; Yao, H.; Friedman, A.E.; Brookes, P.S.; Rahman, I. 2010: SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 24(9): 3145-3159

Zhang, S.; Wang, X.I. 2013: SIRT1 is a useful biomarker for high-grade dysplasia and carcinoma in Barrett's esophagus. Annals of Clinical and Laboratory Science 43(4): 373-377

Dong, Y.; Guo, T.; Traurig, M.; Mason, C.C.; Kobes, S.; Perez, J.; Knowler, W.C.; Bogardus, C.; Hanson, R.L.; Baier, L.J. 2011: SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima Indians. Molecular Genetics and Metabolism 104(4): 661-665

Tegla, C.A.; Azimzadeh, P.; Andrian-Albescu, M.; Martin, A.; Cudrici, C.D.; Trippe, R.; Sugarman, A.; Chen, H.; Boodhoo, D.; Vlaicu, S.I.; Royal, W.; Bever, C.; Rus, V.; Rus, H. 2014: SIRT1 is decreased during relapses in patients with multiple sclerosis. Experimental and Molecular Pathology 96(2): 139-148

Wampfler, J.; Tschan, M.P.; Shan, D.; Laemmle, A.; Leibundgut, E.O.; Baerlocher, G.M.; Stroka, D.; Fey, M.F.; Britschgi, C. 2009: SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells. British Journal of Haematology 146(3): 337-341

Yang, Q.; Wang, B.; Gao, W.; Huang, S.; Liu, Z.; Li, W.; Jia, J. 2013: SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling. Molecular Cancer Research: Mcr 11(12): 1497-1507

Michán, S.; Li, Y.; Chou, M.M.-H.; Parrella, E.; Ge, H.; Long, J.M.; Allard, J.S.; Lewis, K.; Miller, M.; Xu, W.; Mervis, R.F.; Chen, J.; Guerin, K.I.; Smith, L.E.H.; McBurney, M.W.; Sinclair, D.A.; Baudry, M.; de Cabo, R.; Longo, V.D. 2010: SIRT1 is essential for normal cognitive function and synaptic plasticity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(29): 9695-9707

Elangovan, S.; Ramachandran, S.; Venkatesan, N.; Ananth, S.; Gnana-Prakasam, J.P.; Martin, P.M.; Browning, D.D.; Schoenlein, P.V.; Prasad, P.D.; Ganapathy, V.; Thangaraju, M. 2011: SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Research 71(21): 6654-6664

Han, L.; Liang, X.-H.; Chen, L.-X.; Bao, S.-M.; Yan, Z.-Q. 2013: SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. International Journal of Clinical and Experimental Pathology 6(11): 2357-2365

De Bonis, M.L.; Ortega, S.; Blasco, M.A. 2014: SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells. Stem Cell Reports 2(5): 690-706

Han, L.; Zhou, R.; Niu, J.; McNutt, M.A.; Wang, P.; Tong, T. 2010: SIRT1 is regulated by a PPAR{γ}-SIRT1 negative feedback loop associated with senescence. Nucleic acids research 38(21): 7458-7471

Price, N.L.; Gomes, A.P.; Ling, A.J.Y.; Duarte, F.V.; Martin-Montalvo, A.; North, B.J.; Agarwal, B.; Ye, L.; Ramadori, G.; Teodoro, J.S.; Hubbard, B.P.; Varela, A.T.; Davis, J.G.; Varamini, B.; Hafner, A.; Moaddel, R.; Rolo, A.P.; Coppari, R.; Palmeira, C.M.; de Cabo, R.; Baur, J.A.; Sinclair, D.A. 2012: SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metabolism 15(5): 675-690

Lee, J.-S.; Park, J.-R.; Kwon, O.-S.; Lee, T.-H.; Nakano, I.; Miyoshi, H.; Chun, K.-H.; Park, M.-J.; Lee, H.J.; Kim, S.U.; Cha, H.-J. 2015: SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner. Neuro-Oncology 17(1): 95-106

Nihal, M.; Ahmad, N.; Wood, G.S. 2014: SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle 13(4): 632-640

Liu, D.J.; Hammer, D.; Komlos, D.; Chen, K.Yu.; Firestein, B.L.; Liu, A.Y-C. 2014: SIRT1 knockdown promotes neural differentiation and attenuates the heat shock response. Journal of Cellular Physiology 229(9): 1224-1235

Xu, F.; Yan, J.-h.; Liang, H.; Xu, W.; Ye, J.-p.; Weng, J.-p. 2013: SIRT1 knockout impairs the differentiation of adipocyte in C57BL/6J mice and its underlying mechanism. Zhonghua Yi Xue Za Zhi 93(36): 2857-2860

Liu, G.; Bi, Y.; Shen, B.; Yang, H.; Zhang, Y.; Wang, X.; Liu, H.; Lu, Y.; Liao, J.; Chen, X.; Chu, Y. 2014: SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis. Cancer Research 74(3): 727-737

Salminen, A.; Kauppinen, A.; Suuronen, T.; Kaarniranta, K. 2008: SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 30(10): 939-942

Rutanen, J.; Yaluri, N.; Modi, S.; Pihlajamäki, J.; Vänttinen, M.; Itkonen, P.; Kainulainen, S.; Yamamoto, H.; Lagouge, M.; Sinclair, D.A.; Elliott, P.; Westphal, C.; Auwerx, J.; Laakso, M. 2010: SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes 59(4): 829-835

Ho, C.; van der Veer, E.; Akawi, O.; Pickering, J.G. 2009: SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced. Febs Letters 583(18): 3081-3085

Van Gent, R.; Di Sanza, C.; van den Broek, N.J.F.; Fleskens, V.; Veenstra, A.; Stout, G.J.; Brenkman, A.B. 2014: SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner. Plos one 9(5): E98438

Xu, F.; Li, Z.; Zheng, X.; Liu, H.; Liang, H.; Xu, H.; Chen, Z.; Zeng, K.; Weng, J. 2014: SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis. Diabetes 63(11): 3637-3646

Boutant, M.; Cantó, C. 2014: SIRT1 metabolic actions: Integrating recent advances from mouse models. Molecular Metabolism 3(1): 5-18

Montie, H.L.; Pestell, R.G.; Merry, D.E. 2011: SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(48): 17425-17436

Ohguchi, K.; Itoh, T.; Akao, Y.; Inoue, H.; Nozawa, Y.; Ito, M. 2010: SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts. British Journal of Dermatology 163(4): 689-694

Kim, Y.-S.; Lee, Y.-M.; Park, J.-S.; Lee, S.-K.; Kim, E.-C. 2010: SIRT1 modulates high-mobility group box 1-induced osteoclastogenic cytokines in human periodontal ligament cells. Journal of Cellular Biochemistry 111(5): 1310-1320

Herbert, K.J.; Cook, A.L.; Snow, E.T. 2014: SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes. Journal of Dermatological Science 74(2): 142-149

Blum, C.A.; Ellis, J.L.; Loh, C.; Ng, P.Y.; Perni, R.B.; Stein, R.L. 2011: SIRT1 modulation as a novel approach to the treatment of diseases of aging. Journal of Medicinal Chemistry 54(2): 417-432

Lan, F.; Cacicedo, J.M.; Ruderman, N.; Ido, Y. 2008: SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. Journal of Biological Chemistry 283(41): 27628-27635

Cao, L.; Liu, C.; Wang, F.; Wang, H. 2013: SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway. Brazilian Journal of Medical and Biological Research 46(8): 659-669

Peng, L.; Ling, H.; Yuan, Z.; Fang, B.; Bloom, G.; Fukasawa, K.; Koomen, J.; Chen, J.; Lane, W.S.; Seto, E. 2012: SIRT1 negatively regulates the activities, functions, and protein levels of hMOF and TIP60. Molecular and Cellular Biology 32(14): 2823-2836

Ghosh, H.S.; McBurney, M.; Robbins, P.D. 2010: SIRT1 negatively regulates the mammalian target of rapamycin. Plos one 5(2): E9199

Hwang, J.; Lee, S.-Y.; Choi, J.-R.; Shin, K.S.; Choi, C.Y.; Kang, S.J. 2013: SIRT1 negatively regulates the protein stability of HIPK2. Biochemical and Biophysical Research Communications 441(4): 799-804

Watanabe, S.; Ageta-Ishihara, N.; Nagatsu, S.; Takao, K.; Komine, O.; Endo, F.; Miyakawa, T.; Misawa, H.; Takahashi, R.; Kinoshita, M.; Yamanaka, K. 2014: SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system. Molecular Brain 7: 62

Huang, J.; Gan, Q.; Han, L.; Li, J.; Zhang, H.; Sun, Y.; Zhang, Z.; Tong, T. 2008: SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. Plos one 3(3): E1710

Niederer, F.; Ospelt, C.; Brentano, F.; Hottiger, M.O.; Gay, R.E.; Gay, S.; Detmar, M.; Kyburz, D. 2011: SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Annals of the Rheumatic Diseases 70(10): 1866-1873

Beane, J.; Cheng, L.; Soldi, R.; Zhang, X.; Liu, G.; Anderlind, C.; Lenburg, M.E.; Spira, A.; Bild, A.H. 2012: SIRT1 pathway dysregulation in the smoke-exposed airway epithelium and lung tumor tissue. Cancer Research 72(22): 5702-5711

Purushotham, A.; Schug, T.T.; Li, X. 2009: SIRT1 performs a balancing act on the tight-rope toward longevity. Aging 1(7): 669-673

Lau, A.W.; Liu, P.; Inuzuka, H.; Gao, D. 2014: SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation. American Journal of Cancer Research 4(3): 245-255

Figarska, S.M.; Vonk, J.M.; Boezen, H.M. 2013: SIRT1 polymorphism, long-term survival and glucose tolerance in the general population. Plos one 8(3): E58636

Ou, X.; Lee, M.R.; Huang, X.; Messina-Graham, S.; Broxmeyer, H.E. 2014: SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32(5): 1183-1194

Zeng, H-Tao.; Fu, Y-Cai.; Yu, W.; Lin, J-Ming.; Zhou, L.; Liu, L.; Wang, W. 2013: SIRT1 prevents atherosclerosis via liver‑X‑receptor and NF‑κB signaling in a U937 cell model. Molecular Medicine Reports 8(1): 23-28

Sasca, D.; Hähnel, P.S.; Szybinski, J.; Khawaja, K.; Kriege, O.; Pante, S.V.; Bullinger, L.; Strand, S.; Strand, D.; Theobald, M.; Kindler, T. 2014: SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood 124(1): 121-133

Ren, P.-L.; Fan, X.-J.; Yang, X.-L.; Liu, M.-J.; Liu, J.; Huang, J.-J. 2014: SIRT1 promote GTM cell DSBs repair and resist cellular senescence. Sichuan da Xue Xue Bao. Yi Xue Ban 45(4): 572-577

Consiglio, C.R.; Juliana da Silveira, S.; Monticielo, O.A.é; Xavier, R.M.; Brenol, J.ão.C.T.; Chies, J.é A.B. 2014: SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus. Molecular Biology Reports 41(7): 4233-4239

Marshall, G.M.; Liu, P.Y.; Gherardi, S.; Scarlett, C.J.; Bedalov, A.; Xu, N.; Iraci, N.; Valli, E.; Ling, D.; Thomas, W.; van Bekkum, M.; Sekyere, E.; Jankowski, K.; Trahair, T.; Mackenzie, K.L.; Haber, M.; Norris, M.D.; Biankin, A.V.; Perini, G.; Liu, T. 2011: SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. Plos Genetics 7(6): E1002135

Zuo, L.; Khan, R.S.; Lee, V.; Dine, K.; Wu, W.; Shindler, K.S. 2013: SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Investigative Ophthalmology and Visual Science 54(7): 5097-5102

Rajamohan, S.B.; Pillai, V.B.; Gupta, M.; Sundaresan, N.R.; Birukov, K.G.; Samant, S.; Hottiger, M.O.; Gupta, M.P. 2009: SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Molecular and Cellular Biology 29(15): 4116-4129

Lin, L.; Zheng, X.; Qiu, C.; Dongol, S.; Lv, Q.; Jiang, J.; Kong, B.; Wang, C. 2014: SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Oncology Reports 32(6): 2831-2835

Qu, Y.; Zhang, J.; Wu, S.; Li, B.; Liu, S.; Cheng, J. 2012: SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines. Neuroscience Letters 525(2): 168-172

Ohanna, M.ël.; Bonet, C.; Bille, K.; Allegra, M.; Davidson, I.; Bahadoran, P.; Lacour, J.-P.; Ballotti, R.; Bertolotto, C. 2014: SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells. Oncotarget 5(8): 2085-2095

Zu, Y.; Liu, L.; Lee, M.Y.K.; Xu, C.; Liang, Y.; Man, R.Y.; Vanhoutte, P.M.; Wang, Y. 2010: SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circulation Research 106(8): 1384-1393

Satoh, A.; Brace, C.S.; Ben-Josef, G.; West, T.; Wozniak, D.F.; Holtzman, D.M.; Herzog, E.D.; Imai, S.-i. 2010: SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(30): 10220-10232

Wang, H.; Liu, H.; Chen, K.; Xiao, J.; He, K.; Zhang, J.; Xiang, G. 2012: SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncology Reports 28(1): 311-318

Yao, H.; Sundar, I.K.; Ahmad, T.; Lerner, C.; Gerloff, J.; Friedman, A.E.; Phipps, R.P.; Sime, P.J.; McBurney, M.W.; Guarente, L.; Rahman, I. 2014: SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism. American Journal of Physiology. Lung Cellular and Molecular Physiology 306(9): L816-L828

Yao, H.; Chung, S.; Hwang, J.-w.; Rajendrasozhan, S.; Sundar, I.K.; Dean, D.A.; McBurney, M.W.; Guarente, L.; Gu, W.; Rönty, M.; Kinnula, V.L.; Rahman, I. 2012: SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. Journal of Clinical Investigation 122(6): 2032-2045

Donmez, G.; Arun, A.; Chung, C.-Y.; McLean, P.J.; Lindquist, S.; Guarente, L. 2012: SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(1): 124-132

Deppert, W. 2008: SIRT1 protein levels in cancer: tuning SIRT1 to the needs of a cancer cell. Cell Cycle 7(19): 2947-2948

Lee, D.; Goldberg, A.L. 2013: SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. Journal of Biological Chemistry 288(42): 30515-30526

Yao, H.; Hwang, J.-w.; Sundar, I.K.; Friedman, A.E.; McBurney, M.W.; Guarente, L.; Gu, W.; Kinnula, V.L.; Rahman, I. 2013: SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. American Journal of Physiology. Lung Cellular and Molecular Physiology 305(9): L615-L624

Stein, S.; Schäfer, N.; Breitenstein, A.; Besler, C.; Winnik, S.; Lohmann, C.; Heinrich, K.; Brokopp, C.E.; Handschin, C.; Landmesser, U.; Tanner, F.C.; Lüscher, T.F.; Matter, C.M. 2010: SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging 2(6): 353-360

Yang, L.; Zhang, J.; Yan, C.; Zhou, J.; Lin, R.; Lin, Q.; Wang, W.; Zhang, K.; Yang, G.; Bian, X.; Zeng, A. 2012: SIRT1 regulates CD40 expression induced by TNF-α via NF-ĸB pathway in endothelial cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 30(5): 1287-1298

Holloway, K.R.; Calhoun, T.N.; Saxena, M.; Metoyer, C.F.; Kandler, E.F.; Rivera, C.A.; Pruitt, K. 2010: SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling. Proceedings of the National Academy of Sciences of the United States of America 107(20): 9216-9221

Becatti, M.; Fiorillo, C.; Barygina, V.; Cecchi, C.; Lotti, T.; Prignano, F.; Silvestro, A.; Nassi, P.; Taddei, N.ò 2014: SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival. Journal of Cellular and Molecular Medicine 18(3): 514-529

Lin, Q.-Q.; Yan, C.-F.; Lin, R.; Zhang, J.-Y.; Wang, W.-R.; Yang, L.-N.; Zhang, K.-F. 2012: SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway. Cytokine 60(2): 447-455

Zhang, H.-S.; Wu, M.-R. 2009: SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. Virus Research 146(1-2): 51-57

Fan, W.; Luo, J. 2010: SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Molecular Cell 39(2): 247-258

Yamamoto, M.; Iguchi, G.; Fukuoka, H.; Suda, K.; Bando, H.; Takahashi, M.; Nishizawa, H.; Seino, S.; Takahashi, Y. 2013: SIRT1 regulates adaptive response of the growth hormone--insulin-like growth factor-i axis under fasting conditions in liver. Proceedings of the National Academy of Sciences of the United States of America 110(37): 14948-14953

Han, M.-K.; Song, E.-K.; Guo, Y.; Ou, X.; Mantel, C.; Broxmeyer, H.E. 2008: SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2(3): 241-251

Wang, J.; Chen, J. 2010: SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60. Journal of Biological Chemistry 285(15): 11458-11464

Codocedo, J.F.; Allard, C.; Godoy, J.A.; Varela-Nallar, L.; Inestrosa, N.C. 2012: SIRT1 regulates dendritic development in hippocampal neurons. Plos one 7(10): E47073

Simic, P.; Zainabadi, K.; Bell, E.; Sykes, D.B.; Saez, B.; Lotinun, S.; Baron, R.; Scadden, D.; Schipani, E.; Guarente, L. 2013: SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin. Embo Molecular Medicine 5(3): 430-440

Xie, M.; Liu, M.; He, C.-S. 2012: SIRT1 regulates endothelial Notch signaling in lung cancer. Plos one 7(9): E45331

Zhang, Z.Y.; Hong, D.; Nam, S.H.; Kim, J.M.; Paik, Y.H.; Joh, J.W.; Kwon, C.H.D.; Park, J.B.; Choi, G.-S.; Jang, K.Y.; Park, C.K.; Kim, S.J. 2015: SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma. Journal of Hepatology 62(1): 121-130

Arunachalam, G.; Yao, H.; Sundar, I.K.; Caito, S.; Rahman, I. 2010: SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol. Biochemical and Biophysical Research Communications 393(1): 66-72

Liu, X.; Shao, K.; Sun, T. 2013: SIRT1 regulates the human alveolar epithelial A549 cell apoptosis induced by Pseudomonas aeruginosa lipopolysaccharide. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 31(1): 92-101

Salminen, A.; Kaarniranta, K. 2009: SIRT1 regulates the ribosomal DNA locus: epigenetic candles twinkle longevity in the Christmas tree. Biochemical and Biophysical Research Communications 378(1): 6-9

Petegnief, V.ér.; Planas, A.M. 2013: SIRT1 regulation modulates stroke outcome. Translational Stroke Research 4(6): 663-671

Takayama, K.; Ishida, K.; Matsushita, T.; Fujita, N.; Hayashi, S.; Sasaki, K.; Tei, K.; Kubo, S.; Matsumoto, T.; Fujioka, H.; Kurosaka, M.; Kuroda, R. 2009: SIRT1 regulation of apoptosis of human chondrocytes. Arthritis and Rheumatism 60(9): 2731-2740

Panossian, L.; Fenik, P.; Zhu, Y.; Zhan, G.; McBurney, M.W.; Veasey, S. 2011: SIRT1 regulation of wakefulness and senescence-like phenotype in wake neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(11): 4025-4036

Moore, R.L.; Faller, D.V. 2013: SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. Journal of Endocrinology 216(3): 273-285

Di Emidio, G.; Falone, S.; Vitti, M.; D'Alessandro, A.M.; Vento, M.; Di Pietro, C.; Amicarelli, F.; Tatone, C. 2014: SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging. Human Reproduction 29(9): 2006-2017

Woo, S.R.; Park, J.-E.; Kim, Y.H.; Ju, Y.-J.; Shin, H.-J.; Joo, H.-Y.; Park, E.-R.; Hong, S.H.; Park, G.H.; Lee, K.-H. 2013: SIRT1 suppresses activating transcription factor 4 (ATF4) expression in response to proteasome inhibition. Journal of Microbiology and Biotechnology 23(12): 1785-1790

Zhang, R.; Chen, H.-Z.; Liu, J.-J.; Jia, Y.-Y.; Zhang, Z.-Q.; Yang, R.-F.; Zhang, Y.; Xu, J.; Wei, Y.-S.; Liu, D.-P.; Liang, C.-C. 2010: SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. Journal of Biological Chemistry 285(10): 7097-7110

Donmez, G.; Wang, D.; Cohen, D.E.; Guarente, L. 2010: SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142(2): 320-332

Kuo, S.-J.; Lin, H.-Y.; Chien, S.-Y.; Chen, D.-R. 2013: SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein. Oncology Reports 30(1): 125-130

Woo, S.R.; Byun, J.G.; Kim, Y.H.; Park, E.-R.; Joo, H.-Y.; Yun, M.; Shin, H.-J.; Kim, S.-H.; Shen, Y.N.; Park, J.-E.; Park, G.-H.; Lee, K.-H. 2013: SIRT1 suppresses cellular accumulation of β-TrCP E3 ligase via protein degradation. Biochemical and Biophysical Research Communications 441(4): 831-837

Fullerton, M.D.; Steinberg, G.R. 2010: SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 59(3): 551-553

Costa, C.ín.d.S.; Hammes, T.O.; Rohden, F.; Margis, R.ér.; Bortolotto, J.W.; Padoin, A.V.; Mottin, C.áu.C.; Guaragna, R.M. 2010: SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. Obesity Surgery 20(5): 633-639

Bordone, L.; Cohen, D.; Robinson, A.; Motta, M.C.; van Veen, E.; Czopik, A.; Steele, A.D.; Crowe, H.; Marmor, S.; Luo, J.; Gu, W.; Guarente, L. 2007: SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6(6): 759-767

Lynch, C.J.; Shah, Z.H.; Allison, S.J.; Ahmed, S.U.; Ford, J.; Warnock, L.J.; Li, H.; Serrano, M.; Milner, J. 2010: SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. Plos one 5(10): E13502

Zhang, W.-G.; Bai, X.-J.; Chen, X.-M. 2010: SIRT1 variants are associated with aging in a healthy Han Chinese population. Clinica Chimica Acta; International Journal of Clinical Chemistry 411(21-22): 1679-1683

Guerra, B.; Guadalupe-Grau, A.; Fuentes, T.; Ponce-González, Jús.Gustavo.; Morales-Alamo, D.; Olmedillas, H.; Guillén-Salgado, Jé.; Santana, A.; Calbet, Jé.A.L. 2010: SIRT1, AMP-activated protein kinase phosphorylation and downstream kinases in response to a single bout of sprint exercise: influence of glucose ingestion. European Journal of Applied Physiology 109(4): 731-743

Kume, S.; Uzu, T.; Kashiwagi, A.; Koya, D. 2010: SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications. Endocrine Metabolic and Immune Disorders Drug Targets 10(1): 16-24

Seo, J.-S.; Moon, M.-H.; Jeong, J.-K.; Seol, J.-W.; Lee, Y.-J.; Park, B.-H.; Park, S.-Y. 2012: SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiology of Aging 33(6): 1110-1120

Deng, C.-X. 2009: SIRT1, is it a tumor promoter or tumor suppressor?. International Journal of Biological Sciences 5(2): 147-152

Knight, J.R.P.; Milner, J. 2012: SIRT1, metabolism and cancer. Current Opinion in Oncology 24(1): 68-75

Milner, J.; Allison, S.J. 2011: SIRT1, p53 and mitotic chromosomes. Cell Cycle 10(18): 3049

Paneni, F.; Volpe, M.; Lüscher, T.F.; Cosentino, F. 2013: SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together. Diabetes 62(6): 1800-1807

Migotto, C. 2011: SIRT1, the wild card. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 28(1): 13

Feng, Y.-Y.; Li, H. 2008: SIRT1--a potential target for the therapy of nonalcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi 16(12): 958-960

Zhang, T.; Kraus, W.L. 2010: SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochimica et Biophysica Acta 1804(8): 1666-1675

Huber, J.L.; McBurney, M.W.; Distefano, P.S.; McDonagh, T. 2010: SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. Future Medicinal Chemistry 2(12): 1751-1759

Tang, S.; Huang, G.; Fan, W.; Chen, Y.; Ward, J.M.; Xu, X.; Xu, Q.; Kang, A.; McBurney, M.W.; Fargo, D.C.; Hu, G.; Baumgart-Vogt, E.; Zhao, Y.; Li, X. 2014: SIRT1-mediated deacetylation of CRABPIi regulates cellular retinoic acid signaling and modulates embryonic stem cell differentiation. Molecular Cell 55(6): 843-855

Zocchi, L.; Sassone-Corsi, P. 2012: SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 7(7): 695-700

Wan, Y-Zhen.; Gao, P.; Zhou, S.; Zhang, Z-Qin.; Hao, D-Long.; Lian, L-Shan.; Li, Y-Jun.; Chen, H-Zao.; Liu, D-Pei. 2014: SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence. Aging Cell 13(5): 890-899

Pazienza, V.; Borghesan, M.; Mazza, T.; Sheedfar, F.; Panebianco, C.; Williams, R.; Mazzoccoli, G.; Andriulli, A.; Nakanishi, T.; Vinciguerra, M. 2014: SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation. Aging 6(1): 35-47

Sassone-Corsi, P. 2009: SIRT1/PARP-1 functional interplay. Cell Cycle 8(11): 1649

Luna, A.; Aladjem, M.I.; Kohn, K.W. 2013: SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism. Genome Integrity 4(1): 6

Rasouri, S.; Lagouge, M.; Auwerx, J. 2007: SIRT1/PGC-1: a neuroprotective axis?. Medecine Sciences: M/S 23(10): 840-844

Ota, H.; Eto, M.; Ogawa, S.; Iijima, K.; Akishita, M.; Ouchi, Y. 2010: SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. Journal of Atherosclerosis and Thrombosis 17(5): 431-435

Yu, W.; Fu, Y-Cai.; Chen, C-Juan.; Wang, X.; Wang, W. 2009: SIRT1: a novel target to prevent atherosclerosis. Journal of Cellular Biochemistry 108(1): 10-13

Chong, Z.Zhong.; Shang, Y.Chen.; Wang, S.; Maiese, K. 2012: SIRT1: new avenues of discovery for disorders of oxidative stress. Expert Opinion on Therapeutic Targets 16(2): 167-178

Kim, E.-J.; Um, S.-J. 2008: SIRT1: roles in aging and cancer. Bmb Reports 41(11): 751-756

Jung, Y.J.; Lee, A.S.; Nguyen-Thanh, T.; Kim, D.; Kang, K.P.; Lee, S.; Park, S.K.; Kim, W. 2015: SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression. Journal of the American Society of Nephrology: Jasn 26(7): 1549-1560

Bobrowska, A.; Donmez, G.; Weiss, A.; Guarente, L.; Bates, G. 2012: SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo. Plos one 7(4): E34805

He, X.; Nie, H.; Hong, Y.; Sheng, C.; Xia, W.; Ying, W. 2012: SIRT2 activity is required for the survival of C6 glioma cells. Biochemical and Biophysical Research Communications 417(1): 468-472

Lee, A.S.; Jung, Y.J.; Kim, D.; Nguyen-Thanh, T.; Kang, K.P.; Lee, S.; Park, S.K.; Kim, W. 2014: SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochemical and Biophysical Research Communications 450(4): 1363-1369

De Oliveira, R.M.; Sarkander, J.; Kazantsev, A.G.; Outeiro, T.F. 2012: SIRT2 as a Therapeutic Target for Age-Related Disorders. Frontiers in Pharmacology 3: 82

Wang, M.; Yue, Z.; Paus, R.; Ramot, Y. 2014: SIRT2 as a new player in epigenetic programming of keratinocyte differentiation and a candidate tumor suppressor. Experimental Dermatology 23(9): 636-638

Wu, L.E.; Sinclair, D.A. 2014: SIRT2 controls the pentose phosphate switch. EMBO Journal 33(12): 1287-1288

Wang, F.; Nguyen, M.; Qin, F.X.-F.; Tong, Q. 2007: SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6(4): 505-514

Lo Sasso, G.; Menzies, K.J.; Mottis, A.; Piersigilli, A.; Perino, A.; Yamamoto, H.; Schoonjans, K.; Auwerx, J. 2014: SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. Plos one 9(7): E103573

Zhang, H.; Park, S.-H.; Pantazides, B.G.; Karpiuk, O.; Warren, M.D.; Hardy, C.W.; Duong, D.M.; Park, S.-J.; Kim, H.-S.; Vassilopoulos, A.; Seyfried, N.T.; Johnsen, S.A.; Gius, D.; Yu, D.S. 2013: SIRT2 directs the replication stress response through CDK9 deacetylation. Proceedings of the National Academy of Sciences of the United States of America 110(33): 13546-13551

Li, Y.; Matsumori, H.; Nakayama, Y.; Osaki, M.; Kojima, H.; Kurimasa, A.; Ito, H.; Mori, S.; Katoh, M.; Oshimura, M.; Inoue, T. 2011: SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 16(1): 34-45

Inoue, T.; Nakayama, Y.; Yamada, H.; Li, Y.C.; Yamaguchi, S.; Osaki, M.; Kurimasa, A.; Hiratsuka, M.; Katoh, M.; Oshimura, M. 2009: SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest. Cell Cycle 8(8): 1279-1291

Liu, L.; Arun, A.; Ellis, L.; Peritore, C.; Donmez, G. 2014: SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway. Frontiers in Aging Neuroscience 6: 184

North, B.J.; Rosenberg, M.A.; Jeganathan, K.B.; Hafner, A.V.; Michan, S.; Dai, J.; Baker, D.J.; Cen, Y.; Wu, L.E.; Sauve, A.A.; van Deursen, J.M.; Rosenzweig, A.; Sinclair, D.A. 2014: SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO Journal 33(13): 1438-1453

Luthi-Carter, R.; Taylor, D.M.; Pallos, J.; Lambert, E.; Amore, A.; Parker, A.; Moffitt, H.; Smith, D.L.; Runne, H.; Gokce, O.; Kuhn, A.; Xiang, Z.; Maxwell, M.M.; Reeves, S.A.; Bates, G.P.; Neri, C.; Thompson, L.M.; Marsh, J.L.; Kazantsev, A.G. 2010: SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 107(17): 7927-7932

Nguyen, P.; Lee, S.; Lorang-Leins, D.; Trepel, J.; Smart, D.K. 2014: SIRT2 interacts with β-catenin to inhibit Wnt signaling output in response to radiation-induced stress. Molecular Cancer Research: Mcr 12(9): 1244-1253

Lynn, E.G.; McLeod, C.J.; Gordon, J.P.; Bao, J.; Sack, M.N. 2008: SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. Febs Letters 582(19): 2857-2862

Park, S.-H.; Zhu, Y.; Ozden, O.; Kim, H.-S.; Jiang, H.; Deng, C.-X.; Gius, D.; Vassilopoulos, A. 2012: SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis. Translational Cancer Research 1(1): 15-21

Inoue, T.; Nakayama, Y.; Li, Y.; Matsumori, H.; Takahashi, H.; Kojima, H.; Wanibuchi, H.; Katoh, M.; Oshimura, M. 2014: SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. Febs Journal 281(11): 2623-2637

Kim, H.-S.; Vassilopoulos, A.; Wang, R.-H.; Lahusen, T.; Xiao, Z.; Xu, X.; Li, C.; Veenstra, T.D.; Li, B.; Yu, H.; Ji, J.; Wang, X.W.; Park, S.-H.; Cha, Y.I.; Gius, D.; Deng, C.-X. 2011: SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20(4): 487-499

Nie, H.; Hong, Y.; Lu, X.; Zhang, J.; Chen, H.; Li, Y.; Ma, Y.; Ying, W. 2014: SIRT2 mediates oxidative stress-induced apoptosis of differentiated PC12 cells. Neuroreport 25(11): 838-842

Arora, A.; Dey, C.S. 2014: SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells. Biochimica et Biophysica Acta 1842(9): 1372-1378

Chen, J.; Chan, A.W.H.; To, K.-F.; Chen, W.; Zhang, Z.; Ren, J.; Song, C.; Cheung, Y.-S.; Lai, P.B.S.; Cheng, S.-H.; Ng, M.H.L.; Huang, A.; Ko, B.C.B. 2013: SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling. Hepatology 57(6): 2287-2298

Nie, H.; Li, Y.; Wang, C.; Chen, X.; Liu, B.; Wu, D.; Ying, W. 2014: SIRT2 plays a key role in both cell cycle regulation and cell survival of BV2 microglia. International Journal of Physiology Pathophysiology and Pharmacology 6(3): 166-171

Xia, M.; Yu, J.-T.; Miao, D.; Lu, R.-C.; Zheng, X.-P.; Tan, L. 2014: SIRT2 polymorphism rs10410544 is associated with Alzheimer's disease in a Han Chinese population. Journal of the Neurological Sciences 336(1-2): 48-51

Rothgiesser, K.M.; Erener, S.üh.; Waibel, S.; Lüscher, B.; Hottiger, M.O. 2010: SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. Journal of Cell Science 123(Part 24): 4251-4258

Zhou, X.; Fan, L.X.; Li, K.; Ramchandran, R.; Calvet, J.P.; Li, X. 2014: SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1. Human Molecular Genetics 23(6): 1644-1655

Wang, F.; Tong, Q. 2009: SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Molecular biology of the cell 20(3): 801-808

Sayd, S.; Junier, M.-P.; Chneiweiss, H.é 2014: SIRT2, a multi-talented deacetylase. Medecine Sciences: M/S 30(5): 532-536

Harting, K.; Knöll, B. 2010: SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology. European Journal of Cell Biology 89(2-3): 262-269

McGlynn, L.M.; Zino, S.; MacDonald, A.I.; Curle, J.; Reilly, J.E.; Mohammed, Z.M.A.; McMillan, D.C.; Mallon, E.; Payne, A.P.; Edwards, J.; Shiels, P.G. 2014: SIRT2: tumour suppressor or tumour promoter in operable breast cancer?. European Journal of Cancer 50(2): 290-301

Dransfeld, C.-L.; Alborzinia, H.; Wölfl, S.; Mahlknecht, U. 2010: SIRT3 SNPs validation in 640 individuals, functional analyses and new insights into SIRT3 stability. International Journal of Oncology 36(4): 955-960

Zhu, Y.; Yan, Y.; Principe, D.R.; Zou, X.; Vassilopoulos, A.; Gius, D. 2014: SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis. Cancer and Metabolism 2: 15

Schumacker, P.T. 2011: SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF. Cancer Cell 19(3): 299-300

Vassilopoulos, A.; Pennington, J.D.; Andresson, T.; Rees, D.M.; Bosley, A.D.; Fearnley, I.M.; Ham, A.; Flynn, C.R.; Hill, S.; Rose, K.L.; Kim, H.-S.; Deng, C.-X.; Walker, J.E.; Gius, D. 2014: SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress. Antioxidants and Redox Signaling 21(4): 551-564

Samant, S.A.; Zhang, H.J.; Hong, Z.; Pillai, V.B.; Sundaresan, N.R.; Wolfgeher, D.; Archer, S.L.; Chan, D.C.; Gupta, M.P. 2014: SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Molecular and Cellular Biology 34(5): 807-819

Ozden, O.; Park, S.-H.; Wagner, B.A.; Song, H.Y.; Zhu, Y.; Vassilopoulos, A.; Jung, B.; Buettner, G.R.; Gius, D. 2014: SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radical Biology and Medicine 76: 163-172

Shimazu, T.; Hirschey, M.D.; Hua, L.; Dittenhafer-Reed, K.E.; Schwer, B.; Lombard, D.B.; Li, Y.; Bunkenborg, J.; Alt, F.W.; Denu, J.M.; Jacobson, M.P.; Verdin, E. 2010: SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metabolism 12(6): 654-661

Porter, G.A.; Urciuoli, W.R.; Brookes, P.S.; Nadtochiy, S.M. 2014: SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. American Journal of Physiology. Heart and Circulatory Physiology 306(12): H1602-H1609

Huang, K.-H.; Hsu, C.-C.; Fang, W.-L.; Chi, C.-W.; Sung, M.-T.; Kao, H.-L.; Li, A.F.-Y.; Yin, P.-H.; Yang, M.-H.; Lee, H.-C. 2014: SIRT3 expression as a biomarker for better prognosis in gastric cancer. World Journal of Surgery 38(4): 910-917

Iwahara, T.; Bonasio, R.; Narendra, V.; Reinberg, D. 2012: SIRT3 functions in the nucleus in the control of stress-related gene expression. Molecular and Cellular Biology 32(24): 5022-5034

D'Aquila, P.; Rose, G.; Panno, M.Luisa.; Passarino, G.; Bellizzi, D. 2012: SIRT3 gene expression: a link between inherited mitochondrial DNA variants and oxidative stress. Gene 497(2): 323-329

Sebastian, C.; Mostoslavsky, R. 2010: SIRT3 in calorie restriction: can you hear me now?. Cell 143(5): 667-668

Tseng, A.H.-H.; Wu, L.-H.; Shieh, S.-S.; Wang, D.L. 2014: SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochemical Journal 464(1): 157-168

Jacobs, K.M.; Pennington, J.D.; Bisht, K.S.; Aykin-Burns, N.; Kim, H.-S.; Mishra, M.; Sun, L.; Nguyen, P.; Ahn, B.-H.; Leclerc, J.; Deng, C.-X.; Spitz, D.R.; Gius, D. 2008: SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. International Journal of Biological Sciences 4(5): 291-299

Kim, H.-S.; Patel, K.; Muldoon-Jacobs, K.; Bisht, K.S.; Aykin-Burns, N.; Pennington, J.D.; van der Meer, R.; Nguyen, P.; Savage, J.; Owens, K.M.; Vassilopoulos, A.; Ozden, O.; Park, S.-H.; Singh, K.K.; Abdulkadir, S.A.; Spitz, D.R.; Deng, C.-X.; Gius, D. 2010: SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17(1): 41-52

Haigis, M.C.; Deng, C.-X.; Finley, L.W.S.; Kim, H.-S.; Gius, D. 2012: SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Research 72(10): 2468-2472

Yan, S.-M.; Han, X.; Han, P.-J.; Chen, H.-M.; Huang, L.-Y.; Li, Y. 2014: SIRT3 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Medical Oncology 31(8): 103

Sundaresan, N.R.; Samant, S.A.; Pillai, V.B.; Rajamohan, S.B.; Gupta, M.P. 2008: SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Molecular and Cellular Biology 28(20): 6384-6401

Bao, J.; Scott, I.; Lu, Z.; Pang, L.; Dimond, C.C.; Gius, D.; Sack, M.N. 2010: SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radical Biology and Medicine 49(7): 1230-1237

Finley, L.W.S.; Carracedo, A.; Lee, J.; Souza, A.; Egia, A.; Zhang, J.; Teruya-Feldstein, J.; Moreira, P.I.; Cardoso, S.M.; Clish, C.B.; Pandolfi, P.Paolo.; Haigis, M.C. 2011: SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19(3): 416-428

Zhang, B.; Cui, S.; Bai, X.; Zhuo, L.; Sun, X.; Hong, Q.; Fu, B.; Wang, J.; Chen, X.; Cai, G. 2013: SIRT3 overexpression antagonizes high glucose accelerated cellular senescence in human diploid fibroblasts via the SIRT3-FOXO1 signaling pathway. Age 35(6): 2237-2253

Fu, H.; Wada-Hiraike, O.; Hirano, M.; Kawamura, Y.; Sakurabashi, A.; Shirane, A.; Morita, Y.; Isono, W.; Oishi, H.; Koga, K.; Oda, K.; Kawana, K.; Yano, T.; Kurihara, H.; Osuga, Y.; Fujii, T. 2014: SIRT3 positively regulates the expression of folliculogenesis- and luteinization-related genes and progesterone secretion by manipulating oxidative stress in human luteinized granulosa cells. Endocrinology 155(8): 3079-3087

Chen, C.-J.; Fu, Y.-C.; Yu, W.; Wang, W. 2013: SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB. Biochemical and Biophysical Research Communications 430(2): 798-803

Yu, W.; Dittenhafer-Reed, K.E.; Denu, J.M. 2012: SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. Journal of Biological Chemistry 287(17): 14078-14086

Shi, T.; Fan, G.Q.; Xiao, S.D. 2010: SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. Journal of Digestive Diseases 11(1): 55-62

Li, H.; Feng, Z.; Wu, W.; Li, J.; Zhang, J.; Xia, T. 2013: SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2. International Journal of Oncology 43(5): 1420-1430

Hirschey, M.D.; Shimazu, T.; Huang, J-Y.; Schwer, B.; Verdin, E. 2011: SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harbor Symposia on Quantitative Biology 76: 267-277

Smith, B.C.; Settles, B.; Hallows, W.C.; Craven, M.W.; Denu, J.M. 2011: SIRT3 substrate specificity determined by peptide arrays and machine learning. Acs Chemical Biology 6(2): 146-157

Giralt, A.; Villarroya, F. 2012: SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochemical Journal 444(1): 1-10

Lombard, D.B.; Zwaans, B.M.M. 2014: SIRT3: as simple as it seems?. Gerontology 60(1): 56-64

Tao, Y.; Huang, C.; Huang, Y.; Hong, L.; Wang, H.; Zhou, Z.; Qiu, Y. 2015: SIRT4 Suppresses Inflammatory Responses in Human Umbilical Vein Endothelial Cells. Cardiovascular Toxicology 15(3): 217-223

Laurent, G.ël.; German, N.J.; Saha, A.K.; de Boer, V.C.J.; Davies, M.; Koves, T.R.; Dephoure, N.; Fischer, F.; Boanca, G.; Vaitheesvaran, B.; Lovitch, S.B.; Sharpe, A.H.; Kurland, I.J.; Steegborn, C.; Gygi, S.P.; Muoio, D.M.; Ruderman, N.B.; Haigis, M.C. 2013: SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Molecular Cell 50(5): 686-698

Jeong, S.M.; Xiao, C.; Finley, L.W.S.; Lahusen, T.; Souza, A.L.; Pierce, K.; Li, Y.-H.; Wang, X.; Laurent, G.ël.; German, N.J.; Xu, X.; Li, C.; Wang, R.-H.; Lee, J.; Csibi, A.; Cerione, R.; Blenis, J.; Clish, C.B.; Kimmelman, A.; Deng, C.-X.; Haigis, M.C. 2013: SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23(4): 450-463

Chen, Y.; Wang, H.; Luo, G.; Dai, X. 2014: SIRT4 inhibits cigarette smoke extracts-induced mononuclear cell adhesion to human pulmonary microvascular endothelial cells via regulating NF-κB activity. Toxicology Letters 226(3): 320-327

Liu, B.; Che, W.; Xue, J.; Zheng, C.; Tang, K.; Zhang, J.; Wen, J.; Xu, Y. 2013: SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 32(3): 655-662

Jeong, S.M.; Lee, A.; Lee, J.; Haigis, M.C. 2014: SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma. Journal of Biological Chemistry 289(7): 4135-4144

Ho, L.; Titus, A.S.; Banerjee, K.K.; George, S.; Lin, W.; Deota, S.; Saha, A.K.; Nakamura, K.; Gut, P.; Verdin, E.; Kolthur-Seetharam, U. 2013: SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK. Aging 5(11): 835-849

Nasrin, N.; Wu, X.; Fortier, E.; Feng, Y.; Bare', O.C.; Chen, S.; Ren, X.; Wu, Z.; Streeper, R.S.; Bordone, L. 2010: SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. Journal of Biological Chemistry 285(42): 31995-32002

Laurent, G.ël.; de Boer, V.C.J.; Finley, L.W.S.; Sweeney, M.; Lu, H.; Schug, T.T.; Cen, Y.; Jeong, S.M.; Li, X.; Sauve, A.A.; Haigis, M.C. 2013: SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation. Molecular and Cellular Biology 33(22): 4552-4561

Nakagawa, T.; Lomb, D.J.; Haigis, M.C.; Guarente, L. 2009: SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137(3): 560-570

Lin, Z.-F.; Xu, H.-B.; Wang, J.-Y.; Lin, Q.; Ruan, Z.; Liu, F.-B.; Jin, W.; Huang, H.-H.; Chen, X. 2013: SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochemical and Biophysical Research Communications 441(1): 191-195

Lu, W.; Zuo, Y.; Feng, Y.; Zhang, M. 2014: SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(11): 10699-10705

Buler, M.; Aatsinki, S-Mari.; Izzi, V.; Uusimaa, J.; Hakkola, J. 2014: SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 28(7): 3225-3237

Rardin, M.J.; He, W.; Nishida, Y.; Newman, J.C.; Carrico, C.; Danielson, S.R.; Guo, A.; Gut, P.; Sahu, A.K.; Li, B.; Uppala, R.; Fitch, M.; Riiff, T.; Zhu, L.; Zhou, J.; Mulhern, D.; Stevens, R.D.; Ilkayeva, O.R.; Newgard, C.B.; Jacobson, M.P.; Hellerstein, M.; Goetzman, E.S.; Gibson, B.W.; Verdin, E. 2013: SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metabolism 18(6): 920-933

Liu, B.; Che, W.; Zheng, C.; Liu, W.; Wen, J.; Fu, H.; Tang, K.; Zhang, J.; Xu, Y. 2013: SIRT5: a safeguard against oxidative stress-induced apoptosis in cardiomyocytes. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 32(4): 1050-1059

Xiao, C.; Kim, H.-S.; Lahusen, T.; Wang, R.-H.; Xu, X.; Gavrilova, O.; Jou, W.; Gius, D.; Deng, C.-X. 2010: SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. Journal of Biological Chemistry 285(47): 36776-36784

Gil, R.; Barth, S.; Kanfi, Y.; Cohen, H.Y. 2013: SIRT6 exhibits nucleosome-dependent deacetylase activity. Nucleic Acids Research 41(18): 8537-8545

Palmer, N.O.; Fullston, T.; Mitchell, M.; Setchell, B.P.; Lane, M. 2011: SIRT6 in mouse spermatogenesis is modulated by diet-induced obesity. Reproduction Fertility and Development 23(7): 929-939

Silberman, D.M.; Ross, K.; Sande, P.H.; Kubota, S.; Ramaswamy, S.; Apte, R.S.; Mostoslavsky, R. 2014: SIRT6 is required for normal retinal function. Plos one 9(6): E98831

Khongkow, M.; Olmos, Y.; Gong, C.; Gomes, A.R.; Monteiro, L.J.; Yagüe, E.; Cavaco, T.B.; Khongkow, P.; Man, E.P.S.; Laohasinnarong, S.; Koo, C.-Y.; Harada-Shoji, N.; Tsang, J.W.-H.; Coombes, R.C.; Schwer, B.; Khoo, U.-S.; Lam, E.W.-F. 2013: SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis 34(7): 1476-1486

Van Meter, M.; Mao, Z.; Gorbunova, V.; Seluanov, A. 2011: SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle 10(18): 3153-3158

Ming, M.; Han, W.; Zhao, B.; Sundaresan, N.R.; Deng, C.-X.; Gupta, M.P.; He, Y.-Y. 2014: SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer. Cancer Research 74(20): 5925-5933

Mao, Z.; Hine, C.; Tian, X.; Van Meter, M.; Au, M.; Vaidya, A.; Seluanov, A.; Gorbunova, V. 2011: SIRT6 promotes DNA repair under stress by activating PARP1. Science 332(6036): 1443-1446

Kanfi, Y.; Peshti, V.; Gil, R.; Naiman, S.; Nahum, L.; Levin, E.; Kronfeld-Schor, N.; Cohen, H.Y. 2010: SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 9(2): 162-173

Sun, H.; Wu, Y.; Fu, D.; Liu, Y.; Huang, C. 2014: SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway. Stem Cells 32(7): 1943-1955

Engler, A.; Niederer, F.; Klein, K.; Gay, R.E.; Kyburz, D.; Camici, G.G.; Gay, S.; Ospelt, C. 2014: SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts. Journal of Molecular Medicine 92(7): 757-767

McCord, R.A.; Michishita, E.; Hong, T.; Berber, E.; Boxer, L.D.; Kusumoto, R.; Guan, S.; Shi, X.; Gozani, O.; Burlingame, A.L.; Bohr, V.A.; Chua, K.F. 2009: SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging 1(1): 109-121

Gertler, A.A.; Cohen, H.Y. 2013: SIRT6, a protein with many faces. Biogerontology 14(6): 629-639

Zhong, L.; Mostoslavsky, R. 2010: SIRT6: a master epigenetic gatekeeper of glucose metabolism. Transcription 1(1): 17-21

Van Meter, M.; Gorbunova, V.; Seluanov, A. 2014: SIRT6: a promising target for cancer prevention and therapy. Advances in Experimental Medicine and Biology 818: 181-196

Kim, W.; Kim, J.E. 2013: SIRT7 an emerging sirtuin: deciphering newer roles. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 64(5): 531-534

Yoshizawa, T.; Karim, M.F.; Sato, Y.; Senokuchi, T.; Miyata, K.; Fukuda, T.; Go, C.; Tasaki, M.; Uchimura, K.; Kadomatsu, T.; Tian, Z.; Smolka, C.; Sawa, T.; Takeya, M.; Tomizawa, K.; Ando, Y.; Araki, E.; Akaike, T.; Braun, T.; Oike, Y.; Bober, E.; Yamagata, K. 2014: SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metabolism 19(4): 712-721

Shin, J.; He, M.; Liu, Y.; Paredes, S.; Villanova, L.; Brown, K.; Qiu, X.; Nabavi, N.; Mohrin, M.; Wojnoonski, K.; Li, P.; Cheng, H-Ling.; Murphy, A.J.; Valenzuela, D.M.; Luo, H.; Kapahi, P.; Krauss, R.; Mostoslavsky, R.; Yancopoulos, G.D.; Alt, F.W.; Chua, K.F.; Chen, D. 2013: SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Reports 5(3): 654-665

Shimoyama, Y.; Mitsuda, Y.; Tsuruta, Y.; Suzuki, K.; Hamajima, N.; Niwa, T. 2012: SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. Journal of Renal Nutrition: the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 22(1): 114-119

Zschoernig, B.; Mahlknecht, U. 2008: SIRTUIN 1: regulating the regulator. Biochemical and Biophysical Research Communications 376(2): 251-255

Goligorsky, M.S. 2010: SIRTing out the link between autophagy and ageing. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 25(8): 2434-2436

Zhang, L.; Liu, Z.; Cui, P.; Zhao, D.; Chen, W. 2007: SIS with tissue-cultured allogenic cartilages patch tracheoplasty in a rabbit model for tracheal defect. Acta Oto-Laryngologica 127(6): 631-636

Huang, Y.; Li, C.Y.; Qi, Y.; Park, S.; Gibson, S.I. 2014: SIS8, a putative mitogen-activated protein kinase kinase kinase, regulates sugar-resistant seedling development in Arabidopsis. Plant Journal: for Cell and Molecular Biology 77(4): 577-588

Dias, Z.; Dias, U.; Setubal, Jão.C. 2012: SIS: a program to generate draft genome sequence scaffolds for prokaryotes. Bmc Bioinformatics 13: 96

Verrier, I.; Brun, G.; Goure, J.P. 1997: SISAM interferometer for distance measurements. Applied Optics 36(25): 6225-6230

Anderson, N.L.; Jackson, A.; Smith, D.; Hardie, D.; Borchers, C.; Pearson, T.W. 2009: SISCAPA peptide enrichment on magnetic beads using an in-line bead trap device. Molecular and Cellular Proteomics: Mcp 8(5): 995-1005

Breuls, M.; Sell, D.; Manders, E.; Boulet, E.; Vander Poorten, V. 2006: SISL (ScreeningsInstrument Schisis Leuven): assessment of cleft palate speech, resonance and myofunction. B-Ent 2(Suppl 4): 71-84

Passman, L.J.; Farias, A.Maria.Ramalho.Ortigão.; Tomazelli, J.Gláucia.; de Abreu, D.Maria.Franco.; Dias, M.Beatriz.Kneipp.; de Assis, Mônica.; de Almeida, P.Fidellis.; da Silva, R.Corrêa.Ferreira.; Santini, L.Antonio. 2011: SISMAMA--implementation of an information system for breast cancer early detection programs in Brazil. Breast 20 Suppl. 2: S35-S39

Andreucci, C.B.; Cecatti, J.G.; Macchetti, C.E.; Sousa, M.H. 2011: SISPRENATAL as a tool for evaluating quality of prenatal care. Revista de Saude Publica 45(5): 854-864

Zoller, A.S.; Gaal, I.M.; Royer, C.A.; Locascio, J.J.; Amariglio, R.E.; Blacker, D.; Okereke, O.I.; Johnson, K.A.; Sperling, R.A.; Rentz, D.M.; Marshall, G.A. 2014: SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Current Alzheimer Research 11(8): 785-791

Zhabinskaya, D.; Madden, S.; Benham, C.J. 2015: SIST: stress-induced structural transitions in superhelical DNA. Bioinformatics 31(3): 421-422

Saleh-Onoya, D.; Braxton, N.D.; Sifunda, S.; Reddy, P.; Ruiter, R.; van den Borne, B.; Walters, T.Pennick.; Lang, D.; Wingood, G.M. 2008: SISTA South Africa: the adaptation of an efficacious HIV prevention trial conducted with African-American women for isiXhosa-speaking South African women. Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 5(4): 186-191

Wagner, M.; Dresing, K.; Ludwig, W.; Ahrens, C.A.; Bott, O.J. 2012: SIScaR-GPU: fast simulation and visualization of intraoperative scattered radiation to support radiation protection training. Studies in Health Technology and Informatics 180: 968-972

Koelsch, U.; Schraven, B.; Simeoni, L. 2008: SIT and TRIM determine T cell fate in the thymus. Journal of Immunology 181(9): 5930-5939

Pajno, G.B.; Finegold, I. 2011: SIT beyond respiratory diseases. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 107(5): 395-400

Townson, H. 2009: SIT for African malaria vectors: epilogue. Malaria Journal 8(Suppl 2): S10

Allam, J.-P. 2013: SIT for the treatment of atopic dermatitis. Arbeiten aus dem Paul-Ehrlich-Institut Langen/Hessen 97: 186-188

Colgate, S.A.; Moore, E.P.; Colburn, J. 1975: SIT vidicon with magnetic intensifier for astronomical use. Applied Optics 14(6): 1429-1436

Anas, M.-K.I.; Lee, M.B.; Zhou, C.; Hammer, M.-A.; Slow, S.; Karmouch, J.; Liu, X.J.é; Bröer, S.; Lever, M.; Baltz, J.M. 2008: SIT1 is a betaine/proline transporter that is activated in mouse eggs after fertilization and functions until the 2-cell stage. Development 135(24): 4123-4130

Bachert, C.; Canonica, G.Walter.; Bufe, A. 2012: SIT: efficacy depends on product, not on route of application. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 23(4): 401; author reply 401-2

Cole, T.J.; Donaldson, M.D.C.; Ben-Shlomo, Y. 2010: SITAR--a useful instrument for growth curve analysis. International Journal of Epidemiology 39(6): 1558-1566

Romano, E.; Nardelli-Haefliger, D.; Donda, A.; Corgnac, S.; Romero, P. 2012: SITC 26th annual meeting--summary. Journal of translational medicine 10: 105

Bedognetti, D.; Balwit, J.M.; Wang, E.; Disis, M.L.; Britten, C.M.; Delogu, L.G.; Tomei, S.; Fox, B.A.; Gajewski, T.F.; Marincola, F.M.; Butterfield, L.H. 2011: SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery. Journal of Translational Medicine 9: 155

Oh, J.Hun.; Deasy, J.O. 2014: SITDEM: a simulation tool for disease/endpoint models of association studies based on single nucleotide polymorphism genotypes. Computers in Biology and Medicine 45: 136-142

Hernandez, M.; Ghersi, D.; Sanchez, R. 2009: SITEHOUND-web: a server for ligand binding site identification in protein structures. Nucleic Acids Research 37(Web Server Issue): W413-W416

Tsiourlis, G.; Andreadakis, S.; Konstantinidis, P. 2009: SITHON: a Wireless Network of in Situ Optical Cameras Applied to the Early Detection-Notification-Monitoring of Forest Fires. Sensors 9(6): 4465-4482

Kontoes, C.; Keramitsoglou, I.; Sifakis, N.; Konstantinidis, P. 2009: SITHON: An Airborne Fire Detection System Compliant with Operational Tactical Requirements. Sensors 9(2): 1204-1220

Hallevi, H.; Grotta, J.C. 2007: SITS-MOST: old myths laid to rest. Lancet. Neurology 6(4): 292-293

Gershenfeld, L.; Shulik, S.M. 1946: The effect of acetone on the surface tension and the bactericidal efficiency of aerosol OT. American Journal of Pharmacy and the Sciences Supporting Public Health 118: 264-270

Demay, C.; Liens, B.; Burguière, T.; Hill, Véronique.; Couvin, D.; Millet, J.; Mokrousov, I.; Sola, C.; Zozio, T.; Rastogi, N. 2012: SITVITWEB--a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 12(4): 755-766

Alhassan, A.; Alhassan, A. 2010: SIU Scholar: Dr. Abdullah Alhassan. Urology 76(6): 1275-1276

Muhammed, A.; Ahmed, M. 2012: SIU Scholar: Dr. Ahmed Muhammed. Urology 79(1): 3-4

Alkadri, D. 2014: SIU Scholar: Dr. Diarra Alkadri. Urology 83(4): 689-690

Salem Baaboud, F.Abdullah.; Abdullah Salem Baaboud, F. 2012: SIU Scholar: Dr. Fahed Abdullah Salem Baaboud. Urology 79(1): 1-2

Udo Essiet, I.; Essiet, I.Udo. 2014: SIU Scholar: Dr. Ifiok Udo Essiet. Urology 83(6): 1211-1212

Banerji, J.Samuel. 2013: SIU Scholar: Dr. John Samuel Banerji. Urology 81(6): 1119-1120

Zhong, M. 2014: SIU Scholar: Dr. Mingzhu Zhong. Urology 83(4): 687-688

Kingsley, O.Chidi.; Kingsley, O.Chidi. 2010: SIU Scholar: Dr. Oranusi Chidi Kingsley. Urology 76(6): 1277-1278

Olufemi, A.Peter. 2011: SIU Scholar: Dr. Peter Olufemi Areo. Urology 77(5): 1021-1022

Abou Youssif, T.Mohammed. 2011: SIU Scholar: Dr. Tamer Mohammed Abou Youssif. Urology 77(5): 1023-1024

Waheed, S.M.S. 2013: SIU Scholar: Shameem Waheed. Urology 82(4): 753-754

Ajape, A.Akanbi.; Ajape, A.Akanbi. 2011: SIU Scholarship: Dr. Abdulwahab Akanbi Ajape. Urology 78(3): 489-490

Abdullahi, A-Ahmed. 2010: SIU Scholarship: Dr. Abdulwahab-Ahmed Abdullahi. Urology 75(5): 1000-1001

Olajide, A.Olaniyi. 2011: SIU Scholarship: Dr. Abimbola Olaniyi Olajide. Urology 77(2): 265-266

Obi, A.Okwudili. 2010: SIU Scholarship: Dr. Anselm Okwudili Obi. Urology 75(3): 489-490

Shaikh, A.Uddin. 2009: SIU Scholarship: Dr. Azfar Uddin Shaikh. Urology 73(4): 689-690

Ogo, C.Ndukwe. 2009: SIU Scholarship: Dr. Chidiebere Ndukwe Ogo. Urology 73(3): 455-456

Kyei, M. 2011: SIU Scholarship: Dr. Mathew K. Y. Kyei. Urology 77(2): 267-268

Wambani, M. 2010: SIU Scholarship: Dr. Maurice Wambani. Urology 75(5): 1002-1003

Almasri, M.Zahid. 2010: SIU Scholarship: Dr. Mohamed Zahid Musa Almasri. Urology 75(1): 2-3

Almashraki, N.Mohammed. 2010: SIU Scholarship: Dr. Noaman Mohammed Almashraki. Urology 76(2): 259

Sharma, S.; Sharma, S. 2011: SIU Scholarship: Dr. Sachit Sharma. Urology 77(3): 516-517

Iremashvili, V. 2009: SIU Scholarship: Dr. Viacheslav Iremashvili. Urology 73(4): 687-688

Gu, X. 2009: SIU Scholarship: Dr. Xiao Gu. Urology 73(3): 454

Ayogu, B.Okafor.; Ayogu, B.Okafor. 2013: SIU scholar: Dr. Benjamin Okafor Ayogu. Urology 82(2): 261-262

Manuputty, E.Edward. 2010: SIU scholar: Dr. Egi Edward Manuputty. Urology 76(2): 257-258

Slaiman, H.; Slaiman, H. 2013: SIU scholar: Dr. Husein Slaiman. Urology 82(3): 501-502

Nnabugwu, I.Ifeanyi. 2014: SIU scholar: Dr. Ikenna Ifeanyi Nnabugwu. Urology 83(5): 963-964

Syed, J.Raza. 2013: SIU scholar: Dr. Johar Raza Syed. Urology 81(5): 923-924

Maina, S.Njuguna.M. 2013: SIU scholar: Dr. Samson Maina. Urology 81(5): 925-926

Dziwa, B.Ngonidzashe.; Dziwa, B.Ngonidzashe. 2009: SIU scholarship: Dr. Blessing Ngonidzashe Dziwa. Urology 73(5): 931-932

Musau, P.Mutune.; Musau, P.Nutune. 2009: SIU scholarship: Dr. Pius Mutune Musau. Urology 73(5): 933-934

Atim, T. 2011: SIU scholarship: Dr. Terkaa Atim. Urology 78(5): 975-976

Latini, J.M.; McAninch, J.W.; Brandes, S.B.; Chung, J.Yong.; Rosenstein, D. 2014: SIU/ICUD Consultation On Urethral Strictures: Epidemiology, etiology, anatomy, and nomenclature of urethral stenoses, strictures, and pelvic fracture urethral disruption injuries. Urology 83(3 Suppl): S1-S7

Morey, A.F.; Watkin, N.; Shenfeld, O.; Eltahawy, E.; Giudice, C. 2014: SIU/ICUD Consultation on Urethral Strictures: Anterior urethra--primary anastomosis. Urology 83(3 Suppl): S23-S26

Stewart, L.; McCammon, K.; Metro, M.; Virasoro, R. 2014: SIU/ICUD Consultation on Urethral Strictures: Anterior urethra-lichen sclerosus. Urology 83(3 Suppl): S27-S30

Buckley, J.C.; Heyns, C.; Gilling, P.; Carney, J. 2014: SIU/ICUD Consultation on Urethral Strictures: Dilation, internal urethrotomy, and stenting of male anterior urethral strictures. Urology 83(3 Suppl): S18-S22

Angermeier, K.W.; Rourke, K.F.; Dubey, D.; Forsyth, R.J.; Gonzalez, C.M. 2014: SIU/ICUD Consultation on Urethral Strictures: Evaluation and follow-up. Urology 83(3 Suppl): S8-17

Gómez, R.G.; Mundy, T.; Dubey, D.; El-Kassaby, A.Wahab.; Firdaoessaleh; Kodama, R.; Santucci, R. 2014: SIU/ICUD Consultation on Urethral Strictures: Pelvic fracture urethral injuries. Urology 83(3 Suppl): S48-S58

Herschorn, S.; Elliott, S.; Coburn, M.; Wessells, H.; Zinman, L. 2014: SIU/ICUD Consultation on Urethral Strictures: Posterior urethral stenosis after treatment of prostate cancer. Urology 83(3 Suppl): S59-S70

Chapple, C.; Andrich, D.; Atala, A.; Barbagli, G.; Cavalcanti, Aé.; Kulkarni, S.; Mangera, A.; Nakajima, Y. 2014: SIU/ICUD Consultation on Urethral Strictures: The management of anterior urethral stricture disease using substitution urethroplasty. Urology 83(3 Suppl): S31-S47

Kaplan, G.W.; Brock, J.W.; Fisch, M.; Koraitim, M.M.; Snyder, H.M. 2014: SIU/ICUD Consultation on Urethral Strictures: Urethral strictures in children. Urology 83(3 Suppl): S71-S73

Zhang, F.; Landford, W.N.; Ng, M.; McNatt, M.W.; Bieniasz, P.D.; Hatziioannou, T. 2011: SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release. Plos Pathogens 7(5): E1002039

Hu, H.; Gama, L.; Aye, P.P.; Clements, J.E.; Barry, P.A.; Lackner, A.A.; Weissman, D. 2011: SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques. Retrovirology 8: 57

Lindsay, R.W.; Ouellette, I.; Arendt, H.E.; Martinez, J.; DeStefano, J.; Lopez, M.; Pavlakis, G.N.; Chiuchiolo, M.J.; Parks, C.L.; King, C.R. 2013: SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12. Vaccine 31(42): 4749-4758

Neil, S. 2011: SIV envelope acquires a nefarious habit. Cell Host and Microbe 9(1): 3-5

Hughes, A.L.; Becker, E.A.; Lauck, M.; Karl, J.A.; Braasch, A.T.; O'Connor, D.H.; O'Connor, S.L. 2012: SIV genome-wide pyrosequencing provides a comprehensive and unbiased view of variation within and outside CD8 T lymphocyte epitopes. Plos one 7(10): E47818

Mir, K.D.; Gasper, M.A.; Sundaravaradan, V.; Sodora, D.L. 2011: SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes and Infection 13(1): 14-24

Wonderlich, E.R.; Barratt-Boyes, S.M. 2013: SIV infection of rhesus macaques differentially impacts mononuclear phagocyte responses to virus-derived TLR agonists. Journal of Medical Primatology 42(5): 247-253

Zhou, Y.; Bao, R.; Haigwood, N.L.; Persidsky, Y.; Ho, W.-z. 2013: SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans. Retrovirology 10: 89

Klatt, N.R.; Vinton, C.L.; Lynch, R.M.; Canary, L.A.; Ho, J.; Darrah, P.A.; Estes, J.D.; Seder, R.A.; Moir, S.L.; Brenchley, J.M. 2011: SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 118(22): 5803-5812

von Bubnoff, A. 2009: SIV may be much younger than previously thought. Iavi Report: Newsletter on International Aids Vaccine Research 13(3): 16

Sakuma, R.; Takeuchi, H. 2012: SIV replication in human cells. Frontiers in Microbiology 3: 162

Sisk, J.M.; Witwer, K.W.; Tarwater, P.M.; Clements, J.E. 2013: SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology 10: 95

Westmoreland, S.V.; Converse, A.P.; Hrecka, K.; Hurley, M.; Knight, H.; Piatak, M.; Lifson, J.; Mansfield, K.G.; Skowronski, J.; Desrosiers, R.C. 2014: SIV vpx is essential for macrophage infection but not for development of AIDS. Plos one 9(1): E84463

Moeller, A.H.; Shilts, M.; Li, Y.; Rudicell, R.S.; Lonsdorf, E.V.; Pusey, A.E.; Wilson, M.L.; Hahn, B.H.; Ochman, H. 2013: SIV-induced instability of the chimpanzee gut microbiome. Cell Host and Microbe 14(3): 340-345

Wambua, D.; Henderson, R.; Solomon, C.; Hunter, M.; Marx, P.; Sette, A.; Mothé, B.R. 2011: SIV-infected Chinese-origin rhesus macaques express specific MHC class i alleles in either elite controllers or normal progressors. Journal of Medical Primatology 40(4): 244-247

Cromwell, M.A.; Carville, A.; Mansfield, K.; Klumpp, S.; Westmoreland, S.V.; Lackner, A.A.; Johnson, R.P. 2011: SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines. American Journal of Reproductive Immunology 65(3): 242-247

Han, J.; Liu, T.; Huen, M.S.Y.; Hu, L.; Chen, Z.; Huang, J. 2014: SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination. Journal of Cell Biology 205(6): 811-827

Sanchez, A.; Blanc, S.; Climent, S.; Yuste, P.; Ors, R. 2013: SIVEH: numerical computing simulation of wireless energy-harvesting sensor nodes. Sensors 13(9): 11750-11771

Hipp, J.D.; Cheng, J.; Hanson, J.C.; Rosenberg, A.Z.; Emmert-Buck, M.R.; Tangrea, M.A.; Balis, U.J. 2014: SIVQ-LCM protocol for the ArcturusXT instrument. Journal of Visualized Experiments: Jove 2014(89)

Hipp, J.; Cheng, J.; Hanson, J.C.; Yan, W.; Taylor, P.; Hu, N.; Rodriguez-Canales, J.; Hipp, J.; Tangrea, M.A.; Emmert-Buck, M.R.; Balis, U. 2011: SIVQ-aided laser capture microdissection: A tool for high-throughput expression profiling. Journal of Pathology Informatics 2: 19

Berger, G.; Cimarelli, A. 2014: SIVSM/HIV-2 Vpx proteins: function and uses in the infection of primary myeloid cells. Methods in Molecular Biology 1087: 159-165

Ma, D.; Jasinska, A.; Kristoff, J.; Grobler, J.P.; Turner, T.; Jung, Y.; Schmitt, C.; Raehtz, K.; Feyertag, F.; Martinez Sosa, N.; Wijewardana, V.; Burke, D.S.; Robertson, D.L.; Tracy, R.; Pandrea, I.; Freimer, N.; Apetrei, C. 2013: SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations. Plos Pathogens 9(1): E1003011

Lai, L.; Kwa, S-Fen.; Kozlowski, P.A.; Montefiori, D.C.; Nolen, T.L.; Hudgens, M.G.; Johnson, W.E.; Ferrari, G.; Hirsch, V.M.; Felber, B.K.; Pavlakis, G.N.; Earl, P.L.; Moss, B.; Amara, R.Rao.; Robinson, H.L. 2012: SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine 30(9): 1737-1745

Ma, Z.-M.; Keele, B.F.; Qureshi, H.; Stone, M.; Desilva, V.; Fritts, L.; Lifson, J.D.; Miller, C.J. 2011: SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. Aids Research and Human Retroviruses 27(12): 1259-1269

Cai, C.; Rodepeter, F.R.; Rossmann, A.; Teymoortash, A.; Lee, J.-S.; Quint, K.; DI Fazio, P.; Ocker, M.; Werner, J.A.; Mandic, R. 2012: SIVmac₂₃₉-Nef down-regulates cell surface expression of CXCR4 in tumor cells and inhibits proliferation, migration and angiogenesis. Anticancer Research 32(7): 2759-2768

Sremac, M.; Stuart, E.S. 2010: SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation. Bmc Biotechnology 10: 54

Henshaw, P.S. 1947: Atomic energy; cancer cure or cancer cause. Science Illustrated 2(11): 46

Nie, X.; Sun, J.; Gordon, R.E.; Cai, C.-L.; Xu, P.-X. 2010: SIX1 acts synergistically with TBX18 in mediating ureteral smooth muscle formation. Development 137(5): 755-765

Negrisolo, S.; Centi, S.; Benetti, E.; Ghirardo, G.; Della Vella, M.; Murer, L.; Artifoni, L. 2014: SIX1 gene: absence of mutations in children with isolated congenital anomalies of kidney and urinary tract. Journal of Nephrology 27(6): 667-671

Wang, C.-A.; Jedlicka, P.; Patrick, A.N.; Micalizzi, D.S.; Lemmer, K.C.; Deitsch, E.; Casás-Selves, M.; Harrell, J.C.; Ford, H.L. 2012: SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. Journal of Clinical Investigation 122(5): 1895-1906

Liu, D.; Li, L.; Zhang, X.-X.; Wan, D.-Y.; Xi, B.-X.; Hu, Z.; Ding, W.-C.; Zhu, D.; Wang, X.-L.; Wang, W.; Feng, Z.-H.; Wang, H.; Ma, D.; Gao, Q.-L. 2014: SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C. Cancer Research 74(19): 5597-5607

Moree, E.A. 1916: Sixteen Hundred Cases of Sickness and what is to be Done about Them: Review of a Report on the Extent, Care and Prevention of Sickness in Dutchess County, made by the Committee on Hospitals of the new York State Charities Aid Association. American Journal of Public Health 6(1): 32-35

Rosenberg, S.L. 1930: Sixteenth Century German Medicine: Artzneybuch of Hofmedicus Gäbelthouer: Part Ii. California and Western Medicine 33(2): 602-606

Rosenberg, S.L. 1930: Sixteenth Century German Medicine: Artzneybuch of Hofmedicus Gäbelthouer: Part Iii. California and Western Medicine 33(3): 673-679

Howarth, O.J.R.; Darwin, C. 1947: Charles Darwin's life at Downe. Advancement of Science 4(14): 91-96

Miura, K.; Okamoto, H.; Okuma, E.; Shiba, H.; Kamada, H.; Hasegawa, P.M.; Murata, Y. 2013: SIZ1 deficiency causes reduced stomatal aperture and enhanced drought tolerance via controlling salicylic acid-induced accumulation of reactive oxygen species in Arabidopsis. Plant Journal: for Cell and Molecular Biology 73(1): 91-104

Miura, K.; Lee, J.; Gong, Q.; Ma, S.; Jin, J.B.; Yoo, C.Y.; Miura, T.; Sato, A.; Bohnert, H.J.; Hasegawa, P.M. 2011: SIZ1 regulation of phosphate starvation-induced root architecture remodeling involves the control of auxin accumulation. Plant Physiology 155(2): 1000-1012

Miura, K.; Ohta, M. 2010: SIZ1, a small ubiquitin-related modifier ligase, controls cold signaling through regulation of salicylic acid accumulation. Journal of Plant Physiology 167(7): 555-560

Bedoya, L.M.; Márquez, N.; Martínez, N.; Gutiérrez-Eisman, S.; Alvarez, A.; Calzado, M.A.; Rojas, J.é M.; Appendino, G.; Muñoz, E.; Alcamí, J.é 2009: SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro. Biochemical Pharmacology 77(6): 965-978

Al-Saeed, A. 2010: SJA is now on PubMed. Saudi Journal of Anaesthesia 4(2): 45

Al-Saeed, A. 2010: SJA, the dream became real. Saudi Journal of Anaesthesia 4(1): 1

Subramanian, P.T. 2000: SJKDT: the Need for a Cumulative Index. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 11(2): 209-210

Vieira, N.ás.M.; Bueno, C.R.; Brandalise, V.; Moraes, L.V.; Zucconi, E.; Secco, M.; Suzuki, M.F.; Camargo, M.M.; Bartolini, P.; Brum, P.C.; Vainzof, M.; Zatz, M. 2008: SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells 26(9): 2391-2398

Massilamany, C.; Marciano-Cabral, F.; Rocha-Azevedo, B.d.; Jamerson, M.; Gangaplara, A.; Steffen, D.; Zabad, R.; Illes, Z.; Sobel, R.A.; Reddy, J. 2014: SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens. Plos one 9(5): E98506

Takenokuchi, M.; Kadoyama, K.; Chiba, S.; Sumida, M.; Matsuyama, S.; Saigo, K.; Taniguchi, T. 2010: SJLB mice develop tauopathy-induced parkinsonism. Neuroscience Letters 473(3): 182-185

Lonati, D.; Zancan, A.; Pasi, A.; Schreiber, A.; Giampreti, A.; Pignatti, P.; Stella, M.; Locatelli, C.Alessandro.; Manzo, L.; Martinetti, M. 2014: SJS/TEN overlap associated with lomefloxacin: case report and molecular typing studies. Dermatology 229(4): 319-323

Lee, J.; Lim, K.-T. 2013: SJSZ glycoprotein (38 kDa) inhibits cell cycle and oxidative stress in N-methyl-N'-nitro-N-nitrosoguanidine-induced ICR mice. Anti-Cancer Agents in Medicinal Chemistry 13(4): 647-653

Lee, J.; Lim, K.-T. 2013: SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c. Molecular and Cellular Biochemistry 372(1-2): 17-26

Lee, J.; Lim, K-Taek. 2012: SJSZ glycoprotein (38kDa) prevents thymus atrophy and enhances expression of IL-2 and IL-12 in diethylnitrosamine-induced hepatocarcinogenesis. International Immunopharmacology 13(3): 362-369

Lee, J.; Lim, K.-T. 2012: SJSZ glycoprotein (38 kDa) modulates expression of IL-2, IL-12, and IFN-γ in cyclophosphamide-induced Balb/c. Inflammation Research: Official Journal of the European Histamine Research Society . 61(12): 1319-1328

Gu, N.; Hu, H.; Vervaeke, K.; Storm, J.F. 2008: SK (KCa2) channels do not control somatic excitability in CA1 pyramidal neurons but can be activated by dendritic excitatory synapses and regulate their impact. Journal of Neurophysiology 100(5): 2589-2604

Chen, L.; Deltheil, T.; Turle-Lorenzo, N.; Liberge, M.; Rosier, C.; Watabe, I.; Sreng, L.; Amalric, M.; Mourre, C. 2014: SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. International Journal of Neuropsychopharmacology 17(8): 1295-1306

Crespi, F. 2010: SK channel blocker apamin attenuates the effect of SSRi fluoxetine upon cell firing in dorsal raphe nucleus: a concomitant electrophysiological and electrochemical in vivo study reveals implications for modulating extracellular 5-HT. Brain Research 1334: 1-11

Aumann, T.D.; Gantois, I.; Egan, K.; Vais, A.; Tomas, D.; Drago, J.; Horne, M.K. 2008: SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta. Experimental Neurology 213(2): 419-430

Soder, R.P.; Parajuli, S.P.; Hristov, K.L.; Rovner, E.S.; Petkov, G.V. 2013: SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 304(2): R155-R163

Toporikova, N.; Chacron, M.J. 2009: SK channels gate information processing in vivo by regulating an intrinsic bursting mechanism seen in vitro. Journal of Neurophysiology 102(4): 2273-2287

Park, E.-J.; Kim, S.-Y.; Kim, S.-H.; Lee, C.R.; Kim, I.-S.; Park, J.K.; Lee, S.W.; Kim, B.J.; Chun, J.N.; So, I.; Jeon, J.-H. 2011: SK&F 96365 induces apoptosis and autophagy by inhibiting Akt-mTOR signaling in A7r5 cells. Biochimica et Biophysica Acta 1813(12): 2157-2164

Xue, W-Ning.; Wang, Y.; He, S-Ming.; Wang, X-Lian.; Zhu, J-Ling.; Gao, G-Dong. 2012: SK- and h-current contribute to the generation of theta-like resonance of rat substantia nigra pars compacta dopaminergic neurons at hyperpolarized membrane potentials. Brain Structure and Function 217(2): 379-394

Masuda, T.; Hattori, N.; Senoo, T.; Akita, S.; Ishikawa, N.; Fujitaka, K.; Haruta, Y.; Murai, H.; Kohno, N. 2013: SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor progression and angiogenesis. Molecular Cancer Therapeutics 12(11): 2378-2388

Moslehi, M.; Yazdanparast, R. 2013: SK-N-MC cell death occurs by distinct molecular mechanisms in response to hydrogen peroxide and superoxide anions: involvements of JAK2-STAT3, JNK, and p38 MAP kinases pathways. Cell Biochemistry and Biophysics 66(3): 817-829

Seo, J.-S.; Baek, I.-S.; Leem, Y.-H.; Kim, T.-K.; Cho, Y.; Lee, S.M.; Park, Y.H.; Han, P.-L. 2011: SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice. Brain Research 1368: 299-307

Seo, J.-S.; Kim, T.-K.; Leem, Y.-H.; Lee, K.-W.; Park, S.-K.; Baek, I.-S.; Kim, K.-S.; Im, G.-J.; Lee, S.M.; Park, Y.H.; Han, P.-L. 2009: SK-PC-B70M confers anti-oxidant activity and reduces Abeta levels in the brain of Tg2576 mice. Brain Research 1261: 100-108

Deignan, J.; Luján, R.; Bond, C.; Riegel, A.; Watanabe, M.; Williams, J.T.; Maylie, J.; Adelman, J.P. 2012: SK2 and SK3 expression differentially affect firing frequency and precision in dopamine neurons. Neuroscience 217: 67-76

Ohtsuki, G.; Piochon, C.; Adelman, J.P.; Hansel, C. 2012: SK2 channel modulation contributes to compartment-specific dendritic plasticity in cerebellar Purkinje cells. Neuron 75(1): 108-120

Haenel, F.; Biesold, K-H.; Denis, D.; Ebbinghaus, R.; Flatten, G.; Liebermann, P.; Linde, A. 2015: SK2 guidelines for assessment of mental and psychosomatic diseases: A statement. Der Nervenarzt 86(1): 72-73

Pierce, S.L.; England, S.K. 2010: SK3 channel expression during pregnancy is regulated through estrogen and Sp factor-mediated transcriptional control of the KCNN3 gene. American Journal of Physiology. Endocrinology and Metabolism 299(4): E640-E646

Weisbrod, D.; Peretz, A.; Ziskind, A.; Menaker, N.; Oz, S.; Barad, L.; Eliyahu, S.; Itskovitz-Eldor, J.; Dascal, N.; Khananshvili, D.; Binah, O.; Attali, B. 2013: SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 110(18): E1685-E1694

Feng, Z.; Liu, H.; Lang, J.; Li, Y.; Shu, M.; Chen, Z. 2009: SK66-his, a novel glycine-rich peptide derived from Drosophila with antibacterial activity. Bioscience Biotechnology and Biochemistry 73(3): 769-771

Li, J.; Xuan, J.W.; Khatamianfar, V.; Valiyeva, F.; Moussa, M.; Sadek, A.; Yang, B.B.; Dong, B.-J.; Huang, Y.-R.; Gao, W.-Q. 2014: SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis. Journal of Pathology 234(2): 178-189

Fang, L.; Seki, A.; Fang, G. 2009: SKAP associates with kinetochores and promotes the metaphase-to-anaphase transition. Cell Cycle 8(17): 2819-2827

Wang, H.; Lu, Y.; Rudd, C.E. 2010: SKAP1 is dispensable for chemokine-induced migration of primary T-cells. Immunology Letters 128(2): 148-153

Raab, M.; Smith, X.; Matthess, Y.; Strebhardt, K.; Rudd, C.E. 2011: SKAP1 protein PH domain determines RapL membrane localization and Rap1 protein complex formation for T cell receptor (TCR) activation of LFA-1. Journal of Biological Chemistry 286(34): 29663-29670

Zhou, L.; Zhang, Z.; Zheng, Y.; Zhu, Y.; Wei, Z.; Xu, H.; Tang, Q.; Kong, X.; Hu, L. 2011: SKAP2, a novel target of HSF4b, associates with NCK2/F-actin at membrane ruffles and regulates actin reorganization in lens cell. Journal of Cellular and Molecular Medicine 15(4): 783-795

Pyrhönen, K.; Läärä, E.; Kaila, M.; Hiltunen, L.; Näyhä, S. 2011: SKARP--A population-based cohort study of childhood food-associated symptoms perceived by parents and food allergies diagnosed by physicians: design, methods and participation. Scandinavian Journal of Public Health 39(2): 194-202

Feng, J.A.; Marshall, G.R. 2010: SKATE: a docking program that decouples systematic sampling from scoring. Journal of Computational Chemistry 31(14): 2540-2554

Theis, M.; Paszkowski-Rogacz, M.; Buchholz, F. 2009: SKAnking with Ska3: essential role of Ska3 in cell division revealed by combined phenotypic profiling. Cell Cycle 8(21): 3435-3437

Fan, H.; Zhang, Z.; Wang, N.; Cui, Y.; Sun, H.; Liu, Y.; Wu, H.; Zheng, S.; Bao, S.; Ling, H.-Q. 2014: SKB1/PRMT5-mediated histone H4R3 dimethylation of Ib subgroup bHLH genes negatively regulates iron homeostasis in Arabidopsis thaliana. Plant Journal: for Cell and Molecular Biology 77(2): 209-221

Regaya, I.; Aidi-Knani, S.; By, Y.; Condo, J.; Gerolami, V.; Berge-Lefranc, J.-L.; Ben Hamida, J.; Sabatier, J.-M.; Fenouillet, E.; Guieu, R.ég.; Ruf, J. 2013: SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells. Bioresearch Open Access 2(2): 163-168

Cipolla, M.J.; Smith, J.; Kohlmeyer, M.M.; Godfrey, J.A. 2009: SKCa and IKCa Channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 40(4): 1451-1457

Kanterakis, S.; Magira, E.; Rosenman, K.D.; Rossman, M.; Talsania, K.; Monos, D.S. 2008: SKDM human leukocyte antigen (HLA) tool: A comprehensive HLA and disease associations analysis software. Human Immunology 69(8): 522-525

Seelig, M.G. 1946: Management of advanced cancer. American Journal of Surgery 72: 1-3

Zarrindast, M.R.; Honardar, Z.; Sanea, F.; Owji, A.A. 2011: SKF 38393 and SCH 23390 inhibit reuptake of serotonin by rat hypothalamic synaptosomes. Pharmacology 87(1-2): 85-89

Sabioni, P.; D'Almeida, Vânia.; Andersen, M.L.; Andreatini, R.; Galduróz, Jé.C.F. 2012: SKF 38393 reverses cocaine-conditioned place preference in mice. Neuroscience Letters 513(2): 214-218

Faĭn, I.A.; Kuznik, B.I.; Kaminskiĭ, A.V.; Shenkman, L.; Kustovskaia, E.M.; Maksimova, O.G. 2012: SKF index as a new non-invasive parameter for the evaluation of the biological age for healthy and sick people. Advances in Gerontology 25(3): 386-393

Lee, S.-M.; Kant, A.; Blake, D.; Murthy, V.; Boyd, K.; Wyrick, S.J.; Mailman, R.B. 2014: SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C. Neuropharmacology 86: 145-154

Chen, K.-H.; Liu, H.; Yang, L.; Jin, M.-W.; Li, G.-R. 2015: SKF-96365 strongly inhibits voltage-gated sodium current in rat ventricular myocytes. Pflugers Archiv: European Journal of Physiology 467(6): 1227-1236

Kuznik, B.I.; Fain, I.A.; Kaminski, A.V.; Maksimova, O.G.; Kustovskaya, E.M. 2013: SKF-index as an indicator of biological age of hemostasis and blood vessels in children and adults in norm and pathology. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 56-59

Guo, L.; Zhao, J.; Jin, G.; Zhao, B.; Wang, G.; Zhang, A.; Zhen, X. 2013: SKF83959 is a potent allosteric modulator of sigma-1 receptor. Molecular Pharmacology 83(3): 577-586

Chu, H.-Y.; Wu, Q.; Zhou, S.; Cao, X.; Zhang, A.; Jin, G.-Z.; Hu, G.-Y.; Zhen, X. 2011: SKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism. Journal of Neuroscience Research 89(8): 1259-1266

Huang, C.; Wu, J.; Liao, R.; Zhang, W. 2012: SKF83959, an agonist of phosphatidylinositol-linked D(1)-like receptors, promotes ERK1/2 activation and cell migration in cultured rat astrocytes. Plos one 7(11): E49954

Schreyger, F.; Scharioth, G.; Baatz, H. 2008: SKGEL® implant versus T-Flux® implant in the contralateral eye in deep sclerectomy with phacoemulsification: long-term follow-up. Open Ophthalmology Journal 2: 57-61

Roemer, E.; Ottmueller, T.H.; Urban, H.-J.; Baillet-Mignard, C. 2010: SKH-1 mouse skin painting: a short-term assay to evaluate the tumorigenic activity of cigarette smoke condensate. Toxicology Letters 192(2): 155-161

Takahata, M.; Inoue, Y.; Tsuda, H.; Imoto, I.; Koinuma, D.; Hayashi, M.; Ichikura, T.; Yamori, T.; Nagasaki, K.; Yoshida, M.; Matsuoka, M.; Morishita, K.; Yuki, K.; Hanyu, A.; Miyazawa, K.; Inazawa, J.; Miyazono, K.; Imamura, T. 2009: SKi and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. Journal of Biological Chemistry 284(5): 3334-3344

Reed, J.A.; Chen, D.; Lin, Q.; Medrano, E.E. 2008: SKI is critical for repressing the growth inhibitory function of TGF-beta in human melanoma. Pigment Cell and Melanoma Research 21(4): 494-5; Author Reply 496-7

Chen, D.; Lin, Q.; Box, N.; Roop, D.; Ishii, S.; Matsuzaki, K.; Fan, T.; Hornyak, T.J.; Reed, J.A.; Stavnezer, E.; Timchenko, N.A.; Medrano, E.E. 2009: SKi knockdown inhibits human melanoma tumor growth in vivo. Pigment Cell and Melanoma Research 22(6): 761-772

Lin, Q.; Chen, D.; Timchenko, N.A.; Medrano, E.E. 2010: SKi promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta. Cell Cycle 9(9): 1684-1689

Rabbani, S.A.; Valentino, M.-L.; Arakelian, A.; Ali, S.; Boschelli, F. 2010: SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis. Molecular Cancer Therapeutics 9(5): 1147-1157

Kim, W.G.; Guigon, C.J.; Fozzatti, L.; Park, J.W.; Lu, C.; Willingham, M.C.; Cheng, S.-y. 2012: SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(5): 1281-1290

Liu, Y.; Zhu, Z.; Cai, H.; Liu, Q.; Zhou, H.; Zhu, Z. 2014: SKI-Ii reverses the chemoresistance of SGC7901/DDP gastric cancer cells. Oncology Letters 8(1): 367-373

Chiba, Y.; Takeuchi, H.; Sakai, H.; Misawa, M. 2010: SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. Journal of Pharmacological Sciences 114(3): 304-310

Choi, C.H.; Kim, T.-H.; Sung, Y.-K.; Choi, C.-B.; Na, Y.-I.; Yoo, H.; Jun, J.-B. 2014: SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes. Korean Journal of Internal Medicine 29(5): 647-655

Nováček, Vít.; Burns, G.A.P.C. 2014: SKIMMR: facilitating knowledge discovery in life sciences by machine-aided skim reading. Peerj 2: E483

Borsook, M.E. 1933: Skin Infection Due to Alternaria Tenuis: With the Report of a Case. Canadian Medical Association Journal 29(5): 479-482

Fyfe, M. 1982: Skin Temperature, Colour, and Warmth Felt, in Hydrocollator Pack Applications to the Lumbar Region. Australian Journal of PhysioTherapy 28(1): 12-15

Anonymous 1947: SKIN ulcers in warm countries. Journal of Tropical Medicine and Hygiene 50(6): 103

Temel, T.; Aktas, A.ül.; Ozgenel, S.M.; Özakyol, A.ül. 2016: Complete Eradication of Bleeding Duodenal Varices with Endoscopic Polydocanol Sclerotherapy. Euroasian Journal of Hepato-Gastroenterology 6(2): 176-178

Seifert, T.; Lund, A.; Kneissl, B.; Mueller, S.C.; Tautermann, C.S.; Hildebrandt, A. 2014: SKINK: a web server for string kernel based kink prediction in α-helices. Bioinformatics 30(12): 1769-1770

Kocić, J.; Villar, V.; Krstić, A.; Santibanez, J.F. 2012: SKIP Downregulation Increases TGF-β1-Induced Matrix Metalloproteinase-9 Production in Transformed Keratinocytes. Scientifica 2012: 861647

Kostrouch, D.; Kostrouchová, M.ét.; Yilma, P.; Chughtai, A.A.; Novotný, J.P.; Novák, P.; Kostrouchová, V.; Kostrouchová, M.; Kostrouch, Z.ěk. 2014: SKIP and BIR-1/Survivin have potential to integrate proteome status with gene expression. Journal of Proteomics 110: 93-106

Chen, Y.; Zhang, L.; Jones, K.A. 2011: SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Genes and Development 25(7): 701-716

Wang, L.; Zhang, M.; Wu, Y.; Cheng, C.; Huang, Y.; Shi, Z.; Huang, H. 2014: SKIP expression is correlated with clinical prognosis in patients with bladder cancer. International Journal of Clinical and Experimental Pathology 7(4): 1695-1701

Brès, V.; Yoshida, T.; Pickle, L.; Jones, K.A. 2009: SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Molecular Cell 36(1): 75-87

Villar, V.; Kocic, J.; Bugarski, D.; Jovcic, G.; Santibanez, J.F. 2010: SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes. Febs Letters 584(22): 4586-4592

Dumont, A.; Boucrot, E.; Drevensek, S.ép.; Daire, V.; Gorvel, J.-P.; Poüs, C.; Holden, D.W.; Méresse, S.ép. 2010: SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-dependent vacuolar membrane exchanges. Traffic 11(7): 899-911

Fabre, A.; Charroux, B.; Martinez-Vinson, C.; Roquelaure, B.; Odul, E.; Sayar, E.; Smith, H.; Colomb, V.; Andre, N.; Hugot, J.-P.; Goulet, O.; Lacoste, C.; Sarles, J.; Royet, J.; Levy, N.; Badens, C. 2012: SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome. American Journal of Human Genetics 90(4): 689-692

He, C.-M.; Cai, L.-L.; Zheng, H.; Ma, L.; Luo, Y.-F.; Chen, L.-J. 2009: SKLB-102 inhibits acute hepatitis induced by concanavalin a in mice. Sichuan da Xue Xue Bao. Yi Xue Ban 40(4): 697-699; 711

Chen, X.; Liu, Y.; Yang, H.-W.; Zhou, S.; Cheng, C.; Zheng, M.-W.; Zhong, L.; Fu, X.-Y.; Pan, Y.-L.; Ma, S.; Tang, Y.; Chen, Y.-Z.; Li, L.-L.; Yang, S.-Y. 2014: SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model. Neoplasma 61(5): 514-522

Wang, J.; Yang, Z.; Wen, J.; Ma, F.; Wang, F.; Yu, K.; Tang, M.; Wu, W.; Dong, Y.; Cheng, X.; Nie, C.; Chen, L. 2014: SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation. Journal of Pharmacological Sciences 126(3): 198-207

Xie, C.; Ma, L.; Liu, J.; Li, X.; Pei, H.; Xiang, M.; Chen, L. 2013: SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage. Plos one 8(2): E56349

Shen, G.; Li, Y.; Du, T.; Shi, G.; Dai, L.; Chen, X.; Zheng, R.; Li, W.; Su, X.; Zhang, S.; Wei, Y.; Yang, S.; Deng, H. 2012: SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy. Neoplasma 59(5): 486-493

Zhang, S.; Cao, Z.; Tian, H.; Shen, G.; Ma, Y.; Xie, H.; Liu, Y.; Zhao, C.; Deng, S.; Yang, Y.; Zheng, R.; Li, W.; Zhang, N.; Liu, S.; Wang, W.; Dai, L.; Shi, S.; Cheng, L.; Pan, Y.; Feng, S.; Zhao, X.; Deng, H.; Yang, S.; Wei, Y. 2011: SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(13): 4439-4450

Pan, Y.; Xu, Y.; Feng, S.; Luo, S.; Zheng, R.; Yang, J.; Wang, L.; Zhong, L.; Yang, H.-Y.; Wang, B.-L.; Yu, Y.; Liu, J.; Cao, Z.; Wang, X.; Ji, P.; Wang, Z.; Chen, X.; Zhang, S.; Wei, Y.-Q.; Yang, S.-Y. 2012: SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants, ErbB2, ErbB4, and VEGFR2, displays potent antitumor activity both in vitro and in vivo. Molecular Cancer Therapeutics 11(4): 952-962

Xia, Y.; Lei, Q.; Zhu, Y.; Ye, T.; Wang, N.; Li, G.; Shi, X.; Liu, Y.; Shao, B.; Yin, T.; Zhao, L.; Wu, W.; Song, X.; Xiong, Y.; Wei, Y.; Yu, L. 2014: SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo. Cancer Letters 355(2): 297-309

Cao, Z.-X.; Zheng, R.-L.; Lin, H.-J.; Luo, S.-D.; Zhou, Y.; Xu, Y.-Z.; Zeng, X.-X.; Wang, Z.; Zhou, L.-N.; Mao, Y.-Q.; Yang, L.; Wei, Y.-Q.; Yu, L.-T.; Yang, S.-Y.; Zhao, Y.-L. 2011: SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 27(5): 565-574

Han, Y.; He, H.; Peng, F.; Liu, J.; Dai, X.; Lin, H.; Xu, Y.; Zhou, T.; Mao, Y.; Xie, G.; Yang, S.; Yu, L.; Yang, L.; Zhao, Y. 2012: SKLB70326, a novel small-molecule inhibitor of cell-cycle progression, induces G₀/G₁ phase arrest and apoptosis in human hepatic carcinoma cells. Biochemical and Biophysical Research Communications 421(4): 684-689

Liu, Y.; Li, M.; Cheung, Y.M.; Sham, P.C.; Ng, M.K. 2010: SKM-SNP: SNP markers detection method. Journal of Biomedical Informatics 43(2): 233-239

Jansen, R.T.P.; Slingerland, R.J. 2010: SKML-Quality Mark for point-of-care test (POCT) glucose meters and glucose meters for home-use. Clinical Chemistry and Laboratory Medicine 48(7): 1021-1027

Choe, K.P.; Leung, C.K. 2013: SKN-1/Nrf, a new unfolded protein response factor?. Plos Genetics 9(9): E1003827

Vanduyn, N.; Settivari, R.; Wong, G.; Nass, R. 2010: SKN-1/Nrf2 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of methylmercury toxicity. Toxicological Sciences: An Official Journal of the Society of Toxicology 118(2): 613-624

Tree, J.J.; Longmore, C.; Majerus, S.; Evans, N. 2011: SKOOL versus ZOOL: effects of orthographic and phonological long-term memory on nonword immediate serial recall. Memory 19(5): 487-500

Zhai, X-Hui.; Liu, M.; Guo, X-Juan.; Wang, S-Cen.; Zhang, H-Xia.; Guo, Y-Min. 2011: SKOV-3 cell imaging by paramagnetic particles labeled with hairpin cell-penetrating peptides. Chinese Medical Journal 124(1): 111-117

Beaudry, V.G.; Attardi, L.D. 2009: SKP-ing TAp63: stem cell depletion, senescence, and premature aging. Cell Stem Cell 5(1): 1-2

Chen, J.; Shen, B.-Y.; Deng, X.-X.; Zhan, Q.; Peng, C.-H. 2012: SKP1-CULLIN1-F-box (SCF)-mediated DRG2 degradation facilitated chemotherapeutic drugs induced apoptosis in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 420(3): 651-655

Calvisi, D.F.; Ladu, S.; Pinna, F.; Frau, M.; Tomasi, M.L.; Sini, M.; Simile, M.M.; Bonelli, P.; Muroni, M.R.; Seddaiu, M.A.; Lim, D.-S.; Feo, F.; Pascale, R.M. 2009: SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology 137(5): 1816-26.E1-10

Schüler, S.; Diersch, S.; Hamacher, R.; Schmid, R.M.; Saur, D.; Schneider, G.ün. 2011: SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis. International Journal of Oncology 38(1): 219-225

Lv, A.; Li, Z.; Tian, X.; Guan, X.; Zhao, M.; Dong, B.; Hao, C. 2013: SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors. Plos one 8(5): E62951

Bretones, G.; Acosta, J.C.; Caraballo, J.M.; Ferrándiz, N.; Gómez-Casares, M.T.; Albajar, M.; Blanco, R.; Ruiz, P.; Hung, W.-C.; Albero, M.P.; Perez-Roger, I.; León, J. 2011: SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. Journal of Biological Chemistry 286(11): 9815-9825

Fagan-Solis, K.D.; Pentecost, B.T.; Gozgit, J.M.; Bentley, B.A.; Marconi, S.M.; Otis, C.N.; Anderton, D.L.; Schneider, S.S.; Arcaro, K.F. 2014: SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. Journal of Cellular Physiology 229(9): 1160-1169

Xiao, J.; Yin, S.; Li, Y.; Xie, S.; Nie, D.; Ma, L.; Wang, X.; Wu, Y.; Feng, J. 2009: SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells. Acta Biochimica et Biophysica Sinica 41(8): 699-708

Jurado, S.; Triviño, S.Díaz.; Abraham, Z.; Manzano, Cón.; Gutierrez, C.; Del Pozo, C. 2008: SKP2A protein, an F-box that regulates cell division, is degraded via the ubiquitin pathway. Plant Signaling and Behavior 3(10): 810-812

Arcuri, H.A.; Zafalon, G.F.; Marucci, E.A.; Bonalumi, C.E.; da Silveira, N.J.; Machado, J.é M.; de Azevedo, W.F.; Palma, M.ár.S. 2010: SKPDB: a structural database of shikimate pathway enzymes. Bmc Bioinformatics 11: 12

Biernaskie, J.; Paris, M.; Morozova, O.; Fagan, B.M.; Marra, M.; Pevny, L.; Miller, F.D. 2009: SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 5(6): 610-623

Stradling, J.; Kohler, M. 2014: SKUP3 trial: comment. Thorax 69(4): 386

Rodríguez Lombardero, S.; Vizoso Vázquez, A.; Rodríguez Belmonte, E.; González Siso, M.I.; Cerdán, M.E. 2012: SKY1 and IXR1 interactions, their effects on cisplatin and spermine resistance in Saccharomyces cerevisiae. Canadian Journal of Microbiology 58(2): 184-188

Rashid, R.; Munk, P.L.; Heran, M.; Malfair, D.; Chiu, O. 2009: SKyphoplasty. Canadian Association of Radiologists Journal 60(5): 273-278

Lasda, E.L.; Kuersten, S.; Blumenthal, T. 2011: SL trans-splicing in a Caenorhabditis elegans in vitro extract. Cold Spring Harbor Protocols 2: Pdb.Prot 5574

Zhao, C.; Yue, B.; Liu, H.; Sun, C.; Li, W.; Qu, X. 2012: SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine. Toxicology and Applied Pharmacology 262(3): 293-300

Frolova, O.; Benito, J.; Brooks, C.; Wang, R.-Y.; Korchin, B.; Rowinsky, E.K.; Cortes, J.; Kantarjian, H.; Andreeff, M.; Frankel, A.E.; Konopleva, M. 2014: SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia. British Journal of Haematology 166(6): 862-874

Qin, Y.; Lu, Y.; Wang, R.; Li, W.; Qu, X. 2013: SL1122-37, a novel derivative of sorafenib, has greater effects than sorafenib on the inhibition of human hepatocellular carcinoma (HCC) growth and prevention of angiogenesis. Bioscience Trends 7(5): 237-244

Harrison, N.; Kalbfleisch, A.; Connolly, B.; Pettitt, J.; Müller, B. 2010: SL2-like spliced leader RNAs in the basal nematode Prionchulus punctatus: new insight into the evolution of nematode SL2 RNAs. Rna 16(8): 1500-1507

Yeom, S.-C.; Park, C.-G.; Lee, B.-C.; Lee, W.-J. 2010: SLA typing using the PCR-SSP method and establishment of the SLA homozygote line in pedigreed SNU miniature pigs. Animal Science Journal 81(2): 158-164

Couratier, P. 2013: SLA, cognition and clinical practice. Revue Neurologique (Paris) 169(3): 209-210

Ando, A.; Shigenari, A.; Ota, M.; Sada, M.; Kawata, H.; Azuma, F.; Kojima-Shibata, C.; Nakajoh, M.; Suzuki, K.; Uenishi, H.; Kulski, J.K.; Inoko, H. 2011: SLA-DRB1 and -DQB1 genotyping by the PCR-SSOP-Luminex method. Tissue Antigens 78(1): 49-55

Volkmann, M.; Luithle, D.; Zentgraf, H.; Schnölzer, M.; Fiedler, S.; Heid, H.; Schulze-Bergkamen, A.; Strassburg, C.P.; Gehrke, S.G.; Manns, M.P. 2010: SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract. Journal of Autoimmunity 34(1): 59-65

Gale, C.A.; Leonard, M.D.; Finley, K.R.; Christensen, L.; McClellan, M.; Abbey, D.; Kurischko, C.; Bensen, E.; Tzafrir, I.; Kauffman, S.; Becker, J.; Berman, J. 2009: SLA2 mutations cause SWE1-mediated cell cycle phenotypes in Candida albicans and Saccharomyces cerevisiae. Microbiology 155(Part 12): 3847-3859

Waldrop, M.M. 1989: SLAC Feels the Thrill of the Chase: With Z particles now in regular production, Stanford's troubled "Z factory" finally seems to be on the right track. Science 244(4906): 771-773

Hamilton, D.P. 1992: SLAC Sees Writing on the Wall. Science 256(5056): 432-434

Pollock, J.; Giachino, A.A.; Rakhra, K.; DiPrimio, G.; Hrushowy, H.; Conway, A.F.; Andreyechen, M. 2010: SLAC wrist in the absence of recognised trauma and CPPD. Hand Surgery: An International Journal Devoted to Hand and Upper Limb Surgery and Related Research: Journal of the Asia-Pacific Federation of Societies for Surgery of the Hand 15(3): 193-201

H, D.P. 1992: SLAC's Greatest Hits. Science 256(5056): 433

Feliciano, D.; Di Pietro, S.M. 2012: SLAC, a complex between Sla1 and Las17, regulates actin polymerization during clathrin-mediated endocytosis. Molecular Biology of the Cell 23(21): 4256-4272

Walsh, J. 1964: SLAC: Stanford-AEC Accelerator Is Coming Along on Schedule, but Creating Some High Tension. Science 143(3613): 1419-1421

Sun, X.; Liu, D.; Zhang, X.; Li, W.; Liu, H.; Hong, W.; Jiang, C.; Guan, N.; Ma, C.; Zeng, H.; Xu, C.; Song, J.; Huang, L.; Wang, C.; Shi, J.; Wang, R.; Zheng, X.; Lu, C.; Wang, X.; Zheng, H. 2013: SLAF-seq: an efficient method of large-scale de novo SNP discovery and genotyping using high-throughput sequencing. Plos one 8(3): E58700

Van der Vaart, B.; Manatschal, C.; Grigoriev, I.; Olieric, V.; Gouveia, S.M.; Bjelic, S.; Demmers, J.; Vorobjev, I.; Hoogenraad, C.C.; Steinmetz, M.O.; Akhmanova, A. 2011: SLAIN2 links microtubule plus end-tracking proteins and controls microtubule growth in interphase. Journal of Cell Biology 193(6): 1083-1099

Cheein, F.A.A.; Lopez, N.; Soria, C.M.; di Sciascio, F.A.; Pereira, F.L.; Carelli, R. 2010: SLAM algorithm applied to robotics assistance for navigation in unknown environments. Journal of Neuroengineering and Rehabilitation 7: 10

Clifford, H.D.; Richmond, P.; Khoo, S.-K.; Zhang, G.; Yerkovich, S.T.; Le Souëf, P.N.; Hayden, C.M. 2011: SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Vaccine 29(33): 5407-5413

Wang, N.; Xiao, F.; Liu, J.-P.; Wang, D.; Geng, Z.; Wang, J.; Ma, S.-Y.; Shu, L.-L.; Chen, T.-P.; Zhou, J.-F.; Huang, L. 2011: SLAM family predicting the initiation potential of human acute lymphoblastic leukemia in NOD/SCID mice. Chinese Medical Journal 124(19): 3074-3079

Cannons, J.L.; Tangye, S.G.; Schwartzberg, P.L. 2011: SLAM family receptors and SAP adaptors in immunity. Annual Review of Immunology 29: 665-705

Detre, C.; Keszei, M.; Romero, X.; Tsokos, G.C.; Terhorst, C. 2010: SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Seminars in Immunopathology 32(2): 157-171

Bailey, C.M.; Barth, J.T.; Bender, S.D. 2009: SLAM on the stand: how the sports-related concussion literature can inform the expert witness. Journal of Head Trauma Rehabilitation 24(2): 123-130

Huang, Y.-H.; Tsai, K.; Ma, C.; Vallance, B.A.; Priatel, J.J.; Tan, R. 2014: SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis. Journal of Immunology 193(12): 5841-5853

Veillette, A.é 2010: SLAM-family receptors: immune regulators with or without SAP-family adaptors. Cold Spring Harbor Perspectives in Biology 2(3): A002469

Chatterjee, M.; Kis-Toth, K.; Thai, T.-H.; Terhorst, C.; Tsokos, G.C. 2011: SLAMF6-driven co-stimulation of human peripheral T cells is defective in SLE T cells. Autoimmunity 44(3): 211-218

Dvorák, V. 1997: SLAP Injuries - Superior Labrum Anterior Posterior.. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 64(3): 161-165

Tan, B.Y.; Lee, K. 2012: SLAP Lesion with Supraglenoid Labral Cyst causing Suprascapular Nerve Compression: A case report. Malaysian Orthopaedic Journal 6(Suppla): 46-48

Peterson, L.K.; Pennington, L.F.; Shaw, L.A.; Brown, M.; Treacy, E.C.; Friend, S.F.; Hatlevik, Øy.; Rubtsova, K.; Rubtsov, A.V.; Dragone, L.L. 2014: SLAP deficiency decreases dsDNA autoantibody production. Clinical Immunology 150(2): 201-209

Peterson, L.K.; Shaw, L.A.; Joetham, A.; Sakaguchi, S.; Gelfand, E.W.; Dragone, L.L. 2011: SLAP deficiency enhances number and function of regulatory T cells preventing chronic autoimmune arthritis in SKG mice. Journal of Immunology 186(4): 2273-2281

Rokito, S.E.; Myers, K.R.; Ryu, R.K.N. 2014: SLAP lesions in the overhead athlete. Sports Medicine and Arthroscopy Review 22(2): 110-116

Dodson, C.C.; Altchek, D.W. 2009: SLAP lesions: an update on recognition and treatment. Journal of Orthopaedic and Sports Physical Therapy 39(2): 71-80

Chang, D.; Mohana-Borges, A.; Borso, M.; Chung, C.B. 2008: SLAP lesions: anatomy, clinical presentation, MR imaging diagnosis and characterization. European Journal of Radiology 68(1): 72-87

Powers, R. 2011: SLAP lesions: how to recognize and treat this debilitating shoulder injury. Jaapa: Official Journal of the American Academy of Physician Assistants 24(3): 32; 35-38 Passim

Pujol, N.; Hardy, P. 2006: SLAP lesions: treatment. Chirurgie de la Main 25(Suppl 1): S70-S74

Dragone, L.L.; Shaw, L.A.; Myers, M.D.; Weiss, A. 2009: SLAP, a regulator of immunoreceptor ubiquitination, signaling, and trafficking. Immunological Reviews 232(1): 218-228

Schuh, A.; Eibl, P.; Pfeiffer, M.; Manolikakis, G. 2011: SLAP-lesion of the shoulder. MMW Fortschritte der Medizin 153(47): 43-44

Cherpokova, D.; Bender, M.; Morowski, M.; Kraft, P.; Schuhmann, M.K.; Akbar, S.M.; Sultan, C.S.; Hughes, C.E.; Kleinschnitz, C.; Stoll, G.; Dragone, L.L.; Watson, S.P.; Tomlinson, M.G.; Nieswandt, B. 2015: SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice. Blood 125(1): 185-194

Youn, B.U.; Kim, K.; Kim, J.H.; Lee, J.; Moon, J.B.; Kim, I.; Park, Y.-W.; Kim, N. 2013: SLAT negatively regulates RANKL-induced osteoclast differentiation. Molecules and Cells 36(3): 252-257

Feau, S.; Schoenberger, S.P.; Altman, A.; Bécart, S.ép. 2013: SLAT regulates CD8+ T cell clonal expansion in a Cdc42- and NFAT1-dependent manner. Journal of Immunology 190(1): 174-183

Canonigo-Balancio, A.J.; Fos, C.; Prod'homme, T.; Bécart, S.ép.; Altman, A. 2009: SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis. Journal of Immunology 183(11): 7259-7267

Vistica, B.P.; Shi, G.; Nugent, L.; Tan, C.; Altman, A.; Gery, I. 2012: SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU). Molecular Vision 18: 1858-1864

Mishra, S.; Sharma, K.S.; Lee, S.J.; Fox, E.A.; Wang, G. 2012: SLATE: virtualizing multiscale CT training. Journal of X-Ray Science and Technology 20(2): 239-248

Denny, J. 2009: SLAs add accountability. Agreements can address a broad range of issues, including technical performance and customer-service responsiveness. Health Management Technology 30(7): 32 31

Xue, G.; Cheng, Y.; Ran, F.; Li, X.; Huang, T.; Yang, Y.; Zhang, Y. 2013: SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro. Oncology Reports 29(2): 595-604

Zhou, S.; Li, R.; Qin, J.; Zhong, C.; Liang, C. 2010: SLC/CCR7 stimulates the proliferation of BMDCs by the pNF-kappaB p65 pathway. Anatomical Record 293(1): 48-54

Grewer, C.; Gameiro, A.; Rauen, T. 2014: SLC1 glutamate transporters. Pflugers Archiv: European Journal of Physiology 466(1): 3-24

Nakagawa, T.; Kaneko, S. 2013: SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain. Current Molecular Pharmacology 6(2): 66-73

Larhammar, M.; Patra, K.; Blunder, M.; Emilsson, L.; Peuckert, C.; Arvidsson, E.; Rönnlund, D.; Preobraschenski, J.; Birgner, C.; Limbach, C.; Widengren, J.; Blom, H.; Jahn, R.; Wallén-Mackenzie, Ås.; Kullander, K. 2015: SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis. Biological Psychiatry 77(6): 526-536

Jin, J.; Sun, L.; Jiao, W.; Zhao, S.; Li, H.; Guan, X.; Jiao, A.; Jiang, Z.; Shen, A. 2009: SLC11A1 (Formerly NRAMP1) gene polymorphisms associated with pediatric tuberculosis in China. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 48(6): 733-738

Li, X.; Yang, Y.; Zhou, F.; Zhang, Y.; Lu, H.; Jin, Q.; Gao, L. 2011: SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. Plos one 6(1): E15831

Singh, A.; Gaughan, J.P.; Kashyap, V.K. 2011: SLC11A1 and VDR gene variants and susceptibility to tuberculosis and disease progression in East India. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 15(11): 1468-1474 i

Zhang, C.; Wang, Y.; Chen, H.; Gu, C.; Fang, X. 2009: SLC11A1 gene polymorphisms are not associated to somatic cell score and milk yield in Chinese Holstein. Veterinary Immunology and Immunopathology 127(3-4): 389-392

Ejghal, R.â; Hida, M.; Idrissi, M.L.; Hessni, A.E.; Lemrani, M. 2014: SLC11A1 polymorphisms and susceptibility to visceral leishmaniasis in Moroccan patients. Acta Tropica 140: 130-136

Stewart, L.C.; Day, A.S.; Pearson, J.; Barclay, M.L.; Gearry, R.B.; Roberts, R.L.; Bentley, R.W. 2010: SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status. World Journal of Gastroenterology 16(45): 5727-5731

Li, X.; Yu, T.; Huang, X.; Cao, Y.; Li, X.; Liu, B.; Yang, F.; Li, W.; Zhao, X.; Feng, G.; Zhang, X.; Dong, Z.; Lin, Y.; Li, X.; He, L.; Sun, X.; He, G. 2014: SLC17A7 gene may be the indicator of selective serotonin reuptake inhibitor treatment response in the Chinese Han population. Journal of Clinical Psychopharmacology 34(3): 331-336

Cao, Q.; Zhao, K.; Zhong, X.Z.ë; Zou, Y.; Yu, H.; Huang, P.; Xu, T.-L.; Dong, X.-P. 2014: SLC17A9 protein functions as a lysosomal ATP transporter and regulates cell viability. Journal of Biological Chemistry 289(33): 23189-23199

Lima, A.; Bernardes, M.; Sousa, H.; Azevedo, R.; Costa, L.úc.; Ventura, F.; Seabra, V.ít.; Medeiros, R. 2014: SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients. Pharmacogenomics 15(6): 807-820

Gutierrez-Camino, A.; Lopez-Lopez, E.; Garcia-Orad, A. 2014: SLC19A1 hot spot for MTX plasma concentration. Medical Oncology 31(10): 204

Yee, S.Wah.; Gong, L.; Badagnani, I.; Giacomini, K.M.; Klein, T.E.; Altman, R.B. 2010: SLC19A1 pharmacogenomics summary. Pharmacogenetics and Genomics 20(11): 708-715

Lima, A.; Bernardes, M.; Azevedo, R.; Monteiro, J.; Sousa, H.; Medeiros, R.; Seabra, V.ít. 2014: SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients. Toxicological Sciences: An Official Journal of the Society of Toxicology 142(1): 196-209

Ross, J.P.; Rayaprolu, S.; Bernales, C.Q.; Soto-Ortolaza, A.I.; van Gerpen, J.; Uitti, R.J.; Wszolek, Z.K.; Rajput, A.; Rajput, A.H.; Rajput, M.L.; Ross, O.A.; Vilariño-Güell, C. 2014: SLC1A2 rs3794087 does not associate with essential tremor. Neurobiology of Aging 35(4): 935.E9

García-Martín, E.; Martínez, C.; Serrador, M.; Alonso-Navarro, H.; Navacerrada, F.; Agúndez, J.é A.G.; Jiménez-Jiménez, F.él.J. 2014: SLC1A2 rs3794087 variant and risk for migraine. Journal of the Neurological Sciences 338(1-2): 92-95

Tan, E.-K.; Foo, J.-N.; Tan, L.; Au, W.-L.; Prakash, K.M.; Ng, E.; Ikram, M.K.; Wong, T.-Y.; Liu, J.-J.; Zhao, Y. 2013: SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects. Neurology 80(17): 1618-1619

Yu, S.-w.; Chen, C.-M.; Chen, Y.-C.; Chang, C.W.; Chang, H.-S.; Lyu, R.-K.; Ro, L.-S.; Wu, Y.-R. 2013: SLC1A2 variant is associated with essential tremor in Taiwanese population. Plos one 8(8): E71919

Hassanein, M.; Hoeksema, M.D.; Shiota, M.; Qian, J.; Harris, B.K.; Chen, H.; Clark, J.E.; Alborn, W.E.; Eisenberg, R.; Massion, P.P. 2013: SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(3): 560-570

Baker, M.; Strongosky, A.J.; Sanchez-Contreras, M.Y.; Yang, S.; Ferguson, W.; Calne, D.B.; Calne, S.; Stoessl, A.J.; Allanson, J.E.; Broderick, D.F.; Hutton, M.L.; Dickson, D.W.; Ross, O.A.; Wszolek, Z.K.; Rademakers, R. 2014: SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics 15(1): 23-30

Gupta, S.; Burckhardt, G.; Hagos, Y. 2011: SLC22 transporter family proteins as targets for cytostatic uptake into tumor cells. Biological Chemistry 392(1-2): 117-124

Pelis, R.M.; Wright, S.H. 2014: SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties. Current Topics in Membranes 73: 233-261

Singh, O.; Chan, J.Y.; Lin, K.; Heng, C.C.T.; Chowbay, B. 2012: SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia. Plos one 7(12): E51771

Kuriki, S.; Okada, R.; Suzuki, K.; Ito, Y.; Morita, E.; Naito, M.; Hamajima, N. 2011: SLC22A12 W258X frequency according to serum uric acid level among Japanese health checkup examinees. Nagoya Journal of Medical Science 73(1-2): 41-48

Schulz, C.; Fork, C.; Bauer, T.; Golz, S.; Geerts, A.; Schömig, E.; Gründemann, D. 2014: SLC22A13 catalyses unidirectional efflux of aspartate and glutamate at the basolateral membrane of type a intercalated cells in the renal collecting duct. Biochemical Journal 457(2): 243-251

Feng, Y.; Zheng, P.; Zhao, H.; Wu, K. 2009: SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. Journal of Digestive Diseases 10(3): 181-187

Okada, Y.; Mori, M.; Yamada, R.; Suzuki, A.; Kobayashi, K.; Kubo, M.; Nakamura, Y.; Yamamoto, K. 2008: SLC22A4 polymorphism and rheumatoid arthritis susceptibility: a replication study in a Japanese population and a metaanalysis. Journal of Rheumatology 35(9): 1723-1728

Yoon, Y.A.; Lee, D.H.; Ki, C.-S.; Lee, S.-Y.; Kim, J.-W.; Lee, Y.-W.; Park, H.-D. 2012: SLC22A5 mutations in a patient with systemic primary carnitine deficiency: the first Korean case confirmed by biochemical and molecular investigation. Annals of Clinical and Laboratory Science 42(4): 424-428

Wang, C.; Uray, I.P.; Mazumdar, A.; Mayer, J.A.; Brown, P.H. 2012: SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE). Breast Cancer Research and Treatment 134(1): 101-115

De Jong, T.M.H.; Jochens, A.; Jockel-Schneider, Y.; Harks, I.; Dommisch, H.; Graetz, C.; Flachsbart, F.; Staufenbiel, I.; Eberhard, J.ör.; Folwaczny, M.; Noack, B.; Meyle, J.; Eickholz, P.; Gieger, C.; Grallert, H.; Lieb, W.; Franke, A.; Nebel, A.; Schreiber, S.; Doerfer, C.; Jepsen, S.ør.; Bruckmann, C.; van der Velden, U.; Loos, B.G.; Schaefer, A.S. 2014: SLC23A1 polymorphism rs6596473 in the vitamin C transporter SVCT1 is associated with aggressive periodontitis. Journal of Clinical Periodontology 41(6): 531-540

Santiago, M.íl.B.; DE Lima Marson, F.A.; Secolin, R.; Ribeiro, J.é D.; Lima, C.S.íl.P.; Bertuzzo, C.S. 2014: SLC23A2-05 (rs4987219) and KRAS-LCS6 (rs61764370) polymorphisms in patients with squamous cell carcinoma of the head and neck. Oncology Letters 7(6): 1803-1811

Kolukula, V.K.; Sahu, G.; Wellstein, A.; Rodriguez, O.C.; Preet, A.; Iacobazzi, V.; D'Orazi, G.; Albanese, C.; Palmieri, F.; Avantaggiati, M.L. 2014: SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget 5(5): 1212-1225

Song, Y.-Z.; Zhang, Z.-H.; Lin, W.-X.; Zhao, X.-J.; Deng, M.; Ma, Y.-L.; Guo, L.; Chen, F.-P.; Long, X.-L.; He, X.-L.; Sunada, Y.; Soneda, S.; Nakatomi, A.; Dateki, S.; Ngu, L.-H.; Kobayashi, K.; Saheki, T. 2013: SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. Plos one 8(9): E74544

Wen, P.-Q.; Wang, G.-B.; Chen, Z.-L.; Cui, D.; Yuan, Q.; Song, P.; Chen, S.-L.; Liao, J.-X.; Li, C.-R. 2011: SLC25A13 gene analysis in neonates with intrahepatic cholestasis caused by citrin deficiency. Zhongguo Dang Dai Er Ke Za Zhi 13(4): 303-308

Song, Y.-Z.; Ushikai, M.; Sheng, J.-s.; Iijima, M.; Kobayashi, K. 2007: SLC25A13 gene mutation analysis in a pedigree of neonatal intrahepatic cholestasis caused by citrin deficiency. Zhonghua Er Ke Za Zhi 45(6): 408-412

Zhang, S.-r.; Wang, J.-s.; Wang, X.-h.; Zhu, Q.-r.; Liu, L.-y. 2008: SLC25A13 gene mutations in Chinese infants with intrahepatic cholestasis and abnormal blood amino acids. Zhonghua Gan Zang Bing Za Zhi 16(6): 445-448

Chang, K.-W.; Chen, H.-L.; Chien, Y.-H.; Chen, T.-C.; Yeh, C.-T. 2011: SLC25A13 gene mutations in Taiwanese patients with non-viral hepatocellular carcinoma. Molecular Genetics and Metabolism 103(3): 293-296

Spiegel, R.; Shaag, A.; Edvardson, S.; Mandel, H.; Stepensky, P.; Shalev, S.A.; Horovitz, Y.; Pines, O.; Elpeleg, O. 2009: SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Annals of Neurology 66(3): 419-424

Poduri, A.; Heinzen, E.L.; Chitsazzadeh, V.; Lasorsa, F.M.; Elhosary, P.C.; LaCoursiere, C.M.; Martin, E.; Yuskaitis, C.J.; Hill, R.S.; Atabay, K.D.; Barry, B.; Partlow, J.N.; Bashiri, F.A.; Zeidan, R.M.; Elmalik, S.A.; Kabiraj, M.M.U.; Kothare, S.; Stödberg, T.; McTague, A.; Kurian, M.A.; Scheffer, I.E.; Barkovich, A.J.; Palmieri, F.; Salih, M.A.; Walsh, C.A. 2013: SLC25A22 is a novel gene for migrating partial seizures in infancy. Annals of Neurology 74(6): 873-882

Hoffman, N.E.; Chandramoorthy, H.C.; Shanmughapriya, S.; Zhang, X.Q.; Vallem, S.; Doonan, P.J.; Malliankaraman, K.; Guo, S.; Rajan, S.; Elrod, J.W.; Koch, W.J.; Cheung, J.Y.; Madesh, M. 2014: SLC25A23 augments mitochondrial Ca²⁺ uptake, interacts with MCU, and induces oxidative stress-mediated cell death. Molecular Biology of the Cell 25(6): 936-947

Park, K.-P.; Kim, H.-S.; Kim, E.-S.; Park, Y.-E.; Lee, C.-H.; Kim, D.-S. 2011: SLC25A4 and C10ORF2 Mutations in Autosomal Dominant Progressive External Ophthalmoplegia. Journal of Clinical Neurology 7(1): 25-30

Chan, H.C.; Sun, X. 2014: SLC26 anion exchangers in uterine epithelial cells and spermatozoa: clues from the past and hints to the future. Cell Biology International 38(1): 1-7

Stewart, A.K.; Shmukler, B.E.; Vandorpe, D.H.; Reimold, F.; Heneghan, J.F.; Nakakuki, M.; Akhavein, A.; Ko, S.; Ishiguro, H.; Alper, S.L. 2011: SLC26 anion exchangers of guinea pig pancreatic duct: molecular cloning and functional characterization. American Journal of Physiology. Cell Physiology 301(2): C289-C303

Mäkitie, O.; Geiberger, S.; Horemuzova, E.; Hagenäs, L.; Moström, E.; Nordenskjöld, M.; Grigelioniene, G.; Nordgren, A. 2015: SLC26A2 disease spectrum in Sweden - high frequency of recessive multiple epiphyseal dysplasia (rMED). Clinical Genetics 87(3): 273-278

Ishimori, S.; Kaito, H.; Matsunoshita, N.; Otsubo, H.; Hashimoto, F.; Ninchoji, T.; Nozu, K.; Morisada, N.; Iijima, K. 2013: SLC26A3 gene analysis in patients with Bartter and Gitelman syndromes and the clinical characteristics of patients with unidentified mutations. Kobe Journal of Medical Sciences 59(2): E36-E43

Dai, P.; Li, Q.; Huang, D.; Yuan, Y.; Kang, D.; Miller, D.T.; Shao, H.; Zhu, Q.; He, J.; Yu, F.; Liu, X.; Han, B.; Yuan, H.; Platt, O.S.; Han, D.; Wu, B-Lin. 2008: SLC26A4 c.919-2A>G varies among Chinese ethnic groups as a cause of hearing loss. Genetics in Medicine: Official Journal of the American College of Medical Genetics 10(8): 586-592

Belguith-Maalej, S.; Rebuffat, S.A.; Charfeddine, I.; Mnif, M.; Nadir, R.F.; Abid, M.; Ghorbel, A.; Peraldi-Roux, S.; Ayadi, H.; Hadj-Kacem, H. 2011: SLC26A4 expression among autoimmune thyroid tissues. Immunobiology 216(5): 571-578

Zhao, J.; Yuan, Y.; Chen, J.; Huang, S.; Wang, G.; Han, D.; Dai, P. 2012: SLC26A4 gene copy number variations in Chinese patients with non-syndromic enlarged vestibular aqueduct. Journal of Translational Medicine 10: 82

Zhang, J.; Li, Y. 2013: SLC26A4 gene polymorphism and late-onset Alzheimer's disease in a Han Chinese population from Qingdao, China. Neural Regeneration Research 8(8): 754-759

King, K.A.; Choi, B.Y.; Zalewski, C.; Madeo, A.C.; Manichaikul, A.; Pryor, S.P.; Ferruggiaro, A.; Eisenman, D.; Kim, H.J.; Niparko, J.; Thomsen, J.; Butman, J.A.; Griffith, A.J.; Brewer, C.C. 2010: SLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct. Laryngoscope 120(2): 384-389

Ito, T.; Choi, B.Y.; King, K.A.; Zalewski, C.K.; Muskett, J.; Chattaraj, P.; Shawker, T.; Reynolds, J.C.; Butman, J.A.; Brewer, C.C.; Wangemann, P.; Alper, S.L.; Griffith, A.J. 2011: SLC26A4 genotypes and phenotypes associated with enlargement of the vestibular aqueduct. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 28(3): 545-552

Rendtorff, N.D.; Schrijver, I.; Lodahl, M.; Rodriguez-Paris, J.; Johnsen, T.; Hansén, E.C.; Nickelsen, L.A.A.; Tümer, Z.; Fagerheim, T.; Wetke, R.; Tranebjaerg, L. 2013: SLC26A4 mutation frequency and spectrum in 109 Danish Pendred syndrome/DFNB4 probands and a report of nine novel mutations. Clinical Genetics 84(4): 388-391

Mao, J.; Wei, X-ming.; Li, H.; Wang, S-nan.; Chen, Y. 2012: SLC26A4 mutations in a Chinese deafness family discovered by next-generation sequencing technology. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(11): 942-945

Li, X.; Sanneman, J.D.; Harbidge, D.G.; Zhou, F.; Ito, T.; Nelson, R.; Picard, N.; Chambrey, R.ég.; Eladari, D.; Miesner, T.; Griffith, A.J.; Marcus, D.C.; Wangemann, P. 2013: SLC26A4 targeted to the endolymphatic sac rescues hearing and balance in Slc26a4 mutant mice. Plos Genetics 9(7): E1003641

Hadj-Kacem, H.; Kallel, R.; Belguith-Maalej, S.; Mnif, M.; Charfeddine, I.; Ghorbel, A.; Abid, M.; Ayadi, H.; Masmoudi, S. 2010: SLC26A4 variations among Graves' hyper-functioning thyroid gland. Disease Markers 29(2): 63-69

Ohana, E.; Shcheynikov, N.; Moe, O.W.; Muallem, S. 2013: SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis. Journal of the American Society of Nephrology: Jasn 24(10): 1617-1626

Avella, M.; Loriol, C.él.; Boulukos, K.; Borgese, F.; Ehrenfeld, J. 2011: SLC26A9 stimulates CFTR expression and function in human bronchial cell lines. Journal of Cellular Physiology 226(1): 212-223

Anagnostopoulou, P.; Riederer, B.; Duerr, J.; Michel, S.; Binia, A.; Agrawal, R.; Liu, X.; Kalitzki, K.; Xiao, F.; Chen, M.; Schatterny, J.; Hartmann, D.; Thum, T.; Kabesch, M.; Soleimani, M.; Seidler, U.; Mall, M.A. 2012: SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. Journal of Clinical Investigation 122(10): 3629-3634

Wan, H.; Zhu, J.; Chen, F.; Xiao, F.; Huang, H.; Han, X.; Zhong, L.; Zhong, H.; Xu, L.; Ni, B.; Zhong, J. 2014: SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study. Journal of Experimental and Clinical Cancer Research: Cr 33: 90

Cliffe, S.T.; Kramer, J.M.; Hussain, K.; Robben, J.H.; de Jong, E.K.; de Brouwer, A.P.; Nibbeling, E.; Kamsteeg, E.-J.; Wong, M.; Prendiville, J.; James, C.; Padidela, R.; Becknell, C.; van Bokhoven, H.; Deen, P.M.T.; Hennekam, R.C.M.; Lindeman, R.; Schenck, A.; Roscioli, T.; Buckley, M.F. 2009: SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Human Molecular Genetics 18(12): 2257-2265

Jiang, Y.-D.; Chang, Y.-C.; Chiu, Y.-F.; Chang, T.-J.; Li, H.-Y.; Lin, W.-H.; Yuan, H.-Y.; Chen, Y.-T.; Chuang, L.-M. 2010: SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes. Bmc Medical Genetics 11: 126

Freitas, H.S.; Schaan, B.D.; David-Silva, A.; Sabino-Silva, R.; Okamoto, M.M.; Alves-Wagner, A.B.; Mori, R.C.; Machado, U.F. 2009: SLC2A2 gene expression in kidney of diabetic rats is regulated by HNF-1alpha and HNF-3beta. Molecular and Cellular Endocrinology 305(1-2): 63-70

Sansbury, F.H.; Flanagan, S.E.; Houghton, J.A.L.; Shuixian Shen, F.L.; Al-Senani, A.M.S.; Habeb, A.M.; Abdullah, M.; Kariminejad, A.; Ellard, S.; Hattersley, A.T. 2012: SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion. Diabetologia 55(9): 2381-2385

Corrêa-Giannella, M.L.; Machado, U.F. 2013: SLC2A4gene: a promising target for pharmacogenomics of insulin resistance. Pharmacogenomics 14(8): 847-850

Caulfield, M.J.; Munroe, P.B.; O'Neill, D.; Witkowska, K.; Charchar, F.J.; Doblado, M.; Evans, S.; Eyheramendy, S.; Onipinla, A.; Howard, P.; Shaw-Hawkins, S.; Dobson, R.J.; Wallace, C.; Newhouse, S.J.; Brown, M.; Connell, J.M.; Dominiczak, A.; Farrall, M.; Lathrop, G.M.; Samani, N.J.; Kumari, M.; Marmot, M.; Brunner, E.; Chambers, J.; Elliott, P.; Kooner, J.; Laan, M.; Org, E.; Veldre, G.; Viigimaa, M.; Cappuccio, F.P.; Ji, C.; Iacone, R.; Strazzullo, P.; Moley, K.H.; Cheeseman, C. 2008: SLC2A9 is a high-capacity urate transporter in humans. Plos Medicine 5(10): E197

Le, M.T.; Shafiu, M.; Mu, W.; Johnson, R.J. 2008: SLC2A9--a fructose transporter identified as a novel uric acid transporter. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(9): 2746-2749

Leyva-Illades, D.; Chen, P.; Zogzas, C.E.; Hutchens, S.; Mercado, J.M.; Swaim, C.D.; Morrisett, R.A.; Bowman, A.B.; Aschner, M.; Mukhopadhyay, S. 2014: SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 34(42): 14079-14095

Salazar, G.; Falcon-Perez, J.M.; Harrison, R.; Faundez, V. 2009: SLC30A3 (ZnT3) oligomerization by dityrosine bonds regulates its subcellular localization and metal transport capacity. Plos one 4(6): E5896

Da Rocha, T.J.; Korb, C.; Schuch, J.B.; Bamberg, D.P.; de Andrade, F.M.; Fiegenbaum, M. 2014: SLC30A3 and SEP15 gene polymorphisms influence the serum concentrations of zinc and selenium in mature adults. Nutrition Research 34(9): 742-748

Smidt, K.; Jessen, N.; Petersen, A.B.øn.; Larsen, A.; Magnusson, N.; Jeppesen, J.B.; Stoltenberg, M.; Culvenor, J.G.; Tsatsanis, A.; Brock, B.; Schmitz, O.; Wogensen, L.; Bush, A.I.; Rungby, J.ør. 2009: SLC30A3 responds to glucose- and zinc variations in beta-cells and is critical for insulin production and in vivo glucose-metabolism during beta-cell stress. Plos one 4(5): E5684

Gohlke, H.; Ferrari, U.; Koczwara, K.; Bonifacio, E.; Illig, T.; Ziegler, A.-G. 2008: SLC30A8 (ZnT8) Polymorphism is Associated with Young Age at Type 1 Diabetes Onset. Review of Diabetic Studies: Rds 5(1): 25-27

Xu, J.; Wang, J.; Chen, B. 2012: SLC30A8 (ZnT8) variations and type 2 diabetes in the Chinese Han population. Genetics and Molecular Research: Gmr 11(2): 1592-1598

Faghih, H.; Khatami, S.-R.; Azarpira, N.; Foroughmand, A.-M. 2014: SLC30A8 gene polymorphism (rs13266634 C/T) and type 2 diabetes mellitus in south Iranian population. Molecular Biology Reports 41(5): 2709-2715

Rutter, G.A.; Chimienti, F. 2015: SLC30A8 mutations in type 2 diabetes. Diabetologia 58(1): 31-36

Sprouse, C.; Gordish-Dressman, H.; Orkunoglu-Suer, E.Funda.; Lipof, J.S.; Moeckel-Cole, S.; Patel, R.R.; Adham, K.; Larkin, J.S.; Hubal, M.J.; Kearns, A.K.; Clarkson, P.M.; Thompson, P.D.; Angelopoulos, T.J.; Gordon, P.M.; Moyna, N.M.; Pescatello, L.S.; Visich, P.S.; Zoeller, R.F.; Hoffman, E.P.; Tosi, L.L.; Devaney, J.M. 2014: SLC30A8 nonsynonymous variant is associated with recovery following exercise and skeletal muscle size and strength. Diabetes 63(1): 363-368

Jing, Y.L.; Sun, Q.M.; Bi, Y.; Shen, S.M.; Zhu, D.L. 2011: SLC30A8 polymorphism and type 2 diabetes risk: evidence from 27 study groups. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 21(6): 398-405

Pineda-Tenor, D.; Micheloud, D.; Berenguer, J.; Jiménez-Sousa, M.ía.A.; Fernández-Rodríguez, A.; García-Broncano, P.; Guzmán-Fulgencio, M.ía.; Diez, C.; Bellón, J.é M.; Carrero, A.; Aldámiz-Echevarria, T.; García-Álvarez, M.ón.; Resino, S. 2014: SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients. Aids 28(9): 1325-1332

Pehar, M.; Jonas, M.C.; Hare, T.M.; Puglielli, L. 2012: SLC33A1/AT-1 protein regulates the induction of autophagy downstream of IRE1/XBP1 pathway. Journal of Biological Chemistry 287(35): 29921-29930

Chen, D.-R.; Chien, S.-Y.; Kuo, S.-J.; Teng, Y.-H.; Tsai, H.-T.; Kuo, J.-H.; Chung, J.-G. 2010: SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer. Anticancer Research 30(10): 4135-4140

Jönsson, Åsa.Lina.M.; Hilberg, O.; Bendstrup, E.M.; Mogensen, S.; Simonsen, U. 2012: SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis. American Journal of Respiratory and Critical Care Medicine 185(4): 464

Hasani-Ranjbar, S.; Amoli, M.M.; Ebrahim-Habibi, A.; Dehghan, E.; Soltani, A.; Amiri, P.; Larijani, B. 2012: SLC34A3 intronic deletion in a new kindred with hereditary hypophosphatemic rickets with hypercalciuria. Journal of Clinical Research in Pediatric Endocrinology 4(2): 89-93

Chim-ong, A.; Thawornkuno, C.; Chavalitshewinkoon-Petmitr, P.; Punyarit, P.; Petmitr, S. 2014: SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma. Asian Pacific Journal of Cancer Prevention: Apjcp 15(15): 6065-6070

Meng, R.; Wang, Y.; Yao, Y.; Zhang, Z.; Harper, D.C.; Heijnen, H.F.G.; Sitaram, A.; Li, W.; Raposo, G.ça.; Weiss, M.J.; Poncz, M.; Marks, M.S. 2012: SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky-Pudlak syndrome models. Blood 120(2): 404-414

Pillai, S.M.; Meredith, D. 2011: SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes. Journal of Biological Chemistry 286(4): 2455-2460

Pan, C.-J.; Chen, S.-Y.; Jun, H.S.; Lin, S.R.; Mansfield, B.C.; Chou, J.Y. 2011: SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. Plos one 6(9): E23157

Iacopetta, D.; Lappano, R.; Cappello, A.R.; Madeo, M.; De Francesco, E.M.; Santoro, A.; Curcio, R.; Capobianco, L.; Pezzi, V.; Maggiolini, M.; Dolce, V. 2010: SLC37A1 gene expression is up-regulated by epidermal growth factor in breast cancer cells. Breast Cancer Research and Treatment 122(3): 755-764

Karagas, M.R.; Andrew, A.S.; Nelson, H.H.; Li, Z.; Punshon, T.; Schned, A.; Marsit, C.J.; Morris, J.S.; Moore, J.H.; Tyler, A.L.; Gilbert-Diamond, D.; Guerinot, M.-L.; Kelsey, K.T. 2012: SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Human Genetics 131(3): 453-461

Limpongsanurak, W.; Kuptanon, C.; Singhamatr, P.; Singalavanija, S.; Sirisutthisuwan, S. 2014: SLC39A4 mutation in zinc deficiency patients. Journal of the Medical Association of Thailand 97(Suppl 6): S14-S19

Guo, H.; Jin, X.; Zhu, T.; Wang, T.; Tong, P.; Tian, L.; Peng, Y.; Sun, L.; Wan, A.; Chen, J.; Liu, Y.; Li, Y.; Tian, Q.; Xia, L.; Zhang, L.; Pan, Y.; Lu, L.; Liu, Q.; Shen, L.; Li, Y.; Xiong, W.; Li, J.; Tang, B.; Feng, Y.; Zhang, X.; Zhang, Z.; Pan, Q.; Hu, Z.; Xia, K. 2014: SLC39A5 mutations interfering with the BMP/TGF-β pathway in non-syndromic high myopia. Journal of Medical Genetics 51(8): 518-525

Anonymous 2013: SLC39A6 affects esophageal squamous cell carcinoma survival. Cancer discovery 3(7): OF27

Matsuura, W.; Yamazaki, T.; Yamaguchi-Iwai, Y.; Masuda, S.; Nagao, M.; Andrews, G.K.; Kambe, T. 2009: SLC39A9 (ZIP9) regulates zinc homeostasis in the secretory pathway: characterization of the ZIP subfamily i protein in vertebrate cells. Bioscience Biotechnology and Biochemistry 73(5): 1142-1148

Brons, A.-K.; Henthorn, P.S.; Raj, K.; Fitzgerald, C.A.; Liu, J.; Sewell, A.C.; Giger, U. 2013: SLC3A1 and SLC7A9 mutations in autosomal recessive or dominant canine cystinuria: a new classification system. Journal of Veterinary Internal Medicine 27(6): 1400-1408

Nakajima, K.; Tanaka, A.; Matsuda, Y. 2013: SLC4 family transporters in a marine diatom directly pump bicarbonate from seawater. Proceedings of the National Academy of Sciences of the United States of America 110(5): 1767-1772

Albuquerque, D.; Manco, L.ín.; Loua, K.M.; Arez, A.P.; Trovoada, M.d.J.; Relvas, L.ís.; Millimono, T.S.; Rath, S.L.; Lopes, D.; Nogueira, F.át.; Varandas, L.ís.; Alvarez, M.; Ribeiro, M.L.íc. 2011: SLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African population samples. Annals of Human Biology 38(3): 378-381

Speletas, M.; Onoufriadis, E.; Kioumi, A.; Germenis, A.E. 2011: SLC40A1-R178G mutation and ferroportin disease. Journal of Hepatology 55(3): 730-731

Wallace, D.F. 2013: SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting. Journal of Hepatology 59(2): 396-397

Schweigel-Röntgen, M.; Kolisek, M. 2014: SLC41 transporters--molecular identification and functional role. Current Topics in Membranes 73: 383-410

Mandt, T.; Song, Y.; Scharenberg, A.M.; Sahni, J. 2011: SLC41A1 Mg(2+) transport is regulated via Mg(2+)-dependent endosomal recycling through its N-terminal cytoplasmic domain. Biochemical Journal 439(1): 129-139

Kolisek, M.; Galaviz-Hernández, C.; Vázquez-Alaniz, F.; Sponder, G.; Javaid, S.; Kurth, K.; Nestler, A.; Rodríguez-Moran, M.; Verlohren, S.; Guerrero-Romero, F.; Aschenbach, J.ör.R.; Vormann, J.ür. 2013: SLC41A1 is the only magnesium responsive gene significantly overexpressed in placentas of preeclamptic women. Hypertension in Pregnancy 32(4): 378-389

Yu, N.; Jiang, J.; Yu, Y.; Li, H.; Huang, X.; Ma, Y.; Zhang, L.; Zou, J.; Zhang, B.; Chen, S.; Liu, P. 2014: SLC41A1 knockdown inhibits angiotensin II-induced cardiac fibrosis by preventing Mg(2+) efflux and Ca(2+) signaling in cardiac fibroblasts. Archives of Biochemistry and Biophysics 564: 74-82

Tseng, A.P.-T.; Wei, H.; Hsiung, N.; Chen, S.-H.; Chen, H.-Y.; Cheng, F.-C. 2014: SLC41A1, a Na+/Mg2+ exchanger, is downregulated during exercise. Biomedical Reports 2(4): 599-601

Mauri, L.; Barone, L.; Al Oum, M.; Del Longo, A.; Piozzi, E.; Manfredini, E.; Stanzial, F.; Benedicenti, F.; Penco, S.; Patrosso, M.C. 2014: SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies. Gene 533(1): 398-402

Fernandez, L.P.; Milne, R.L.; Pita, G.; Avilés, J.A.; Lázaro, P.; Benítez, J.; Ribas, G. 2008: SLC45A2: a novel malignant melanoma-associated gene. Human Mutation 29(9): 1161-1167

Kumar-Sinha, C.; Kalyana-Sundaram, S.; Chinnaiyan, A.M. 2012: SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing. Cancer Discovery 2(7): 582-585

Rickman, D.S.; Pflueger, D.; Moss, B.; VanDoren, V.E.; Chen, C.X.; de la Taille, A.; Kuefer, R.; Tewari, A.K.; Setlur, S.R.; Demichelis, F.; Rubin, M.A. 2009: SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Research 69(7): 2734-2738

Choi, I. 2012: SLC4A transporters. Current Topics in Membranes 70: 77-103

Gröger, N.; Fröhlich, H.; Maier, H.; Olbrich, A.; Kostin, S.; Braun, T.; Boettger, T. 2010: SLC4A11 prevents osmotic imbalance leading to corneal endothelial dystrophy, deafness, and polyuria. Journal of Biological Chemistry 285(19): 14467-14474

Coury, F.; Zenger, S.; Stewart, A.K.; Stephens, S.; Neff, L.; Tsang, K.; Shull, G.E.; Alper, S.L.; Baron, R.; Aliprantis, A.O. 2013: SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts. Proceedings of the National Academy of Sciences of the United States of America 110(6): 2163-2168

Kumar, S.; Flacke, J.-P.; Kostin, S.; Appukuttan, A.; Reusch, H.P.; Ladilov, Y. 2011: SLC4A7 sodium bicarbonate co-transporter controls mitochondrial apoptosis in ischaemic coronary endothelial cells. Cardiovascular Research 89(2): 392-400

Raja, M.; Puntheeranurak, T.; Hinterdorfer, P.; Kinne, R. 2012: SLC5 and SLC2 transporters in epithelia-cellular role and molecular mechanisms. Current Topics in Membranes 70: 29-76

Brim, H.; Kumar, K.; Nazarian, J.; Hathout, Y.; Jafarian, A.; Lee, E.; Green, W.; Smoot, D.; Park, J.; Nouraie, M.; Ashktorab, H. 2011: SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas. PloS one 6(6): e20216

Helm, J.; Coppola, D.; Ganapathy, V.; Lloyd, M.; Centeno, B.A.; Chen, D.-T.; Malafa, M.P.; Park, J.Y. 2012: SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Pancreas 41(6): 904-909

Fenker, K.E.; Hansen, A.A.; Chong, C.A.; Jud, M.C.; Duffy, B.A.; Norton, J.P.; Hansen, J.M.; Stanfield, G.M. 2014: SLC6 family transporter SNF-10 is required for protease-mediated activation of sperm motility in C. elegans. Developmental Biology 393(1): 171-182

Kristensen, A.S.; Andersen, J.; Jørgensen, T.N.; Sørensen, L.; Eriksen, J.; Loland, C.J.; Strømgaard, K.; Gether, U. 2011: SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacological Reviews 63(3): 585-640

Karunakaran, S.; Ramachandran, S.; Coothankandaswamy, V.; Elangovan, S.; Babu, E.; Periyasamy-Thandavan, S.; Gurav, A.; Gnanaprakasam, J.P.; Singh, N.; Schoenlein, P.V.; Prasad, P.D.; Thangaraju, M.; Ganapathy, V. 2011: SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. Journal of Biological Chemistry 286(36): 31830-31838

Li, M.; Ge, T.; Feng, J.; Su, B. 2013: SLC6A15 rs1545843 and depression: implications from brain imaging data. American Journal of Psychiatry 170(7): 805

Azzato, E.M.; Morton, L.M.; Bergen, A.W.; Wang, S.S.; Chatterjee, N.; Kvale, P.; Yeager, M.; Hayes, R.B.; Chanock, S.J.; Caporaso, N.E. 2009: SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Bmc Medical Genetics 10: 9

Zhai, D.; Li, S.; Zhao, Y.; Lin, Z. 2014: SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies. Neuroscience Letters 564: 99-104

Pizzo de Castro, M.ár.R.; Maes, M.; Guembarovski, R.L.; Ariza, C.B.; Reiche, E.M.V.; Vargas, H.O.; Vargas, M.M.ça.; de Melo, L.G.P.; Dodd, S.; Berk, M.; Watanabe, M.A.E.; Nunes, S.O.V. 2014: SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study. Bmc Genetics 15: 78

Chamba, A.; Holder, M.J.; Jarrett, R.F.; Shield, L.; Toellner, K.M.; Drayson, M.T.; Barnes, N.M.; Gordon, J. 2010: SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies. Leukemia Research 34(8): 1103-1106

Córdoba, M.; Consalvo, D.án.; Moron, D.G.; Kochen, S.; Kauffman, M.A.és. 2012: SLC6A4 gene variants and temporal lobe epilepsy susceptibility: a meta-analysis. Molecular Biology Reports 39(12): 10615-10619

Jaiswal, P.; Guhathakurta, S.; Singh, A.S.; Verma, D.; Pandey, M.; Varghese, M.; Sinha, S.; Ghosh, S.; Mohanakumar, K.P.; Rajamma, U. 2015: SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population. Progress in Neuro-Psychopharmacology and Biological Psychiatry 56: 196-206

Koenen, K.C.; Uddin, M.; Chang, S-Chiao.; Aiello, A.E.; Wildman, D.E.; Goldmann, E.; Galea, S. 2011: SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depression and Anxiety 28(8): 639-647

Gelernter, J. 2014: SLC6A4 polymorphism, population genetics, and psychiatric traits. Human Genetics 133(4): 459-461

Shiroma, P.R.; Drews, M.S.; Geske, J.R.; Mrazek, D.A. 2014: SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 22(11): 1140-1148

Camarena, B.; González, L.; Hernández, S.; Caballero, A. 2012: SLC6A4 rare variant associated with eating disorders in Mexican patients. Journal of Psychiatric Research 46(8): 1106-1107

Zhang-James, Y.; DasBanerjee, T.; Sagvolden, T.; Middleton, F.A.; Faraone, S.V. 2011: SLC9A9 mutations, gene expression, and protein-protein interactions in rat models of attention-deficit/hyperactivity disorder. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 156b (7): 835-843

Sissung, T.M.; Pressler, H.; Price, D.K.; Figg, W.D. 2011: SLCO transport genes in prostate cancer--letter. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(10): 2325; Author Reply 2326-7

Li, L.-M.; Chen, L.; Deng, G.-H.; Tan, W.-T.; Dan, Y.-J.; Wang, R.-Q.; Chen, W.-S. 2012: SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury. Molecular Medicine Reports 6(1): 75-82

Zhang, W.; Chen, B-Lian.; Ozdemir, V.; He, Y-Jing.; Zhou, G.; Peng, D-Di.; Deng, S.; Xie, Q-Ying.; Xie, W.; Xu, L-Yong.; Wang, L-Ci.; Fan, L.; Wang, A.; Zhou, H-Hao. 2007: SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. British Journal of Clinical Pharmacology 64(3): 346-352

Stewart, A. 2013: SLCO1B1 Polymorphisms and Statin-Induced Myopathy. Plos Currents 5

Huang, L.; Zhang, T.; Xie, C.; Liao, X.; Yu, Q.; Feng, J.; Ma, H.; Dai, J.; Li, M.; Chen, J.; Zang, A.; Wang, Q.; Ge, S.; Qin, K.; Cai, J.; Yuan, X. 2013: SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer. Plos one 8(10): E77223

Sortica, V.A.; Fiegenbaum, M.; Lima, L.O.; Van der Sand, C.éz.R.; Van der Sand, L.C.; Ferreira, M.E.W.; Pires, R.C.; Hutz, M.H. 2012: SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians. Clinical Chemistry and Laboratory Medicine 50(3): 441-448

Michelon, H.; König, J.ör.; Durrbach, A.; Quteineh, L.; Verstuyft, C.él.; Furlan, V.ér.; Ferlicot, S.; Letierce, A.; Charpentier, B.; Fromm, M.F.; Becquemont, L. 2010: SLCO1B1 genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients. Pharmacogenomics 11(12): 1703-1713

Santos, P.C.J.L.; Gagliardi, A.C.M.; Miname, M.ár.H.; Chacra, A.P.; Santos, R.D.; Krieger, J.E.; Pereira, A.C. 2012: SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. European Journal of Clinical Pharmacology 68(3): 273-279

Kalliokoski, A.; Neuvonen, P.J.; Niemi, M. 2010: SLCO1B1 polymorphism and oral antidiabetic drugs. Basic and Clinical Pharmacology and Toxicology 107(4): 775-781

Santos, P.C.J.L.; Soares, R.A.G.; Nascimento, R.M.; Machado-Coelho, G.L.L.; Mill, Jé.G.; Krieger, Jé.E.; Pereira, A.C. 2011: SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group. Bmc Medical Genetics 12: 136

Vladutiu, G.D.; Isackson, P.J. 2009: SLCO1B1 variants and statin-induced myopathy. New England Journal of Medicine 360(3): 304

Link, E.; Parish, S.; Armitage, J.; Bowman, L.; Heath, S.; Matsuda, F.; Gut, I.; Lathrop, M.; Collins, R.; Meade, T.; Sleight, P.; Collins, R.; Armitage, J.; Parish, S.; Barton, J.; Bray, C.; Wincott, E.; Bowman, L.; Clarke, R.; Graham, I.; Simpson, D.; Warlow, C.; Wilcken, D.; Tobert, J.; Musliner, T.; Wilhelmsen, L.; Doll, R.; Fox, K.M.; Hill, C.; Sandercock, P.; Peto, R.; Webster, J.; Jamieson, J.; Nixon, A.; Lackie, S.; Thompson, J.; Brown, M.; Blackwood, S.; Morgan, M.; Rhoden, W.; Saeed, B.; Houghton, M.; Nicholson, A.; Simpson, C.; Hoburn, B.; Cooper, I.; Gallivan, A.; Pickerell, E.; Hancock, J.; Watkinson, J.; Ryder, B.; Jones, S.; Burbridge, W.; Kitchen, M.; O'Leary, H.; Verow, C.; Meynell, L.; Rollinson, L.; Bain, S.; Jones, 2008: SLCO1B1 variants and statin-induced myopathy--a genomewide study. New England Journal of Medicine 359(8): 789-799

Gribble, M.O.; Voruganti, V.S.; Cropp, C.D.; Francesconi, K.A.; Goessler, W.; Umans, J.G.; Silbergeld, E.K.; Laston, S.L.; Haack, K.; Kao, W.H.L.; Fallin, M.D.; Maccluer, J.W.; Cole, S.A.; Navas-Acien, A. 2013: SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study. Toxicological Sciences: An Official Journal of the Society of Toxicology 136(1): 19-25

Bui, H.T.T.; Fujimoto, N.; Kubo, T.; Inatomi, H.; Matsumoto, T. 2014: SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk. Cancer Investigation 32(6): 256-261

Yang, M.; Xie, W.; Mostaghel, E.; Nakabayashi, M.; Werner, L.; Sun, T.; Pomerantz, M.; Freedman, M.; Ross, R.; Regan, M.; Sharifi, N.; Figg, W.Douglas.; Balk, S.; Brown, M.; Taplin, M-Ellen.; Oh, W.K.; Lee, G-Shu.Mary.; Kantoff, P.W. 2011: SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(18): 2565-2573

Tapaninen, T.; Karonen, T.; Backman, J.T.; Neuvonen, P.J.; Niemi, M. 2013: SLCO2B1 c.935G>A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren. Pharmacogenetics and Genomics 23(1): 19-24

Kim, K.-A.; Joo, H.-J.; Lee, H.-M.; Park, J.-Y. 2013: SLCO2B1 genetic polymorphisms in a Korean population: pyrosequencing analyses and comprehensive comparison with other populations. Molecular Biology Reports 40(7): 4211-4217

Wei, S.-C.; Tan, Y.-Y.; Weng, M.-T.; Lai, L.-C.; Hsiao, J.-H.; Chuang, E.Y.; Shun, C.-T.; Wu, D.-C.; Kao, A.-W.; Chuang, C.-S.; Ni, Y.-H.; Shieh, M.-J.; Tung, C.-C.; Chen, Y.; Wang, C.-Y.; Xavier, R.J.; Podolsky, D.K.; Wong, J.-M. 2014: SLCO3A1, a novel crohn's disease-associated gene, regulates nf-κB activity and associates with intestinal perforation. Plos one 9(6): E100515

Toyohara, T.; Suzuki, T.; Morimoto, R.; Akiyama, Y.; Souma, T.; Shiwaku, H.O.; Takeuchi, Y.; Mishima, E.; Abe, M.; Tanemoto, M.; Masuda, S.; Kawano, H.; Maemura, K.; Nakayama, M.; Sato, H.; Mikkaichi, T.; Yamaguchi, H.; Fukui, S.; Fukumoto, Y.; Shimokawa, H.; Inui, K.-i.; Terasaki, T.; Goto, J.; Ito, S.; Hishinuma, T.; Rubera, I.; Tauc, M.; Fujii-Kuriyama, Y.; Yabuuchi, H.; Moriyama, Y.; Soga, T.; Abe, T. 2009: SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. Journal of the American Society of Nephrology: Jasn 20(12): 2546-2555

Pasaribu, B.; Lin, I.-P.; Tzen, J.T.C.; Jauh, G.-Y.; Fan, T.-Y.; Ju, Y.-M.; Cheng, J.-O.; Chen, C.-S.; Jiang, P.-L. 2014: SLDP: a novel protein related to caleosin is associated with the endosymbiotic Symbiodinium lipid droplets from Euphyllia glabrescens. Marine Biotechnology 16(5): 560-571

Yue, Z.; Wan, P.; Huang, H.; Xie, Z.; Chen, J.Y. 2014: SLDR: a computational technique to identify novel genetic regulatory relationships. Bmc Bioinformatics 15(Suppl 11): S1

Zhu, J.; Mohan, C. 2007: SLE 1, 2, 3...genetic dissection of lupus. Advances in Experimental Medicine and Biology 601: 85-95

Wardle, E.Nigel. 2010: SLE Conundrums. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 21(1): 163

Patra, A.; Bhattacharya, S.K. 2013: SLE Developing in a Follow-Up Patient of Kikuchi's Disease: a Rare Disorder. Journal of Clinical and Diagnostic Research: Jcdr 7(4): 752-753

Fegan, D.; Glennon, M.J. 2014: SLE and dental erosion: a lethal cocktail. Tropical Doctor 44(2): 122-123

Parker, B.; Bruce, I. 2013: SLE and metabolic syndrome. Lupus 22(12): 1259-1266

Nam, A.-Y.; Kim, H.-A.; Suh, C.-H. 2009: SLE developed in a preadolescent child with Klinefelter syndrome who had no detectable sex hormone. Rheumatology International 29(8): 975-977

Doria, A.; Zen, M.; Canova, M.; Bettio, S.; Bassi, N.; Nalotto, L.; Rampudda, M.; Ghirardello, A.; Iaccarino, L. 2010: SLE diagnosis and treatment: when early is early. Autoimmunity Reviews 10(1): 55-60

Laustrup, H.; Voss, A.; Green, A.; Junker, P. 2010: SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus 19(3): 239-246

Tang, X.L.; Griffith, J.F.; Qin, L.; Hung, V.W.; Kwok, A.W.; Zhu, T.Y.; Kun, E.W.; Leung, P.C.; Li, E.K.; Tam, L-S. 2013: SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 22(11): 1162-1168

Yetim, E.; Gocmen, R.; Topcuoglu, M.A.; Arsava, E.M. 2014: SLE mimicking infectious myelitis. Joint Bone Spine 81(5): 453

Becker, A.M.; Dao, K.H.; Han, B.Kwanghoon.; Kornu, R.; Lakhanpal, S.; Mobley, A.B.; Li, Q-Zhen.; Lian, Y.; Wu, T.; Reimold, A.M.; Olsen, N.J.; Karp, D.R.; Chowdhury, F.Z.; Farrar, J.David.; Satterthwaite, A.B.; Mohan, C.; Lipsky, P.E.; Wakeland, E.K.; Davis, L.S. 2013: SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. Plos one 8(6): E67003

Kallingal, M.P. 2010: SLE presenting as epistaxis. Indian Journal of Pediatrics 77(5): 561-562

Grover, S.; Singh, A.; Sarkar, S.; Bhalla, A. 2013: SLE presenting with catatonia in an adolescent girl. Journal of Pediatric Neurosciences 8(3): 262-263

Mehta, P.; Norsworthy, P.J.; Hall, A.E.; Kelly, S.J.; Walport, M.J.; Botto, M.; Pickering, M.C. 2010: SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience. Rheumatology 49(4): 823-824

Yongsiri, S.; Thammakumpee, J.; Annanon, N. 2012: SLE with diffuse alveolar hemorrhage, microangiopathic hemolytic anemia and acute renal failure. Journal of Clinical Apheresis 27(5): 263-264

Candilio, L.; D'Cruz, D.; Perera, D. 2011: SLE with recurrent heart failure and a dermatological clue to another added possibility. BMJ Case Reports

Mula, M.; Bolamperti, L.; Varrasi, C.; Mittino, D.; Colombi, S.; Stecco, A.; Cantello, R.; Monaco, F. 2009: SLE-related longitudinal myelitis with favorable outcome. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 36(3): 393-397

Blanco, I. 2012: SLE: serving the underserved in an academic medical center. Social Work in Health Care 51(7): 587-596

Basile, C.; Lomonte, C. 2013: SLED v CRRT: the choice between a Rolls and a Ferrari?. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 30(3)

Touma, Z.; Urowitz, M.B.; Ibañez, D.; Gladman, D.D. 2011: SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation. Lupus 20(1): 67-70

Touma, Z.; Gladman, D.D.; Ibañez, D.; Urowitz, M.B. 2012: SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years. Lupus 21(12): 1305-1311

Touma, Z.; Urowitz, M.B.; Gladman, D.D. 2010: SLEDAI-2K for a 30-day window. Lupus 19(1): 49-51

Anonymous 1913: Sleeping Sickness and big Game: Colonial Office Committee. British Medical Journal 2(2744): 262

Anonymous 1912: SLEEPING SICKNESS: Operations by Natives on Cervical Glands. British Medical Journal 1(2684): 1310

Wu, M.; Robinson, J.E.; Joiner, W.J. 2014: SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission. Current Biology: Cb 24(6): 621-629

Treweek, J.B.; Moreno, A.Y.; Janda, K.D. 2009: SLEEPLESS-ness and insomnia in fruit flies. Angewandte Chemie 48(3): 438-440

Helmiö, M.; Victorzon, M.; Ovaska, J.; Leivonen, M.; Juuti, A.; Jaser, N.; Peromaa, P.; Tolonen, P.; Hurme, S.; Salminen, P. 2012: SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surgical Endoscopy 26(9): 2521-2526

Yi, M.; Stephens, R.M. 2008: SLEPR: a sample-level enrichment-based pathway ranking method -- seeking biological themes through pathway-level consistency. Plos one 3(9): E3288

Zhu, H.; Huang, G.H. 2011: SLFP: a stochastic linear fractional programming approach for sustainable waste management. Waste Management 31(12): 2612-2619

Anderson, C.; Zhou, S.; Sawin, E.; Horvitz, H.R.; Hurwitz, M.E. 2012: SLI-1 Cbl inhibits the engulfment of apoptotic cells in C. elegans through a ligase-independent function. Plos Genetics 8(12): E1003115

Kubben, P.L. 2012: SLIC 2: Improved decision support for subaxial cervical spine injury. Surgical Neurology International 3: 30

Achanta, R.; Shaji, A.; Smith, K.; Lucchi, A.; Fua, P.; Süsstrunk, S. 2012: SLIC superpixels compared to state-of-the-art superpixel methods. IEEE Transactions on Pattern Analysis and Machine Intelligence 34(11): 2274-2282

Li, M.Z.; Elledge, S.J. 2012: SLIC: a method for sequence- and ligation-independent cloning. Methods in Molecular Biology 852: 51-59

Shang, Q.; Yip, G.W.K.; Tam, L.S.; Zhang, Q.; Sanderson, J.E.; Lam, Y.Y.; Li, C.M.; Wang, T.; Li, E.K.M.; Yu, C.M. 2012: SLICC/ACR damage index independently associated with left ventricular diastolic dysfunction in patients with systemic lupus erythematosus. Lupus 21(10): 1057-1062

Dong, J.; Gao, Z.; Liu, S.; Li, G.; Yang, Z.; Huang, H.; Xu, L. 2013: SLIDE, the protein interacting domain of Imitation Switch remodelers, binds DDT-domain proteins of different subfamilies in chromatin remodeling complexes. Journal of Integrative Plant Biology 55(10): 928-937

Boyen, P.; Van Dyck, D.; Neven, F.; van Ham, R.C.H.J.; van Dijk, A.D.J. 2011: SLIDER: a generic metaheuristic for the discovery of correlated motifs in protein-protein interaction networks. Ieee/Acm Transactions on Computational Biology and Bioinformatics 8(5): 1344-1357

Anonymous 1947: SLIGHT decline in the suicide rate in this capital. Anais paulistas de medicina e cirurgia 53(5): 361

Anonymous 1946: SLIGHT setback in health record for 1946. Statistical Bulletin 27(4): 4-6

Hu, X.; Wu, Z. 1993: SLIM revisited. IEEE Transactions on Medical Imaging 12(3): 583-587

Waluyo, A.B.; Pek, I.; Chen, X.; Yeoh, W.-S. 2008: SLIM: a Secured Lightweight Interactive Middleware for wireless body area network. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2008: 1821-1824

Rück, A.; Hülshoff, C.; Kinzler, I.; Becker, W.; Steiner, R. 2007: SLIM: a new method for molecular imaging. Microscopy Research and Technique 70(5): 485-492

Wang, H.-Q.; Tuominen, L.K.; Tsai, C.-J. 2011: SLIM: a sliding linear model for estimating the proportion of true null hypotheses in datasets with dependence structures. Bioinformatics 27(2): 225-231

Setzler, J.; Seith, C.; Brieg, M.; Wenzel, W. 2014: SLIM: an improved generalized Born implicit membrane model. Journal of Computational Chemistry 35(28): 2027-2039

Cottle, D.L.; McGrath, M.J.; Wilding, B.R.; Cowling, B.S.; Kane, J.M.; D'Arcy, C.E.; Holdsworth, M.; Hatzinisiriou, I.; Prescott, M.; Brown, S.; Mitchell, C.A. 2009: SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. Journal of Biological Chemistry 284(39): 26964-26977

Duijzer, G.; Haveman-Nies, A.; Jansen, S.C.; ter Beek, J.; Hiddink, G.J.; Feskens, E.J.M. 2014: SLIMMER: a randomised controlled trial of diabetes prevention in Dutch primary health care: design and methods for process, effect, and economic evaluation. Bmc Public Health 14: 602

Van Rossum, T.; Tripp, B.; Daley, D. 2010: SLIMS--a user-friendly sample operations and inventory management system for genotyping labs. Bioinformatics 26(14): 1808-1810

Lim, B.Gun.; Kim, K.Jong.; Kong, M.Hoon.; Kim, N.Suk.; Lim, S.Ho.; Lee, M.Kyoung.; Lee, I.Ok. 2012: SLIPA™ may be more useful than other LMADs for difficult airway management. Canadian Journal of Anaesthesia 59(1): 120-121

Roy, R.S.; Chen, K.C.; Sengupta, A.M.; Schliep, A. 2012: SLIQ: simple linear inequalities for efficient contig scaffolding. Journal of Computational Biology: a Journal of Computational Molecular Cell Biology 19(10): 1162-1175

Esch, R.E. 2013: SLIT clinical trials for allergic rhinitis in the U.S. Arbeiten aus dem Paul-Ehrlich-Institut Langen/Hessen 97: 180-181

Macias, H.; Moran, A.; Samara, Y.; Moreno, M.; Compton, J.E.; Harburg, G.; Strickland, P.; Hinck, L. 2011: SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number. Developmental Cell 20(6): 827-840

Harburg, G.; Compton, J.; Liu, W.; Iwai, N.; Zada, S.; Marlow, R.; Strickland, P.; Zeng, Y.A.; Hinck, L. 2014: SLIT/ROBO2 signaling promotes mammary stem cell senescence by inhibiting Wnt signaling. Stem Cell Reports 3(3): 385-393

Tseng, R.-C.; Lee, S.-H.; Hsu, H.-S.; Chen, B.-H.; Tsai, W.-C.; Tzao, C.; Wang, Y.-C. 2010: SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Research 70(2): 543-551

Qiu, H.; Zhu, J.; Yu, J.; Pu, H.; Dong, R. 2011: SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated. Asian Pacific Journal of Cancer Prevention: Apjcp 12(3): 791-795

Lim, R.; Barker, G.; Lappas, M. 2014: SLIT3 is increased in supracervical human foetal membranes and in labouring myometrium and regulates pro-inflammatory mediators. American Journal of Reproductive Immunology 71(4): 297-311

Paul, J.D.; Coulombe, K.L.K.; Toth, P.T.; Zhang, Y.; Marsboom, G.; Bindokas, V.P.; Smith, D.W.; Murry, C.E.; Rehman, J. 2013: SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo. Journal of Molecular and Cellular Cardiology 64: 124-131

Dávila, I.; Navarro, A.; Domínguez-Ortega, J.; Alonso, A.; Antolín-Amérigo, D.; Diéguez, M.C.; González-Mancebo, E.; Martíns, C.; Martínez, C.; Núñez, B.; Prior, N.; Rechel, M.; Rosado, A.; Ruiz-Hornillos, J.; Sansosti, A.; Torrecillas, M.; Jerez, M.J. 2014: SLIT: indications, follow-up, and management. Journal of Investigational Allergology and Clinical Immunology 24(Suppl 1): 1-35

Lee, P.-H.; Kuo, K.-L.; Chu, P.-Y.; Liu, E.M.; Lin, J.-H. 2009: SLITHER: a web server for generating contiguous conformations of substrate molecules entering into deep active sites of proteins or migrating through channels in membrane transporters. Nucleic Acids Research 37(Web Server Issue): W559-W564

Kajiwara, Y.; Buxbaum, J.D.; Grice, D.E. 2009: SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. Biological Psychiatry 66(10): 918-925

Mah, A.K. 2010: SLITRK5, a protein that links striatal deficits to OCD-like behaviours in mice. Clinical Genetics 78(4): 350-352

Tekin, M.; Chioza, B.A.; Matsumoto, Y.; Diaz-Horta, O.; Cross, H.E.; Duman, D.; Kokotas, H.; Moore-Barton, H.L.; Sakoori, K.; Ota, M.; Odaka, Y.S.; Foster, J.; Cengiz, F.B.; Tokgoz-Yilmaz, S.; Tekeli, O.; Grigoriadou, M.; Petersen, M.B.; Sreekantan-Nair, A.; Gurtz, K.; Xia, X.-J.; Pandya, A.; Patton, M.A.; Young, J.I.; Aruga, J.; Crosby, A.H. 2013: SLITRK6 mutations cause myopia and deafness in humans and mice. Journal of Clinical Investigation 123(5): 2094-2102

Marlow, R.; Strickland, P.; Lee, J.S.; Wu, X.; Pebenito, M.; Binnewies, M.; Le, E.K.; Moran, A.; Macias, H.; Cardiff, R.D.; Sukumar, S.; Hinck, L. 2008: SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Research 68(19): 7819-7827

Machicoane, M.; de Frutos, C.A.; Fink, J.; Rocancourt, M.; Lombardi, Y.; Garel, S.; Piel, M.; Echard, A. 2014: SLK-dependent activation of ERMs controls LGN-NuMA localization and spindle orientation. Journal of Cell Biology 205(6): 791-799

Gee, E.P.S.; Yüksel, D.; Stultz, C.M.; Ingber, D.E. 2013: SLLISWD sequence in the 10FNIIi domain initiates fibronectin fibrillogenesis. Journal of Biological Chemistry 288(29): 21329-21340

Anonymous 1983: SLM Instruments, Inc. Analytical Chemistry 55(13): 1351A

Nikolenko, V.; Watson, B.O.; Araya, R.; Woodruff, A.; Peterka, D.S.; Yuste, R. 2008: SLM Microscopy: Scanless Two-Photon Imaging and Photostimulation with Spatial Light Modulators. Frontiers in Neural Circuits 2: 5

Steiger, R.; Bernet, S.; Ritsch-Marte, M. 2012: SLM-based off-axis Fourier filtering in microscopy with white light illumination. Optics Express 20(14): 15377-15384

Lai, F.; Sinico, C.; De Logu, A.; Zaru, M.; Müller, R.H.; Fadda, A.M. 2007: SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. International Journal of Nanomedicine 2(3): 419-425

Cody, H.S. 2011: SLN biopsy for large and/or multicentric breast cancers: should we worry?. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 37(5): 386-387

Küchler, S.; Herrmann, W.; Panek-Minkin, G.; Blaschke, T.; Zoschke, C.; Kramer, K.D.; Bittl, R.; Schäfer-Korting, M. 2010: SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. International Journal of Pharmaceutics 390(2): 225-233

Nordgård, O.; Smaaland, R. 2011: SLN mapping in colorectal cancer. Lancet. Oncology 12(11): 990; Author Reply 990-1

Mittendorf, E.A.; Boughey, J.C.; Hunt, K.K. 2014: SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy. Bulletin of the American College of Surgeons 99(7): 52-54

Knopp, S.; Nesland, J.M.; Tropé, C. 2008: SLNB and the importance of micrometastases in vulvar squamous cell carcinoma. Surgical Oncology 17(3): 219-225

Welz, C.; Krüger, N.; Schniederjans, M.; Miltsch, S.M.; Krücken, J.ür.; Guest, M.; Holden-Dye, L.; Harder, A.; von Samson-Himmelstjerna, G. 2011: SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants. Plos Pathogens 7(4): E1001330

Wojtovich, A.P.; Sherman, T.A.; Nadtochiy, S.M.; Urciuoli, W.R.; Brookes, P.S.; Nehrke, K. 2011: SLO-2 is cytoprotective and contributes to mitochondrial potassium transport. Plos one 6(12): E28287

Zhang, Z.; Tang, Q.-Y.; Alaimo, J.T.; Davies, A.G.; Bettinger, J.C.; Logothetis, D.E. 2013: SLO-2 isoforms with unique Ca(2+) - and voltage-dependence characteristics confer sensitivity to hypoxia in C. elegans. Channels 7(3): 194-205

Zhu, Q.; Dugardeyn, J.; Zhang, C.; Takenaka, M.; Kühn, K.; Craddock, C.; Smalle, J.; Karampelias, M.; Denecke, J.; Peters, J.; Gerats, T.; Brennicke, A.; Eastmond, P.; Meyer, E.H.; Van Der Straeten, D. 2012: SLO2, a mitochondrial pentatricopeptide repeat protein affecting several RNA editing sites, is required for energy metabolism. Plant Journal: for Cell and Molecular Biology 71(5): 836-849

Chávez, J.César.; Ferreira, J.José.; Butler, A.; De La Vega Beltrán, Jé.Luis.; Treviño, C.L.; Darszon, A.; Salkoff, L.; Santi, C.M. 2014: SLO3 K+ channels control calcium entry through CATSPER channels in sperm. Journal of Biological Chemistry 289(46): 32266-32275

Sheldon, A.L.; Zhang, J.; Fei, H.; Levitan, I.B. 2011: SLOB, a SLOWPOKE channel binding protein, regulates insulin pathway signaling and metabolism in Drosophila. Plos one 6(8): E23343

Abel, H.J.; Duncavage, E.J.; Becker, N.; Armstrong, J.R.; Magrini, V.J.; Pfeifer, J.D. 2010: SLOPE: a quick and accurate method for locating non-SNP structural variation from targeted next-generation sequence data. Bioinformatics 26(21): 2684-2688

Situ, W.; Li, Y.; Li, Z.; Hu, Z.; He, J. 2009: SLOT Scan imaging in teenagers with scoliosis. Zhong Nan da Xue Xue Bao. Yi Xue Ban 34(7): 675-679

Lohmann, D.; Stacey, N.; Breuninger, H.; Jikumaru, Y.; Müller, D.ör.; Sicard, A.; Leyser, O.; Yamaguchi, S.; Lenhard, M. 2010: SLOW MOTION is required for within-plant auxin homeostasis and normal timing of lateral organ initiation at the shoot meristem in Arabidopsis. Plant Cell 22(2): 335-348

Dempsey, R.B. 1916: SLOW POISONING BY "CHRISTIAN SCIENCE.": Report of Caesarian Section on a subject of Myxaedema of fourteen years' duration with living mother and child which was born a Cretin. California State Journal of Medicine 14(5): 199-200

Li, N.; Yuan, L.; Liu, N.; Shi, D.; Li, X.; Tang, Z.; Liu, J.; Sundaresan, V.; Yang, W.-C. 2009: SLOW WALKER2, a NOC1/MAK21 homologue, is essential for coordinated cell cycle progression during female gametophyte development in Arabidopsis. Plant Physiology 151(3): 1486-1497

Liu, M.; Shi, D.-Q.; Yuan, L.; Liu, J.; Yang, W.-C. 2010: SLOW WALKER3, encoding a putative DEAD-box RNA helicase, is essential for female gametogenesis in Arabidopsis. Journal of Integrative Plant Biology 52(9): 817-828

Stafford, J. 1948: Medical weapons against atom. Chemistry 21(8): 7-10

Kume, N. 2010: SLOX-1 (soluble lectin-like oxidized low-density lipoprotein receptor-1). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 859-861

Da Cruz, S.; De Marchi, U.; Frieden, M.; Parone, P.A.; Martinou, J.-C.; Demaurex, N. 2010: SLP-2 negatively modulates mitochondrial sodium-calcium exchange. Cell Calcium 47(1): 11-18

Cao, W.; Zhang, B.; Li, J.; Liu, Y.; Liu, Z.; Sun, B. 2011: SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer. Pathology 43(7): 713-718

Chang, D.; Ma, K.; Gong, M.; Cui, Y.; Liu, Z.-h.; Zhou, X.-g.; Zhou, C.-n.; Wang, T.-y. 2010: SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 15(2): 104-110

Oellerich, T.; Grønborg, M.; Neumann, K.; Hsiao, H.-H.; Urlaub, H.; Wienands, J.ür. 2009: SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins. Molecular and Cellular Proteomics: Mcp 8(7): 1738-1750

Reeve, J.L.; Zou, W.; Liu, Y.; Maltzman, J.S.; Ross, F.P.; Teitelbaum, S.L. 2009: SLP-76 couples Syk to the osteoclast cytoskeleton. Journal of Immunology 183(3): 1804-1812

Hidano, S.; Kitamura, D.; Kumar, L.; Geha, R.S.; Goitsuka, R. 2012: SLP-76 is required for high-affinity IgE receptor- and IL-3 receptor-mediated activation of basophils. International Immunology 24(11): 719-727

Lee, D.; Kim, J.; Baker, R.G.; Koretzky, G.A.; Hammer, D.A. 2012: SLP-76 is required for optimal CXCR4-stimulated T lymphocyte firm arrest to ICAM-1 under shear flow. European Journal of Immunology 42(10): 2736-2743

Liu, H.; Thaker, Y.R.; Stagg, L.; Schneider, H.; Ladbury, J.E.; Rudd, C.E. 2013: SLP-76 sterile α motif (SAM) and individual H5 α helix mediate oligomer formation for microclusters and T-cell activation. Journal of Biological Chemistry 288(41): 29539-29549

Wang, H.; Wei, B.; Bismuth, G.; Rudd, C.E. 2009: SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility. Proceedings of the National Academy of Sciences of the United States of America 106(30): 12436-12441

Scott, A.; Weldon, S.éa.; Taggart, C.C. 2011: SLPi and elafin: multifunctional antiproteases of the WFDC family. Biochemical Society Transactions 39(5): 1437-1440

McKiernan, P.J.; McElvaney, N.G.; Greene, C.M. 2011: SLPi and inflammatory lung disease in females. Biochemical Society Transactions 39(5): 1421-1426

Zani, M.-L.; Tanga, A.; Saidi, A.; Serrano, H.él.èn.; Dallet-Choisy, S.; Baranger, K.év.; Moreau, T. 2011: SLPi and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions. Biochemical Society Transactions 39(5): 1441-1446

Nolte, M.A. 2014: SLPi is essential for granulopoiesis. Blood 123(8): 1121-1123

Seto, T.; Takai, T.; Ebihara, N.; Matsuoka, H.; Wang, X-Ling.; Ishii, A.; Ogawa, H.; Murakami, A.; Okumura, K. 2009: SLPI prevents cytokine release in mite protease-exposed conjunctival epithelial cells. Biochemical and Biophysical Research Communications 379(3): 681-685

Martow, E.; Hutnik, C.M.L.; Mao, A. 2011: SLT and adjunctive medical therapy: a prediction rule analysis. Journal of Glaucoma 20(4): 266-270

Ackerman, R.; Backer, J.M.; Backer, M.; Skariah, S.; Hamby, C.V. 2010: SLT-VEGF reduces lung metastases, decreases tumor recurrence, and improves survival in an orthotopic melanoma model. Toxins 2(9): 2242-2257

Uygur, B.; Wu, W.-S. 2011: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Molecular Cancer 10: 139

Mittal, M.K.; Singh, K.; Misra, S.; Chaudhuri, G. 2011: SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. Journal of Biological Chemistry 286(1): 469-479

Bhat-Nakshatri, P.; Appaiah, H.; Ballas, C.; Pick-Franke, P.; Goulet, R.; Badve, S.; Srour, E.F.; Nakshatri, H. 2010: SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. Bmc Cancer 10: 411

Lambertini, E.; Franceschetti, T.; Torreggiani, E.; Penolazzi, L.; Pastore, A.; Pelucchi, S.; Gambari, R.; Piva, R. 2010: SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. Bmc Molecular Biology 11: 13

Swamynathan, S.; Swamynathan, S.K. 2014: SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator. Investigative Ophthalmology and Visual Science 55(10): 6251-6261

Fujii, T.; Horiguchi, K.; Sunaga, H.; Moriwaki, Y.; Misawa, H.; Kasahara, T.; Tsuji, S.; Kawashima, K. 2014: SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity. Journal of Neuroimmunology 267(1-2): 43-49

Tjiu, J.-W.; Lin, P.-J.; Wu, W.-H.; Cheng, Y.-P.; Chiu, H.-C.; Thong, H.-Y.; Chiang, B.-L.; Yang, W.-S.; Jee, S.-H. 2011: SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda. British Journal of Dermatology 164(1): 47-53

De Bruin, N.M.W.J.; Lange, J.H.M.; Kruse, C.G.; Herremans, A.H.; Schoffelmeer, A.N.M.; van Drimmelen, M.; De Vries, T.J. 2011: SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats. Behavioural Brain Research 217(2): 408-415

De Bruin, N.M.W.J.; Prickaerts, J.; Lange, J.H.M.; Akkerman, S.; Andriambeloson, E.; de Haan, M.; Wijnen, J.; van Drimmelen, M.; Hissink, E.; Heijink, L.; Kruse, C.G. 2010: SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents. Neurobiology of Learning and Memory 93(4): 522-531

Kannagi, R.; Izawa, M.; Sakuma, K. 2010: SLX(sialyl SSEA-1, sialyl Le(x)-i). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 720-725

Saito, T.T.; Mohideen, F.; Meyer, K.; Harper, J.W.; Colaiácovo, M.P. 2012: SLX-1 is required for maintaining genomic integrity and promoting meiotic noncrossovers in the Caenorhabditis elegans germline. Plos Genetics 8(8): E1002888

Zhuang, X.-J.; Shi, Y.-Q.; Xu, B.; Chen, L.; Tang, W.-H.; Huang, J.; Lian, Y.; Liu, P.; Qiao, J. 2014: SLX2 interacting with BLOS2 is differentially expressed during mouse oocyte meiotic maturation. Cell Cycle 13(14): 2231-2237

Wan, B.; Yin, J.; Horvath, K.; Sarkar, J.; Chen, Y.; Wu, J.; Wan, K.; Lu, J.; Gu, P.; Yu, E.Y.; Lue, N.F.; Chang, S.; Liu, Y.; Lei, M. 2013: SLX4 assembles a telomere maintenance toolkit by bridging multiple endonucleases with telomeres. Cell Reports 4(5): 861-869

Zhuang, X.-j.; Hou, X.-j.; Liao, S.-Y.; Wang, X.-X.; Cooke, H.J.; Zhang, M.; Han, C. 2011: SLXL1, a novel acrosomal protein, interacts with DKKL1 and is involved in fertilization in mice. Plos one 6(6): E20866

Nogueira, C.; Erlmann, P.; Villeneuve, J.; Santos, A.ón.J.; Martínez-Alonso, E.; Martínez-Menárguez, J.é Án.; Malhotra, V. 2014: SLY1 and Syntaxin 18 specify a distinct pathway for procollagen VIi export from the endoplasmic reticulum. Elife 3: E02784

Fiebig, M.; Gluenz, E.; Carrington, M.; Kelly, S. 2014: SLaP mapper: a webserver for identifying and quantifying spliced-leader addition and polyadenylation site usage in kinetoplastid genomes. Molecular and Biochemical Parasitology 196(2): 71-74

Zhang, Y.; Werling, U.; Edelmann, W. 2012: SLiCE: a novel bacterial cell extract-based DNA cloning method. Nucleic Acids Research 40(8): E55

Hugo, W.; Song, F.; Aung, Z.; Ng, S.-K.; Sung, W.-K. 2010: SLiM on Diet: finding short linear motifs on domain interaction interfaces in Protein Data Bank. Bioinformatics 26(8): 1036-1042

Messer, P.W. 2013: SLiM: simulating evolution with selection and linkage. Genetics 194(4): 1037-1039

Edwards, R.J.; Davey, N.E.; Shields, D.C. 2007: SLiMFinder: a probabilistic method for identifying over-represented, convergently evolved, short linear motifs in proteins. Plos one 2(10): E967

Davey, N.E.; Haslam, N.J.; Shields, D.C.; Edwards, R.J. 2010: SLiMFinder: a web server to find novel, significantly over-represented, short protein motifs. Nucleic Acids Research 38(Web Server Issue): W534-W539

Davey, N.E.; Cowan, J.L.; Shields, D.C.; Gibson, T.J.; Coldwell, M.J.; Edwards, R.J. 2012: SLiMPrints: conservation-based discovery of functional motif fingerprints in intrinsically disordered protein regions. Nucleic Acids Research 40(21): 10628-10641

O'Brien, K.T.; Haslam, N.J.; Shields, D.C. 2013: SLiMScape: a protein short linear motif analysis plugin for Cytoscape. Bmc Bioinformatics 14: 224

Davey, N.E.; Haslam, N.J.; Shields, D.C.; Edwards, R.J. 2011: SLiMSearch 2.0: biological context for short linear motifs in proteins. Nucleic Acids Research 39(Web Server Issue): W56-W60

Kohlwein, S.D.; Petschnigg, J. 2007: SLipid-induced cell dysfunction and cell death: lessons from yeast. Current Hypertension Reports 9(6): 455-461

Ryngajllo, M.; Childs, L.; Lohse, M.; Giorgi, F.M.; Lude, A.; Selbig, J.; Usadel, B.ör. 2011: SLocX: Predicting Subcellular Localization of Arabidopsis Proteins Leveraging Gene Expression Data. Frontiers in Plant Science 2: 43

Castelvecchi, D. 2010: SLook, ma--no junctions. Scientific American 302(6): 26

Schmitt, F.; Schäll, D.; Bucher, K.; Schindler, T.I.; Hector, A.; Biedermann, T.; Zemlin, M.; Hartl, D.; Beer-Hammer, S. 2015: SLy2 controls the antibody response to pneumococcal vaccine through an IL-5Rα-dependent mechanism in B-1 cells. European Journal of Immunology 45(1): 60-70

Brandt, S.; Ellwanger, K.; Beuter-Gunia, C.; Schuster, M.; Hausser, A.; Schmitz, I.; Beer-Hammer, S. 2010: SLy2 targets the nuclear SAP30/HDAC1 complex. International Journal of Biochemistry and Cell Biology 42(9): 1472-1481

Lobingier, B.T.; Nickerson, D.P.; Lo, S.-Y.; Merz, A.J. 2014: SM proteins Sly1 and Vps33 co-assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18. Elife 3: E02272

Lu, J.; Bai, L.; Sun, H.; Nikolovska-Coleska, Z.; McEachern, D.; Qiu, S.; Miller, R.S.; Yi, H.; Shangary, S.; Sun, Y.; Meagher, J.L.; Stuckey, J.A.; Wang, S. 2008: SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Research 68(22): 9384-9393

Nariai, T.; Fujita, K.; Mori, M.; Katayama, S.; Hori, S.; Matsui, K. 2012: SM-368229, a novel promising mineralocorticoid receptor antagonist, shows antihypertensive efficacy with minimal effect on serum potassium level in rats. Journal of Cardiovascular Pharmacology 59(5): 458-464

Nariai, T.; Fujita, K.; Mori, M.; Katayama, S.; Hori, S.; Matsui, K. 2011: SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity. Journal of Pharmacological Sciences 115(3): 346-353

Chi, M.; Zhou, Y.; Sopariwala, D.; Periasamy, M. 2011: SM2(+/-) male mice are predisposed to develop urinary tract obstruction and hyper contractility of the bladder smooth muscle upon ageing. Journal of Smooth Muscle Research 47(3-4): 67-78

Kim, T.R.; Moon, J.H.; Lee, H.M.; Cho, E.W.; Paik, S.G.; Kim, I.G. 2009: SM22alpha inhibits cell proliferation and protects against anticancer drugs and gamma-radiation in HepG2 cells: involvement of metallothioneins. Febs Letters 583(20): 3356-3362

El-Bizri, N.; Guignabert, C.; Wang, L.; Cheng, A.; Stankunas, K.; Chang, C.-P.; Mishina, Y.; Rabinovitch, M. 2008: SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis. Development 135(17): 2981-2991

Ogawa, A.; Sakatsume, M.; Wang, X.; Sakamaki, Y.; Tsubata, Y.; Alchi, B.; Kuroda, T.; Kawachi, H.; Narita, I.; Shimizu, F.; Gejyo, F. 2007: SM22alpha: the novel phenotype marker of injured glomerular epithelial cells in anti-glomerular basement membrane nephritis. Nephron. Experimental Nephrology 106(3): E77-E87

Kim, T.R.; Lee, H.M.; Lee, S.Y.; Kim, E.J.; Kim, K.C.; Paik, S.G.; Cho, E.W.; Kim, I.G. 2010: SM22α-induced activation of p16INK4a/retinoblastoma pathway promotes cellular senescence caused by a subclinical dose of γ-radiation and doxorubicin in HepG2 cells. Biochemical and Biophysical Research Communications 400(1): 100-105

Friedrich, A.; Garnier, N.; Gagnière, N.; Nguyen, H.; Albou, L.-P.; Biancalana, V.ér.; Bettler, E.; Deléage, G.; Lecompte, O.; Muller, J.; Moras, D.; Mandel, J.-L.; Toursel, T.; Moulinier, L.; Poch, O. 2010: SM2PH-db: an interactive system for the integrated analysis of phenotypic consequences of missense mutations in proteins involved in human genetic diseases. Human Mutation 31(2): 127-135

Ma, X.; Cheng, Z.; Jin, Y.; Liang, X.; Yang, X.; Dai, Z.; Tian, J. 2014: SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy. Biomaterials 35(9): 2878-2889

Hou, L.-F.; He, S.-J.; Li, X.; Wan, C.-P.; Yang, Y.; Zhang, X.-H.; He, P.-L.; Zhou, Y.; Zhu, F.-H.; Yang, Y.-F.; Li, Y.; Tang, W.; Zuo, J.-P. 2012: SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development. Plos one 7(2): E32424

Hou, L.-F.; He, S.-J.; Wang, J.-X.; Yang, Y.; Zhu, F.-H.; Zhou, Y.; He, P.-L.; Zhang, Y.; Yang, Y.-F.; Li, Y.; Tang, W.; Zuo, J.-P. 2009: SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo. International Immunopharmacology 9(13-14): 1509-1517

Swoboda, K.J.; Scott, C.B.; Crawford, T.O.; Simard, L.R.; Reyna, S.P.; Krosschell, K.J.; Acsadi, G.; Elsheik, B.; Schroth, M.K.; D'Anjou, G.; LaSalle, B.; Prior, T.W.; Sorenson, S.L.; Maczulski, J.A.; Bromberg, M.B.; Chan, G.M.; Kissel, J.T. 2010: SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. Plos one 5(8): E12140

Kissel, J.T.; Scott, C.B.; Reyna, S.P.; Crawford, T.O.; Simard, L.R.; Krosschell, K.J.; Acsadi, G.; Elsheik, B.; Schroth, M.K.; D'Anjou, G.; LaSalle, B.; Prior, T.W.; Sorenson, S.; Maczulski, J.A.; Bromberg, M.B.; Chan, G.M.; Swoboda, K.J. 2011: Sma Carnival Trial Part Ii: a Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy. Plos one 6(7): E21296

Kim, S.; Kim, Y.Seok.; Min, Y-Don. 2014: SMA Syndrome Treated by Single Incision Laparoscopic Duodenojejunostomy. Clinical Medicine Insights. Case Reports 7: 87-89

Anonymous 1975: SMA acts to preserve public confidence in anesthesia and medicine generally. Canadian Medical Association Journal 113(6): 587

MacDonald, W.K.; Hamilton, D.; Kuhle, S. 2014: SMA carrier testing: a meta-analysis of differences in test performance by ethnic group. Prenatal Diagnosis 34(12): 1219-1226

Kekou, K.; Sofocleous, C.; Konstantinidis, G.; Fryssira, H.; Mavrou, A.; Kitsiou, S.; Kanavakis, E. 2015: SMA prenatal diagnosis: a modified protocol to help differentiation between deletions and gene conversion. Molecular and Cellular Probes 29(1): 71-73

Kissel, J.T.; Elsheikh, B.; King, W.M.; Freimer, M.; Scott, C.B.; Kolb, S.J.; Reyna, S.P.; Crawford, T.O.; Simard, L.R.; Krosschell, K.J.; Acsadi, G.; Schroth, M.K.; D'Anjou, G.; LaSalle, B.; Prior, T.W.; Sorenson, S.; Maczulski, J.A.; Swoboda, K.J. 2014: SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy. Muscle and Nerve 49(2): 187-192

Kayadjanian, N.; Burghes, A.; Finkel, R.S.; Mercuri, E.; Rouault, F.; Schwersenz, I.; Talbot, K. 2013: SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe. Orphanet Journal of Rare Diseases 8: 44

Kobayashi, D.T.; Shi, J.; Stephen, L.; Ballard, K.L.; Dewey, R.; Mapes, J.; Chung, B.; McCarthy, K.; Swoboda, K.J.; Crawford, T.O.; Li, R.; Plasterer, T.; Joyce, C.; Chung, W.K.; Kaufmann, P.; Darras, B.T.; Finkel, R.S.; Sproule, D.M.; Martens, W.B.; McDermott, M.P.; De Vivo, D.C.; Walker, M.G.; Chen, K.S.; Acsadi, G.; Campbell, C.; Coates, A.; Connolly, A.M.; Crawford, T.O.; Darras, B.T.; Finkel, R.S.; Iannaccone, S.T.; Kaufmann, P.; Khongkhatithum, C.; Kissel, J.T.; Kolb, S.J.; Kunz, N.L.; Makris, C.; Mathews, K.D.; Matthews, D.; Schroth, M.K.; Swoboda, K.J.; Vajsar, J.; Wang, C.H.; Wong, B.L.; Sahin, M.; Antiel, L.; Florence, J.; Gee, R.; Glanzman, A.M.; Hartman, J.; King, W.; Krosschell, K.; Laubenthal, K.; McGuire, M.; Montes, J.; Nels 2013: SMA-MAP: a plasma protein panel for spinal muscular atrophy. Plos one 8(4): E60113

Praveen, K.; Wen, Y.; Gray, K.M.; Noto, J.J.; Patlolla, A.R.; Van Duyne, G.D.; Matera, A.G. 2014: SMA-causing missense mutations in survival motor neuron (Smn) display a wide range of phenotypes when modeled in Drosophila. Plos Genetics 10(8): E1004489

Fang, J.; Iyer, A.K.; Seki, T.; Nakamura, H.; Greish, K.; Maeda, H. 2009: SMA-copolymer conjugate of AHPP: a polymeric inhibitor of xanthine oxidase with potential antihypertensive effect. Journal of Controlled Release: Official Journal of the Controlled Release Society 135(3): 211-217

Rettinger, E.; Glatthaar, A.; Abhari, B.A.; Oelsner, S.; Pfirrmann, V.; Huenecke, S.; Kuçi, S.; Kreyenberg, H.; Willasch, A.M.; Klingebiel, T.; Fulda, S.; Bader, P. 2014: SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: a Potential Challenge for Combination Therapy. Frontiers in Pediatrics 2: 75

Greer, R.M.; Peyton, M.; Larsen, J.E.; Girard, L.; Xie, Y.; Gazdar, A.F.; Harran, P.; Wang, L.; Brekken, R.A.; Wang, X.; Minna, J.D. 2011: SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Cancer Research 71(24): 7640-7648

Müller-Sienerth, N.; Dietz, L.; Holtz, P.; Kapp, M.; Grigoleit, G.öt.U.; Schmuck, C.; Wajant, H.; Siegmund, D. 2011: SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells. Plos one 6(6): E21556

Pan, Q.; Huang, Y.; Chen, L.; Gu, J.; Zhou, X. 2014: SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC. Human Cell 27(4): 162-171

Tews, D.S.; Behrhof, W.; Schindler, S. 2008: SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins. Applied Immunohistochemistry and Molecular Morphology: Aimm 16(1): 66-70

Haque, R.; Nazir, A. 2016: SMAD Transcription Factor, Sma-9, Attunes TGF-β Signaling Cascade Towards Modulating Amyloid Beta Aggregation and Associated Outcome in Transgenic C. elegans. Molecular Neurobiology 53(1): 109-119

Witkowska, M.; Smolewski, P. 2014: SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases. Postepy Higieny i Medycyny Doswiadczalnej 68: 301-309

O'Kane, D.; Jackson, M.V.; Kissenpfennig, A.; Spence, S.; Damkat-Thomas, L.; Tolland, J.P.; Smyth, A.E.; Denton, C.P.; Stuart Elborn, J.; McAuley, D.F.; O'Kane, C.M. 2014: SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro. Experimental Dermatology 23(7): 497-503

Stettner, M.R.; Nance, J.A.; Wright, C.A.; Kinoshita, Y.; Kim, W.-K.; Morgello, S.; Rappaport, J.; Khalili, K.; Gordon, J.; Johnson, E.M. 2009: SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. Journal of General Virology 90(Part 8): 2005-2014

Goldstein, J.A.; Kelly, S.M.; LoPresti, P.P.; Heydemann, A.; Earley, J.U.; Ferguson, E.L.; Wolf, M.J.; McNally, E.M. 2011: SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy. Human Molecular Genetics 20(5): 894-904

Khurana, S.; Melacarne, A.; Yadak, R.; Schouteden, S.; Notelaers, T.; Pistoni, M.; Maes, C.; Verfaillie, C.M. 2014: SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors. Stem Cells 32(11): 3012-3022

Guzman, A.; Zelman-Femiak, M.; Boergermann, J.H.; Paschkowsky, S.; Kreuzaler, P.A.; Fratzl, P.; Harms, G.S.; Knaus, P. 2012: SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors. Journal of Biological Chemistry 287(47): 39492-39504

Rocher, C.; Singla, D.K. 2013: SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages. Plos one 8(12): E84009

Heger, J.; Peters, S.C.; Piper, H.-M.; Euler, G. 2009: SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes. Journal of Cellular Physiology 220(2): 515-523

Cabrera-Sharp, V.; Read, J.E.; Richardson, S.; Kowalski, A.A.; Antczak, D.F.; Cartwright, J.E.; Mukherjee, A.; de Mestre, A.M. 2014: SMAD1/5 signaling in the early equine placenta regulates trophoblast differentiation and chorionic gonadotropin secretion. Endocrinology 155(8): 3054-3064

Mahid, S.S.; Minor, K.S.; Brangers, B.C.; Cobbs, G.A.; Galandiuk, S. 2008: SMAD2 and the relationship of colorectal cancer to inflammatory bowel disease. International Journal of Biological Markers 23(3): 169-175

Nomura, M.; Zhu, H.-L.; Wang, L.; Morinaga, H.; Takayanagi, R.; Teramoto, N. 2014: SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity. Diabetologia 57(1): 157-166

Malhotra, N.; Robertson, E.; Kang, J. 2010: SMAD2 is essential for TGF beta-mediated Th17 cell generation. Journal of Biological Chemistry 285(38): 29044-29048

Fleming, N.I.; Jorissen, R.N.; Mouradov, D.; Christie, M.; Sakthianandeswaren, A.; Palmieri, M.; Day, F.; Li, S.; Tsui, C.; Lipton, L.; Desai, J.; Jones, I.T.; McLaughlin, S.; Ward, R.L.; Hawkins, N.J.; Ruszkiewicz, A.R.; Moore, J.; Zhu, H.-J.; Mariadason, J.M.; Burgess, A.W.; Busam, D.; Zhao, Q.; Strausberg, R.L.; Gibbs, P.; Sieber, O.M. 2013: SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Research 73(2): 725-735

Fortin, J.ér.ôm.; Bernard, D.J. 2010: SMAD3 and EGR1 physically and functionally interact in promoter-specific fashion. Cellular Signalling 22(6): 936-943

Otsuka, K.; Takeshita, S.; Enomoto, H.; Takahashi, T.; Hirota, T.; Tamari, M.; Ebe, K.; Otsuka, F.; Shibasaki, M.; Arinami, T.; Noguchi, E. 2009: SMAD3 as an atopic dermatitis susceptibility gene in the Japanese population. Journal of Dermatological Science 55(3): 200-202

Bollinger, L.M.; Witczak, C.A.; Houmard, J.A.; Brault, J.J. 2014: SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner. American Journal of Physiology. Cell Physiology 307(3): C278-C287

Uchiyama, Y.; Guttapalli, A.; Gajghate, S.; Mochida, J.; Shapiro, I.M.; Risbud, M.V. 2008: SMAD3 functions as a transcriptional repressor of acid-sensing ion channel 3 (ASIC3) in nucleus pulposus cells of the intervertebral disc. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 23(10): 1619-1628

Fowler, S.A.; Ananthakrishnan, A.N.; Gardet, A.; Stevens, C.R.; Korzenik, J.R.; Sands, B.E.; Daly, M.J.; Xavier, R.J.; Yajnik, V. 2014: SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. Journal of Crohn's and Colitis 8(8): 845-851

Aref-Eshghi, E.; Zhang, Y.; Hart, D.; Valdes, A.M.; Furey, A.; Martin, G.; Sun, G.; Rahman, P.; Arden, N.; Spector, T.D.; Zhai, G. 2014: SMAD3 is associated with the total burden of radiographic osteoarthritis: the Chingford study. Plos one 9(5): E97786

Giroux, M.; Delisle, J-Sébastien.; Gauthier, S-David.; Heinonen, K.M.; Hinsinger, J.; Houde, B.; Gaboury, L.; Brochu, S.; Wu, J.; Hébert, M-Josée.; Perreault, C. 2011: SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage. Blood 117(5): 1734-1744

García-Bermúdez, M.; López-Mejías, R.; Genre, F.; Castañeda, S.; González-Juanatey, C.; Llorca, J.; Corrales, A.; Miranda-Filloy, J.é A.; Rueda-Gotor, J.; Gómez-Vaquero, C.; Rodríguez-Rodríguez, L.; Fernández-Gutiérrez, B.ín.; Pascual-Salcedo, D.; Balsa, A.; López-Longo, F.J.; Carreira, P.; Blanco, R.; González-Álvaro, I.; Martín, J.; González-Gay, M.A. 2013: SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients. Plos one 8(10): E77695

López-Gómez, M.; Moreno-Rubio, J.; Suárez-García, I.; Cejas, P.; Madero, R.; Casado, E.; Jiménez, A.; Sereno, M.; Gómez-Raposo, C.; Zambrana, F.; Merino, M.; Fernández-Luengas, D.; Feliu, J. 2015: SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 17(2): 133-138

Blackford, A.; Serrano, O.K.; Wolfgang, C.L.; Parmigiani, G.; Jones, S.ân.; Zhang, X.; Parsons, D.W.; Lin, J.C.-H.; Leary, R.J.; Eshleman, J.R.; Goggins, M.; Jaffee, E.M.; Iacobuzio-Donahue, C.A.; Maitra, A.; Cameron, J.L.; Olino, K.; Schulick, R.; Winter, J.; Herman, J.M.; Laheru, D.; Klein, A.P.; Vogelstein, B.; Kinzler, K.W.; Velculescu, V.E.; Hruban, R.H. 2009: SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15(14): 4674-4679

Xu, J.; Zhu, M.; Cai, H.-Q.; Zhang, K.; Duan, W.-W.; Wang, T.; Wang, L.; Wang, S.-S.; Ye, Y.; Ni, C.-H. 2010: SMAD4 gene polymorphisms and genetic susceptibility of coal work's pneumoconiosis. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 28(10): 766-771

Singh, P.; Srinivasan, R.; Wig, J.D. 2012: SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas 41(4): 541-546

Szigeti, R.; Pangas, S.A.; Nagy-Szakal, D.; Dowd, S.E.; Shulman, R.J.; Olive, A.P.; Popek, E.J.; Finegold, M.J.; Kellermayer, R. 2012: SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice. Annals of Clinical and Laboratory Science 42(4): 401-408

Langeveld, D.; van Hattem, W.A.; de Leng, W.W.J.; Morsink, F.H.; Ten Kate, F.J.W.; Giardiello, F.M.; Offerhaus, G.J.A.; Brosens, L.A.A. 2010: SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 16(16): 4126-4134

Perea, J.; García-Nebreda, M.; Hidalgo, M.; Urioste, M. 2010: SMAD4 in early onset colorectal cancer. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 12(9): 948

Liu, N.-n.; Xi, Y.; Callaghan, M.U.; Fribley, A.; Moore-Smith, L.; Zimmerman, J.W.; Pasche, B.; Zeng, Q.; Li, Y.-l. 2014: SMAD4 is a potential prognostic marker in human breast carcinomas. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(1): 641-650

Pan, H.; Ding, E.; Hu, M.; Lagoo, A.S.; Datto, M.B.; Lagoo-Deenadayalan, S.A. 2010: SMAD4 is required for development of maximal endotoxin tolerance. Journal of Immunology 184(10): 5502-5509

Chen, Y.-W.; Hsiao, P.-J.; Weng, C.-C.; Kuo, K.-K.; Kuo, T.-L.; Wu, D.-C.; Hung, W.-C.; Cheng, K.-H. 2014: SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. Bmc Cancer 14: 181

Pohl, M.; Radacz, Y.; Pawlik, N.; Schoeneck, A.; Baldus, S.E.; Munding, J.; Schmiegel, W.; Schwarte-Waldhoff, I.; Reinacher-Schick, A. 2010: SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. Anticancer Research 30(7): 2603-2613

Iyer, N.K.; Burke, C.A.; Leach, B.H.; Parambil, J.G. 2010: SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia. Thorax 65(8): 745-746

Andrabi, S.; Bekheirnia, M.R.; Robbins-Furman, P.; Lewis, R.A.; Prior, T.W.; Potocki, L. 2011: SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. American Journal of Medical Genetics. Part a 155a (5): 1165-1169

Sameer, A.S.; Siddiqi, M.A. 2011: SMAD4 promoter hypermethylation in Kashmiri colorectal cancer cases. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 17(4): 297

Kang, Y.'a.; Ling, J.; Suzuki, R.; Roife, D.; Chopin-Laly, X.; Truty, M.J.; Chatterjee, D.; Wang, H.; Thomas, R.M.; Katz, M.H.; Chiao, P.J.; Fleming, J.B. 2014: SMAD4 regulates cell motility through transcription of N-cadherin in human pancreatic ductal epithelium. Plos one 9(9): E107948

Jia, L.; Lee, H.S.; Wu, C.F.; Kundu, J.; Park, S.G.; Kim, R.N.; Wang, L.-H.; Erkin, Öz.ür.C.; Choi, J.-S.; Chae, S.W.; Yang, H.B.; Choi, Y.-L.; Shin, Y.K. 2014: SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner. Molecular Cancer Research: Mcr 12(12): 1779-1795

Sameer, A.S.; Chowdri, N.A.; Syeed, N.; Banday, M.Z.; Shah, Z.A.; Siddiqi, M.A. 2010: SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene. Bmc Cancer 10: 300

Thornley, J.A.; Trask, H.W.; Ringelberg, C.S.; Ridley, C.J.A.; Wang, S.; Sal-Lari, R.C.; Moore, J.H.; Korc, M.; Tomlinson, C.R. 2012: SMAD4-dependent polysome RNA recruitment in human pancreatic cancer cells. Molecular Carcinogenesis 51(10): 771-782

Li, J.; Huang, X.; Xu, X.; Mayo, J.; Bringas, P.; Jiang, R.; Wang, S.; Chai, Y. 2011: SMAD4-mediated WNT signaling controls the fate of cranial neural crest cells during tooth morphogenesis. Development 138(10): 1977-1989

Dempe, S.; Stroh-Dege, A.Y.; Schwarz, E.; Rommelaere, J.; Dinsart, C. 2010: SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV. International Journal of Cancer 126(12): 2914-2927

Jeon, H-Sung.; Dracheva, T.; Yang, S-Hoon.; Meerzaman, D.; Fukuoka, J.; Shakoori, A.; Shilo, K.; Travis, W.D.; Jen, J. 2008: SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. Cancer Research 68(23): 9686-9692

Loh, Y.H.; Mitrou, P.N.; Wood, A.; Luben, R.N.; McTaggart, A.; Khaw, K.-T.; Rodwell, S.A. 2011: SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Cancer Epidemiology 35(4): 369-374

Gao, Y.; Wen, H.; Wang, C.; Li, Q. 2013: SMAD7 antagonizes key TGFβ superfamily signaling in mouse granulosa cells in vitro. Reproduction 146(1): 1-11

Mleczko-Sanecka, K.; Casanovas, G.; Ragab, A.; Breitkopf, K.; Müller, A.; Boutros, M.; Dooley, S.; Hentze, M.W.; Muckenthaler, M.U. 2010: SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 115(13): 2657-2665

Hu, Y.; Sun, Z.; Zhang, A.; Zhang, J. 2014: SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(1): 695-699

Kirac, I.; Matošević, P.; Augustin, G.; Šimunović, I.; Hostić, V.; Župančić, S.; Hayward, C.; Antoljak, N.; Rudan, I.; Campbell, H.; Dunlop, M.G.; Velimir Vrdoljak, D.; Kovačević, D.; Zgaga, L. 2013: SMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population. Plos one 8(9): E74042

Luo, L.; Li, N.; Lv, N.; Huang, D. 2014: SMAD7: a timer of tumor progression targeting TGF-β signaling. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 35(9): 8379-8385

Fraser, D. 2007: SMAD7: at the interface of TGF-beta and proinflammatory signaling. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(5): 523-525

Treiber, T.; Meister, G. 2010: SMADs stimulate miRNA processing. Molecular Cell 39(3): 315-316

Rappold, E. 2007: SMAF, RAi and ICF--nursing assessment tools for home based care. Pflege 20(4): 205-210

Tompkins, W.J. 1984: SMAL/80 This new microcomputer language is great. So why isn't it selling like hotcakes?. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 3(1): 34-35

Wei, W.; Ning, L.-W.; Ye, Y.-N.; Li, S.-J.; Zhou, H.-Q.; Huang, J.; Guo, F.-B. 2014: SMAL: a Resource of Spontaneous Mutation Accumulation Lines. Molecular Biology and Evolution 31(5): 1302-1308

Duan, P.; Rao, Y.; Zeng, D.; Yang, Y.; Xu, R.; Zhang, B.; Dong, G.; Qian, Q.; Li, Y. 2014: SMALL GRAIN 1, which encodes a mitogen-activated protein kinase kinase 4, influences grain size in rice. Plant Journal: for Cell and Molecular Biology 77(4): 547-557

DeBELLE, J.E. 1946: Medical records are essential to sound medical practice. Canadian Hospital 23(10): 44

Erikson, C.A. 1946: New wing; function dictates modern layout. Modern Hospital 66(3): 63-66

Kubovy, J.; Boswell, T.D.; Vautier, G.; Arnold, M.M. 2018: Complete esophageal obstruction following endoscopic variceal ligation: a case report and literature review. Clinical and Experimental Gastroenterology 11: 165-168

Anonymous 1905: Small-Pox in the German Army: "new and Interesting Testimony.". British Medical Journal 2(2343): 1410-1411

Liu, Z.; Li, H.; Qiu, Z.; Zhang, S.-L.; Zhang, Z.-B. 2012: SMALL-hysteresis thin-film transistors achieved by facile dip-coating of nanotube/polymer composite. Advanced Materials 24(27): 3633-3638

DeBAKEY, M.E.; Simeone, F.A. 1946: Battle injuries of the arteries in World War Ii. Bulletin of the U.S. Army Medical DePartment. United States. Army. Medical DePartment 5: 295-300

Anonymous 1946: SMALLPOX at its lowest ebb in 1945. Statistical Bulletin 27(5): 8-10

Anonymous 1947: SMALLPOX can be wiped out. Statistical Bulletin 28(4): 5-7

Anonymous 1949: SMALLPOX cases at new low in 1948. Statistical Bulletin 30(6): 9

Zondek, B.; Rozin, S. 1949: The resorption and action of precipitates of steroid hormones especially estrone and progesterone. Harefuah 36(11): 123-128

Ren, J.; Xie, L.; Li, W.W.; Bourne, P.E. 2010: SMAP-WS: a parallel web service for structural proteome-wide ligand-binding site comparison. Nucleic Acids Research 38(Web Server Issue): W441-W444

Matsudaira, T.; Uchida, Y.; Tanabe, K.; Kon, S.; Watanabe, T.; Taguchi, T.; Arai, H. 2013: SMAP2 regulates retrograde transport from recycling endosomes to the Golgi. Plos one 8(7): E69145

Pavithra, L.; Mukherjee, S.; Sreenath, K.; Kar, S.; Sakaguchi, K.; Roy, S.; Chattopadhyay, S. 2009: SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. Journal of Molecular Biology 388(4): 691-702

Singh, S.; Sreenath, K.; Pavithra, L.; Roy, S.; Chattopadhyay, S. 2010: SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity. International Journal of Biochemistry and Cell Biology 42(7): 1105-1114

Loe-Mie, Y.; Lepagnol-Bestel, A.-M.; Maussion, G.; Doron-Faigenboim, A.; Imbeaud, S.; Delacroix, H.é; Aggerbeck, L.; Pupko, T.; Gorwood, P.; Simonneau, M.; Moalic, J.-M. 2010: SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Human Molecular Genetics 19(14): 2841-2857

Hasselblatt, M.; Nagel, I.; Oyen, F.; Bartelheim, K.; Russell, R.B.; Schüller, U.; Junckerstorff, R.; Rosenblum, M.; Alassiri, A.H.; Rossi, S.; Schmid, I.; Gottardo, N.G.; Toledano, H.; Viscardi, E.; Balbin, M.; Witkowski, L.; Lu, Q.; Betts, M.J.; Foulkes, W.D.; Siebert, R.; Frühwald, M.C.; Schneppenheim, R. 2014: SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis. Acta Neuropathologica 128(3): 453-456

Gigek, C.O.; Lisboa, L.C.F.; Leal, M.F.; Silva, P.N.O.; Lima, E.M.; Khayat, A.é S.; Assumpção, P.P.; Burbano, R.R.; Smith, M.d.A.C. 2011: SMARCA5 methylation and expression in gastric cancer. Cancer Investigation 29(2): 162-166

Bansbach, C.E.; Boerkoel, C.F.; Cortez, D. 2010: SMARCAL1 and replication stress: an explanation for SIOD?. Nucleus 1(3): 245-248

Baradaran-Heravi, A.; Raams, A.; Lubieniecka, J.; Cho, K.S.; DeHaai, K.A.; Basiratnia, M.; Mari, P.-O.; Xue, Y.; Rauth, M.; Olney, A.H.; Shago, M.; Choi, K.; Weksberg, R.A.; Nowaczyk, M.J.M.; Wang, W.; Jaspers, N.G.J.; Boerkoel, C.F. 2012: SMARCAL1 deficiency predisposes to non-Hodgkin lymphoma and hypersensitivity to genotoxic agents in vivo. American Journal of Medical Genetics. Part a 158a (9): 2204-2213

Zivicnjak, M.; Franke, D.; Zenker, M.; Hoyer, J.; Lücke, T.; Pape, L.; Ehrich, J.H.H. 2009: SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephrotic syndrome. Pediatric Research 65(5): 564-568

Bishop, J.A.; Antonescu, C.R.; Westra, W.H. 2014: SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. American Journal of Surgical Pathology 38(9): 1282-1289

Agaimy, A.; Rau, T.T.; Hartmann, A.; Stoehr, R. 2014: SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. American Journal of Surgical Pathology 38(7): 910-920

Rizzo, D.; Fréneaux, P.; Brisse, H.é; Louvrier, C.; Lequin, D.; Nicolas, A.é; Ranchère, D.; Verkarre, V.; Jouvet, A.; Dufour, C.; Edan, C.; Stéphan, J.-L.; Orbach, D.; Sarnacki, S.; Pierron, G.ël.; Parfait, B.éa.; Peuchmaur, M.; Delattre, O.; Bourdeaut, F. 2012: SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?. American Journal of Surgical Pathology 36(7): 964-972

Bahrami, A.; Lee, S.; Caradine, K.D.; Raimondi, S.C.; Folpe, A.L. 2014: SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor. Cancer Genetics 207(9): 437-440

Papp, G.ő; Krausz, T.; Stricker, T.P.; Szendrői, M.ós.; Sápi, Z.án. 2014: SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels. Genes Chromosomes and Cancer 53(2): 168-176

Sano, K.; Matsuda, K.; Yoichi, K. 2010: SMARCB1 gene with a 27-base pair (bp) deletion is not a mutation. Cancer Genetics and Cytogenetics 199(1): 65

Hulsebos, T.J.M.; Kenter, S.; Siebers-Renelt, U.; Hans, V.; Wesseling, P.; Flucke, U. 2014: SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis. American Journal of Surgical Pathology 38(3): 421-425

Hadfield, K.D.; Smith, M.J.; Trump, D.; Newman, W.G.; Evans, D.G. 2010: SMARCB1 mutations are not a common cause of multiple meningiomas. Journal of Medical Genetics 47(8): 567-568

Smith, M.J.; Wallace, A.J.; Bowers, N.L.; Eaton, H.; Evans, D.G.R. 2014: SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genetics 207(9): 373-378

Agaimy, A.; Koch, M.; Lell, M.; Semrau, S.; Dudek, W.; Wachter, D.L.; Knöll, A.; Iro, H.; Haller, F.; Hartmann, A. 2014: SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. American Journal of Surgical Pathology 38(9): 1274-1281

Russo, P.; Biegel, J.A. 2009: SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?. Pediatric Blood and Cancer 52(3): 312-313

Brenca, M.; Rossi, S.; Lorenzetto, E.; Piccinin, E.; Piccinin, S.; Rossi, F.M.; Giuliano, A.; Dei Tos, A.P.; Maestro, R.; Modena, P. 2013: SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ. Molecular Cancer Therapeutics 12(6): 1060-1072

Rousseau, G.; Noguchi, T.; Bourdon, V.; Sobol, H.; Olschwang, S. 2011: SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. Bmc Neurology 11: 9

Hulsebos, T.J.M.; Kenter, S.B.; Jakobs, M.E.; Baas, F.; Chong, B.; Delatycki, M.B. 2010: SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis. Clinical Genetics 77(1): 86-91

Gong, P.; Yang, Y.; Lei, W.; Feng, Y.; Li, S.; Peng, X.; Gong, Y. 2012: SMARCE1 Promotes chicken embryonic gonad development by regulating ER α and AR expression. Sexual Development: Genetics Molecular Biology Evolution Endocrinology Embryology and Pathology of Sex Determination and Differentiation 6(4): 178-187

Letunic, I.; Doerks, T.; Bork, P. 2009: SMART 6: recent updates and new developments. Nucleic Acids Research 37(Database Issue): D229-D232

Letunic, I.; Doerks, T.; Bork, P. 2012: SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Research 40(Database Issue): D302-D305

Hayward, K.S.; Barker, R.N.; Brauer, S.G.; Lloyd, D.; Horsley, S.A.; Carson, R.G. 2013: SMART Arm with outcome-triggered electrical stimulation: a pilot randomized clinical trial. Topics in Stroke Rehabilitation 20(4): 289-298

Kushida, C.A.; Nichols, D.A.; Holmes, T.H.; Miller, R.; Griffin, K.; Cardell, C.-Y.; Hyde, P.R.; Cohen, E.; Manber, R.; Walsh, J.K. 2015: SMART DOCS: a new patient-centered outcomes and coordinated-care management approach for the future practice of sleep medicine. Sleep 38(2): 315-326

Almirall, D.; Lizotte, D.J.; Murphy, S.A. 2012: SMART Design Issues and the Consideration of Opposing Outcomes: Discussion of "Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer" by by Wang, Rotnitzky, Lin, Millikan, and Thall. Journal of the American Statistical Association 107(498): 509-512

van't Hooft, I.; Norberg, A.Lindahl. 2010: SMART cognitive training combined with a parental coaching programme for three children treated for medulloblastoma. Neurorehabilitation 26(2): 105-113

Jagić, N.; Stamenković, D.; Toncev, S.; Petrović, D.; Miloradović, V.; Milicić, B. 2008: SMART control stents in femoropopliteal region. Vojnosanitetski Pregled 65(12): 871-875

Kidwell, K.M. 2014: SMART designs in cancer research: Past, present, and future. Clinical Trials 11(4): 445-456

Scherrer, J.F.; Balasubramanian, S.; Freedland, K.E.; Lustman, P.J. 2014: SMART designs in observational studies. Journal of General Internal Medicine 29(7): 986

Jackson, J.W.; Gagne, J.J. 2014: SMART designs in observational studies of opioid therapy duration. Journal of General Internal Medicine 29(3): 429-431

Maddaloni, E.; Pozzilli, P. 2014: SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes). Endocrine 46(1): 3-5

Chapman, K.R. 2010: SMART isn't. Journal of Allergy and Clinical Immunology 125(3): 609-610

Evans, C.E.L.; Greenwood, D.C.; Thomas, J.D.; Cleghorn, C.L.; Kitchen, M.S.; Cade, J.E. 2010: SMART lunch box intervention to improve the food and nutrient content of children's packed lunches: UK wide cluster randomised controlled trial. Journal of Epidemiology and Community Health 64(11): 970-976

Gleeson, L.; Alam, J.; Lane, S. 2012: SMART phones and the acute respiratory patient. Irish Medical Journal 105(5): 143-146

Kerklaan, J.P.; Lycklama á Nijeholt, G.J.; Wiggenraad, R.G.J.; Berghuis, B.; Postma, T.J.; Taphoorn, M.J.B. 2011: SMART syndrome: a late reversible complication after radiation therapy for brain tumours. Journal of Neurology 258(6): 1098-1104

Diniz, F.d.V.; Lopes, L.C.G.; Castro, L.H.M.; Nitrini, R.; Leite, C.d.C.; Lucato, L.T. 2013: SMART syndrome: a late reversible complication of radiotherapy. Arquivos de Neuro-Psiquiatria 71(5): 336-337

Sheehan, J. 2014: SMART syndrome: a reversible complication after radiation therapy and surgery for brain tumors. World Neurosurgery 82(1-2): E193-E194

Truntzer, P.; Monjour, A.; Gaultier, C.; Ahle, G.; Guillerme, F.; Boutenbat, G.; Stilhart, B.; Salze, P.; Atlani, D. 2012: SMART syndrome: case report of a rare complication after cerebral radiation therapy. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 16(4): 295-301

Burke, L.E.; Styn, M.A.; Glanz, K.; Ewing, L.J.; Elci, O.U.; Conroy, M.B.; Sereika, S.M.; Acharya, S.D.; Music, E.; Keating, A.L.; Sevick, M.A. 2009: SMART trial: a randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings. Contemporary Clinical Trials 30(6): 540-551

Van Es, J.M.; Visser, M.R.M.; Wieringa-De Waard, M. 2012: SMART, SMARTER, SMARTEST: the influence of peer groups compared to practice visits on the quality of action plans. Medical Teacher 34(8): E582-E588

Kumar, A.P.K.; Boualem, A.; Bhattacharya, A.; Parikh, S.; Desai, N.; Zambelli, A.; Leon, A.; Chatterjee, M.; Bendahmane, A. 2013: SMART--Sunflower Mutant population And Reverse genetic Tool for crop improvement. Bmc Plant Biology 13: 38

Curtis, D.W.; Pino, E.J.; Bailey, J.M.; Shih, E.I.; Waterman, J.; Vinterbo, S.A.; Stair, T.O.; Guttag, J.V.; Greenes, R.A.; Ohno-Machado, L. 2008: SMART--an integrated wireless system for monitoring unattended patients. Journal of the American Medical Informatics Association: Jamia 15(1): 44-53

Lechner, D. 1994: SMART-LiftSM. Work 4(3): 223-225

Shukla, M.; Wen, J.; White, K.S.; Aslin, R.N. 2011: SMART-T: a system for novel fully automated anticipatory eye-tracking paradigms. Behavior Research Methods 43(2): 384-398

Russo, T.; Parisi, A.; Garofalo, G.; Gristina, M.; Cataudella, S.; Fiorentino, F. 2014: SMART: a spatially explicit bio-economic model for assessing and managing demersal fisheries, with an application to italian trawlers in the strait of sicily. Plos one 9(1): E86222

Letunic, I.; Doerks, T.; Bork, P. 2015: SMART: recent updates, new developments and status in 2015. Nucleic Acids Research 43(Database Issue): D257-D260

Fa, R.; Roberts, D.J.; Nandi, A.K. 2014: SMART: unique splitting-while-merging framework for gene clustering. Plos one 9(4): E94141

Rydberg, P.; Gloriam, D.E.; Zaretzki, J.; Breneman, C.; Olsen, L. 2010: SMARTCyp: a 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism. Acs Medicinal Chemistry Letters 1(3): 96-100

Mougiakakou, S.G.; Bartsocas, C.S.; Bozas, E.; Chaniotakis, N.; Iliopoulou, D.; Kouris, I.; Pavlopoulos, S.; Prountzou, A.; Skevofilakas, M.; Tsoukalis, A.; Varotsis, K.; Vazeou, A.; Zarkogianni, K.; Nikita, K.S. 2010: SMARTDIAB: a communication and information technology approach for the intelligent monitoring, management and follow-up of type 1 diabetes patients. IEEE Transactions on Information Technology in Biomedicine: a Publication of the IEEE Engineering in Medicine and Biology Society 14(3): 622-633